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ABSTRACT OF THE DISSERTATION
Chemical damage to mRNA and its impact on ribosome quality-control and stress-response
pathways in eukaryotic cells
by
Liewei (Leo) Yan
Doctor of Philosophy in Biology and Biomedical Sciences
Plant and Microbial Biosciences
Washington University in St. Louis, 2021
Professor Hani S. Zaher, Chair
Ribosome often faces defective adducts that disrupt its movement along the mRNA template.
These adducts are primarily caused by chemical damage to mRNA and are highly detrimental to
the decoding process on the ribosome. Hence, unless dealt with, chemical damage to RNA has
been hypothesized to lead to the production of toxic protein products. Even more detrimental is
the ability of damaged mRNA to drastically affect ribosome homeostasis through stalling. This in
turn would lead to greatly diminished translation capacity of cells. Therefore, the inability of cells
to recognize and resolve translational-stalling events is detrimental to proteostasis and could even
lead to disease development. No-go decay (NGD) is a eukaryotic quality control mechanism that
evolved to cope with translational arrests. The process is characterized by an endonucleolytic
cleavage near the stall sequence, but the mechanistic details are unclear. It was, however, unclear
whether organisms evolved NGD to deal with RNA damage. In work presented in this thesis, I
showed that NGD and the associated ribosome-quality control (RQC) are activated in response to
nucleobase alkylation and oxidation. Our findings reveal that these processes are important for
clearing chemically modified mRNA and the resulting aberrant-protein products and highlighted
ix

the burden of chemically damaged mRNA on cellular homeostasis and suggest that organisms
evolved mechanisms to counter their accumulation.
In addition to activating RQC, stalling has been recently linked to the activation of the
integrated-stress response (ISR) by Gcn2, suggesting that the activation of the two processes are
likely to be coordinated. To investigate this potential coordination, I preformed genetic and
biochemical analysis in yeast. My data revealed that activation of RQC by Hel2 suppresses that of
Gcn2. I further showed that Hel2 and Gcn2 are activated by a similar set of agents that cause
ribosome stalling, with maximal activation of Hel2 observed at a lower frequency of stalling.
Interestingly, inactivation of one pathway was found to result in the overactivation of the other,
suggesting that both are activated by the same signal of ribosome collisions. Notably, the processes
do not appear to be in direct competition with each other; ISR prefers a vacant A site, whereas
RQC displays no preference. Collectively, our findings provide important details about how
multiple pathways that recognize stalled ribosomes coordinate to mount the appropriate response.
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CHAPTER 1: How do cells cope with RNA
damage and its consequences?
Liewei L. Yan and Hani S. Zaher
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ABSTRACT
Similar to many other biological molecules, RNA is vulnerable to chemical insults from
endogenous and exogenous sources. Noxious agents such as reactive oxygen species or
alkylating chemicals have the potential to profoundly affect the chemical properties and hence
the function of RNA molecules in the cell. Given the central role of RNA in many fundamental
biological processes, including translation and splicing, changes to its chemical composition can
have a detrimental impact on cellular fitness, with some evidence suggesting that RNA damage
has roles in diseases such as neurodegenerative disorders. We are only just beginning to learn
about how cells cope with RNA damage, with recent studies revealing the existence of qualitycontrol processes that are capable of recognizing and degrading or repairing damaged RNA.
Here, we begin by reviewing the most abundant types of chemical damage to RNA, including
oxidation and alkylation. Focusing on mRNA damage, we then discuss how alterations to this
species of RNA affect its function, and how cells respond to these challenges to maintain
proteostasis. Finally, we briefly discuss how chemical damage to noncoding RNAs such as
rRNA, tRNA, snRNA and snoRNA is likely to affect their function.
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INTRODUCTION
Biomolecules possess unique chemical properties that are essential for their function. Yet,
the overabundance of reactive species in both the environment and within living cells constantly
threaten these properties (Simms and Zaher, 2016; Wurtmann and Wolin, 2009). Unwanted
modifications to the chemical structure of nucleic acids, proteins, lipids or carbohydrates often
result in drastic effects on the ability of these molecules to carry out these functions. Changes to
proteins, for example, are known to cause misfolding and aggregation, and the inability of cells to
degrade these aberrant protein products has been associated with disease states (Chondrogianni et
al., 2014; Stefani, 2004). Similarly, lipid peroxidation contributes to the pathogenicity of several
diseases (Mylonas and Kouretas, 1999). Due to the reactivity of the oxygen and nitrogen atoms on
the nucleobase, nucleic acids are especially susceptible to certain types of chemical damage from
sources such as reactive oxygen species (ROS), ultraviolet light (UV), and alkylating agents
(Wurtmann and Wolin, 2009) (Figure 1A). The oxygen atoms of the ribose and the phosphodiester
backbone are also vulnerable to chemical damage (Figure 1B). In the case of DNA, and most RNA
species, small changes have the ability to severely affect their structure and hence their function
(Lindahl T, 1993). This is due to the fact that, by-and-large, nucleic acids require strict WatsonCrick base pairs between the nucleobases.
Since DNA damage can lead to permanent alteration of genomic information, it is not
surprising that organisms from E. coli to humans evolved exquisite and conserved pathways to
repair it and respond to it. Given their importance in maintaining genomic integrity together with
their role in cancer biology, DNA-repair pathways have been extensively studied for more than
half a century (Cheung-Ong et al., 2013; Fu et al., 2012; Miao et al., 2006). Similar to DNA, RNA
3

is vulnerable to the same chemical insults, and, as we shall see later, is damaged to a much larger
extent (Wurtmann and Wolin, 2009). However, until recently the processes by which cells might
cope with this type of damage was largely ignored likely due to the assumption that the transient
nature of RNA means that damage to it does not matter. This, for example, is true for bacteria,
whose mRNAs are known to turn over rapidly with half-lives measured in minutes (Deutscher,
2006; Ross, 1995). In contrast, functional RNAs like tRNAs and rRNAs are long lived (Deutscher,
2006; Johnson et al., 1976), and as a result any alteration to their chemical structure could have
long-lasting effects. Furthermore, many mRNAs in mammals, and especially in certain cell types
like neurons, are very stable with day-long half-lives (Bolognani and Perrone-Bizzozero, 2008).
Therefore, modifications to the mRNA that affect its base-pairing properties are likely to lead to
defects in protein synthesis. Unless cells have pathways to recognize and degrade/repair mRNAs,
chemical damage to mRNA is highly likely to result in the accumulation of aberrant protein
products and/or stall ribosomes. Indeed, emerging evidence strongly suggests that quality control
for damaged RNA is vital to cell survival and should not be ignored (Simms and Zaher, 2016;
Simms et al., 2014). To this end, the accumulation of damaged RNA has been correlated with the
development of several neurodegenerative diseases (Fimognari, 2015; Nunomura et al., 2007;
Simms and Zaher, 2016; Wurtmann and Wolin, 2009).
This review is divided into two main sections: the first one is focused on the chemistry of
different types of RNA damage, and how they affect its chemical and functional properties; the second is
focused on the cellular mechanisms that are likely to respond to damaged RNA. In particular, we discuss
ribosome-dependent and -independent mechanisms of quality control of damaged mRNA as well as
RNA-repair pathways.
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Figure 1. Effects of alkylation and oxidation on the chemical structure of RNA.
A) Structures of the four RNA nucleobases with the location of common oxidation sites (red
arrows) and alkylative damage sites (blue arrows) marked. B) Targets of chemical insults (mainly
alkylative damage) to the phosphodiester backbone and 2’-OH of the ribose. C) The reaction
between a hydroxyl radical and guanosine, forming the 8-oxoG adduct. D) The reaction between
MNNG and guanosine, which forms the O-alkyl adduct O6-mG (Top). The bottom shows the
reaction between MMS and adenosine forming the N-alkyl adduct m1A. E) Common modified
bases that result from chemical insults: Alkylative adducts, grouped by the position of
modification: O-alkyl adducts: O6-methylguanosine (O6-mG), O4-methyluridine (O4-mU); Nalkyl adducts: N1-methyladenosine (m1A), N3-methyladenosine (m3A), N3-methylcytidine
(m3C), N1-methylguanosine (m1G), N7-methylguanosine (m7G); Oxidative adducts: 8-oxo-7,8dihydroguanosine (8-oxoG), 8-oxo-7,8-dihydroadenosine (8-oxoA). F) Damaged nucleobases
disrupt base pairing. The base pairing between adenosine and uridine (top) is disrupted by the
formation of the alkylative adduct m1A (bottom).
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Chemistries of RNA damage
Reactive oxygen species. The highly-reactive-superoxide anion (O2•−) is a key component of ROS
and is produced in eukaryotes under normal physiological conditions by a number of cytosolic
enzymes and membrane-bound ones (Sohal and Weindruch, 1996). It is essential for stress
responses, maintenance of the redox state, inflammation, autophagy and signal transduction
(Schieber and Chandel, 2014). However, the levels of O2•− need to be carefully monitored as high
levels of superoxide are known to cause cellular damage and even death (Fimognari, 2015). High
levels of O2•− are produced through side reactions between molecular oxygen (O 2) and reduced
nicotinamide adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH 2) in the
electron-transport chain in the mitochondria (Murphy, 2009). Thus, the mitochondria, and hence
cellular respiration, are considered as the major endogenous source of ROS production, including
both O2•− and hydrogen peroxide (H2O2). In addition to the mitochondria, recent studies on humanliver cells reported that other organelles such as peroxisomes, microsomes and the endoplasmic
reticulum are also capable of producing high levels of ROS (Brown and Borutaite, 2012; CasasGrajales and Muriel, 2017).
The highly reactive nature of O2•− makes it exceptionally harmful because as it reacts, it
generates even more ROS such as hydroxyl radical ( •OH), perhydroxyl radical (HO2•) and
hydrogen peroxide H2O2 (Lü et al., 2010). Due to their ability to severely disrupt the integrity of
biological molecules, organisms evolved multiple pathways to rid cells of ROS (Imlay, 2008).
These include superoxide dismutase, which catalyzes the dismutation of O 2•− into molecular
oxygen and hydrogen peroxide (Fukai and Ushio-Fukai, 2011), and catalase, which catalyzes the
decomposition of hydrogen peroxide to water and molecular oxygen (Zámocký and Koller, 1999).
6

Even with the presence of these mechanisms, disruption of the normal redox state of cells by
exposure to oxidative agents or aging often leads to the accumulation of free radicals and peroxides
resulting from an imbalance between the production and detoxification of ROS (Hopkins and
Neumann, 2019). Under these conditions, pathways such as Haber-Weiss, the Fenton reaction, or
diethylnitrosamine (DEN) metabolism generate the highly reactive •OH radical (Kehrer, 2000).
Reactions with •OH have been suggested to be the main source of oxidative damage to nucleic
acids. Besides •OH, H2O2 is known to elicit damage (Imlay et al., 1988); while singlet-oxygen
species (1O2), which are produced by wounding or photooxidative stresses, oxidize both RNA and
DNA (Neeley and Essigmann, 2006). In addition to these endogenous sources, exogenous factors
including X- and gamma-rays, ultraviolet radiation and toxic compounds from air pollution,
tobacco and xenobiotics such as drugs, environmental agents and natural compounds are known
to generate ROS (Cadet and Wagner, 2013).
Oxidation adducts. The reaction of •OH with free nucleobases, nucleosides, nucleotides and
nucleic acids abstracts H from C⎯H bonds (Dizdaroglu and Jaruga, 2012; Fimognari, 2015). This
results in the production of numerous distinct modifications on nucleic acids such as 8-oxo-7,8dihydroguanosine

(8-oxoG)

(Figure

1C),

8-oxo-7,8-dihydroadenosine

(8-oxoA),

5-

hydroxyuridine (5-HO-U), 5-hydroxycytidine (5-HO-C), and cytosine glycol (Casas-Grajales and
Muriel, 2017; Dizdaroglu and Jaruga, 2012; Fimognari, 2015). Furthermore, products such as 2,6diamino-4-hydroxy-5-formamidoguanine

(FapyG)

and

4,6-diamino-5-formamidoadenine

(FapyA) are also formed as intermediates during the process of generating 8-oxoG and 8-oxoA
(Gajewski et al., 1990; Simms and Zaher, 2016). Oxidation of other cellular components such as
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lipid peroxidation is also known to introduce oxidative damage to the nucleobase and generate
etheno-adducts 1,N6-ethenoadenosine (-rA) and 3,N4-ethenocytidine (-rC ) (Blair, 2008).
Of the oxidized adducts, oxidation of the guanine base to form 8-oxoG is most notable
mainly because of its abundance and its effect on the structure of DNA and RNA. The
accumulation of 8-oxoG in RNA and DNA is driven by the low reduction potential of G among
all 5 bases (Casas-Grajales and Muriel, 2017; Simms and Zaher, 2016). Under normal
physiological conditions, the frequency of 8-oxoG in RNA has been estimated to be 1 per 105 of
unmodified G (Shen et al., 2000). This ratio increases dramatically, as much as 10 fold, under only
mild oxidative stress such as that experienced during conditions of inflammation (Shen et al., 2000;
VALAVANIDIS et al., 2009). In addition to its abundance, the modification has a profound effect
on the structure of the nucleotide and its ability to form a Watson-Crick base pair. The steric clash
between the oxygen at carbon 8 and the phosphate group at carbon 5 forces the nucleotide to form
the less favorable syn conformation (Sampoli Benítez et al., 2013). In this conformation, 8-oxoG
base pairs with A and is the basis of its mutagenic potential during DNA replication (Hsu et al.,
2004; Sampoli Benítez et al., 2013). As we shall see later, 8-oxoG severely disrupts RNA-RNA
interactions and has a drastic effect on decoding during translation.
Alkylating agents. Similar to oxidizing agents, alkylating chemicals are widespread; they are
found endogenously, as a result of cellular metabolism, and exogenously in the environment
(Drabløs et al., 2004). Endogenous alkylating agents include the universal-methyl donor Sadenosyl methionine (SAM), nitrosated amines and bile acids. SAM is notable due to its relatively
high cellular concentration, in the mM range (Hoffman et al., 1980), which overcomes its weak
nonenzymatic reactivity with biomolecules. In vitro, SAM reacts with nucleic acids to form a
8

number of adducts (Rydberg and Lindahl, 1982). In contrast to SAM, nitrosated amines and bile
acids result from enzymatic-side reactions (García-Santos et al., 2001). In starving bacterial cells,
nitrosation of glycine and its derivatives forms N-alkyl-N-nitroso compounds which readily react
with G to form O6-methylguanosine (O6-mG) (Shuker and Margison, 1997; Taverna and
Sedgwick, 1996) (Figure 1D). In the intestine, nitrosation of bile acids forms highly reactive Oalkylating agents and has been associated with elevated levels of methylated bases (Acid et al.,
1985).
Among environmental alkylating chemicals, halogenated hydrocarbons are the most
abundant. For example, chloromethane is produced naturally by plants and fungi, and artificially
through industrial processes (Gribble, 1994; Hamilton, 2003; McCulloch et al., 1999). In contrast
to chloromethane, which is found predominantly in the atmosphere, bromomethane and
iodomethane are mainly found in marine environments (Ballschmiter, 2003). These compounds
readily react with nucleic acids (Bolt and Gansewendt, 1993), but their contribution to RNA
damage is unknown given their overall low concentrations. Unlike halocarbons, N-nitroso
compounds are not abundant in the environment, but they pose the most significant risk to humans
because of their association with tobacco smoke and certain food compounds. Tobacco smoke
contains many nitrosamines, which when metabolized by cells are activated to form potent
alkylating agents (Hecht, 1999). Food products- especially those that are overcooked, smoked and
cured- contain nitrosoamines and nitrosating agents that are carcinogenic through their mutagenic
effect on DNA (Song et al., 2015). Finally, some of the most well-known alkylating agents are
those used as chemotherapeutic agents and their reactivity with nucleic acids is the precise reason
they are used to treat cancers (Hurley, 2002). These include cyclophosphamide, streptozotocin,
9

and Temodar, which are all known to modify RNA in addition to DNA (Bellacosa and Moss,
2003). The efficacy of many of these drugs in treating cancer to a large extent relies on their ability
to modify RNA and alter its function.
Alkylative adducts. Nucleobases, sugars and the phosphate backbone of DNA and RNA harbor
oxygen and nitrogen atoms that are all susceptible to modification by alkylating agents. In general,
O-alkyl adducts are highly mutagenic and genotoxic (Margison et al., 2002) because they alter the
base-pairing preference of the nucleobase. This is best exemplified by O6-alkylguanosine (O6AlkylG), such as O6-mG, and O4-alkylthymidine or O4-alkyluridine, such as O4-mU. O6-mG
readily base pairs with U, whereas O4-mU readily base pairs with G (Eadie et al., 1984; Preston
et al., 1986) (Figure 1E). The geometry of both base pairs is indistinguishable from that of
Watson-Crick ones explaining their highly mutagenic nature (Warren et al., 2006). N-alkylation,
in contrast, is generally cytotoxic because it disrupts base pairing during template-driven
processes. Cytotoxic modifications include N1- and N3-alkyl adducts of A (e.g: m1A and m3A),
and N3-alkyl adducts of C (e.g: m3C). These modifications alter either: the Watson-Crick face of
the nucleobase and introduce a bulky group, which prevents base-pairing from taking place; or the
minor groove, which disrupts the mechanism by which polymerases and likely the ribosome
monitor the base-pair geometry (Figure 1F). Interestingly one of the most prevalent modifications
that results from alkylation stress is m7G (Figure 1E), which neither disrupts hydrogen bonding
required for base pairing nor the minor groove of the base pair (Soll et al., 2017). However, this
modification affects binding of proteins that recognize the major groove of helices (Ezaz-Nikpay
and Verdine, 1994), and also accelerates the depurination of the nucleotide (Boysen et al., 2009).
As such, m7G is likely to be detrimental to RNA function.
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It is also worth noting that the chemotherapeutic drugs of doxorubicin, 5-fluorouracil and
cisplatin do not alkylate RNA directly but modify RNA through their reactions. This reactivity
with RNA appears to be important for their effectiveness in treating cancer. Doxorubicin
intercalates into RNA helices, which affects the activity of many functional RNAs (Zhu et al.,
1999). 5-fluorouracil is metabolized by the cell into a nucleotide triphosphate that is utilized by
RNA polymerases and, as a result, is incorporated into RNA (Pettersen et al., 2011). Cisplatin
forms cross-links on the ribosome and inhibits translation (Heminger et al., 1997). Recent
structural studies of cisplatin-induced Pt-RNA adducts on the ribosome offered some clues about
how the drug inhibits translation (Melnikov et al., 2016). Many of the sites on the ribosome that
are modified by cisplatin encompass functionally important regions that include the GTPase center
and the mRNA channel of the ribosome. Therefore, not only is RNA damage likely to pose
significant challenges to organisms, but it can also be utilized to treat tumors.

Susceptibility of RNA to damage
Although RNA undergoes analogous biochemical reactions to those documented to occur
between DNA and ROS or alkylating agents (Simms and Zaher, 2016), it has been long predicted
that RNA molecules, especially mRNAs, are more prone to chemical damage than DNA for
various reasons. 1) mRNA is on average 30-40% single-stranded; as a result the nucleobase on
RNA is more vulnerable to chemical modification due to its unprotected Watson-Crick face. In
DNA, this is protected because it participates in hydrogen-bonding with the complementary strand
(Cobley et al., 2018; Hofer et al., 2005; Jr et al., 2003). 2) In eukaryotic cells, unlike DNA, mRNA
typically lacks the protection afforded by proteins such as histones (Cobley et al., 2018; Simms
and Zaher, 2016). 3) The nuclear compartmentation in eukaryotic cells also offers protection of
11

DNA from exogenous agents that have to travel through the cytoplasm to access it (Cobley et al.,
2018; Simms and Zaher, 2016); in fact, the close proximity of RNA to mitochondria in the cytosol
has been proposed as a potential source of oxidative damage to the RNA pool (Nunomura et al.,
1999). 4) the pool size of ribonucleotides is hundreds of times larger than that of 2’dexoyribonucleotides (Traut, 1994), and as a result modifications are more likely to get
incorporated into RNA during transcription relative to DNA incorporation during replication; to
this end, oxidized and alkylated NTPs have been measured to accumulate to much higher levels
relative to modified dNTPs (Fiala et al., 1989; Hofer et al., 2006; Nunomura et al., 1999).
In support of these predictions, findings from numerous reports have revealed that the same
damage to a nucleobase accumulates to much higher levels in RNA relative to DNA under both
oxidative and alkylative conditions (Cobley et al., 2018; Hofer et al., 2005). For instance, a recent
study showed that human lung epithelial cells accumulate the oxidative adduct 8-oxoG to levels
that are 14-25 times higher than 8-oxodG when challenged with hydrogen peroxide (Hofer et al.,
2005). Similarly, UV-A radiation induces approximately a seven-fold higher degree of RNA
oxidation over DNA in human skin fibroblast cells, while the hepatocarcinogen 2-nitropropane
leads to considerably more RNA oxidation over DNA (Fiala et al., 1989; Wamer and Wei, 1997).
Among the different types of RNA species, the degree to which they associate with proteins
and their secondary structure appear to be important for the extent a certain RNA is vulnerable to
chemical damage (Görg et al., 2008). As a-case-in point, a recent report indicates that mRNA
harbors fivefold higher 8-oxoG levels when compared to total RNA, which consists mainly of
rRNA and tRNA that adopt complex tertiary structures and are bound by proteins (Simms et al.,
2014). Interestingly, even among mRNAs and within an mRNA itself, the extent of damage varies
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significantly. Certain transcripts and regions within them appear to be more vulnerable to oxidative
damage than others, in an abundance-independent manner (Chang et al., 2008; McKinlay et al.,
2012; Shan et al., 2003a). Many factors have been speculated to contribute to these differences
(Núñez et al., 1999). For instance, sequence identity and context play important roles, especially
given that the oxidation of guanosine relies heavily on the neighboring nucleotides (Núñez et al.,
1999). Additionally, the level of association with RNA-binding proteins, translation efficiency and
secondary-structural differences affect the reactivity between the mRNA and damaging agents
(Simms and Zaher, 2016).
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Figure 2. Chemical damage to RNA could affect multiple steps of translation.
At the center is a schematic highlighting a eukaryotic mRNA being translated. Damage might alter
the structure of the rRNA, the tRNA and the mRNA. On the rRNA, modifications could affect
important functional sites of the ribosome. Shown are the peptidyl-transferase center (PTC), the
GTPase activation center (GAC) and the decoding center (DC). On the tRNA, modifications to the
anticodon and acceptor stem, for example, could affect decoding and aminoacylation, respectively.
On the mRNA, modifications to the coding sequence could affect the speed and accuracy of
translation during elongation.
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Damaged mRNA and the ribosome
A priori, chemical modification to the mRNA could have three distinct effects on its
function during translation (Figure 2): 1) Modifications that do not alter base pairing between the
codon and anticodon interaction are expected to have no effect on protein synthesis. 2)
Modifications that change the base-pairing preference of nucleotides are expected to result in
miscoding and production of proteins with errors. 3) Modification that disrupts base-pairing
altogether are expected to stall the ribosome and lead to the production of abortive protein
products. Obviously the latter two are detrimental to proteostasis and potentially necessitates the
evolution of pathways to cope with them. This is especially true for the last one, which in addition
to producing truncated protein products sequesters valuable ribosomes and prevents them from
carrying out their function (Figure 2).
Although one could learn a lot about how modifications to the nucleobase affect translation
from equivalent studies conducted on DNA polymerases, the fact that the ribosome reads three
nucleotides at a time makes the decoding process somewhat different from replication.
Furthermore, the RNA-rich decoding center and the mechanism by which it recognizes the codonanticodon minihelix is quite different from the active site of polymerases, which is made entirely
of amino acids (Zaher and Green, 2009). These distinctions between the ribosome and DNA
polymerases are best exemplified by studies characterizing the effect of 8-oxoG on translation.
During DNA replication, the oxidative adduct 8-oxoG is highly mutagenic, when it adopts a syn
conformation and base pairs with A (Hsu et al., 2004). During translation, the modification stalls
translation and causes little to no miscoding (Simms et al., 2014). Indeed, initial studies by Shan
et al. found that the yield of protein synthesis from RNAs containing 8-oxoG is significantly lower
than from those that do not harbor the modification (Shan et al., 2007). RNAs treated with
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hydrogen peroxide and transfected into cell culture produce significantly less functional proteins
in a transcript-level-independent manner (Shan et al., 2003b). These observations suggest that
oxidation of mRNA disrupts protein synthesis and likely stalls elongation by the ribosome.
Consistent with these ideas, studies by Tanaka et al. showed that oxidized mRNAs associate with
polysomes but produce much less protein products (Tanaka et al., 2007). Since RNA oxidation
results in a myriad of modifications, it is difficult to assess which one of these modifications is
responsible for stalling the ribosome. Later studies by our group showed that 8-oxoG reduces the
rate of peptide-bond formation by up to four orders of magnitude using a well-defined in vitro
system (Simms et al., 2014). Interestingly, this effect on decoding is independent of the position
of the adduct in the codon. In particular, the third position, which allows for unusual base pairing
between the codon and the anticodon, is equally sensitive to the presence of the modification.
Based on these observations from multiple groups, it is now generally accepted that 8-oxoGcontrary to its effect during DNA replication- does not cause miscoding, but instead is highly
disruptive to translation and leads to the generation of truncated protein products.
In contrast to RNA oxidation, which has been investigated by a number of groups, only a
couple of studies have explored the effect of alkylation damage to mRNA on translation. In one
study from our group, we examined the effect of O6-mG on decoding using a bacterial
reconstituted system (Hudson and Zaher, 2015). This adduct is notable as it is highly mutagenic
during DNA replication, whereby the O6-mG:T base pair is almost indistinguishable from a
normal Watson-Crick base pair such that mismatch repair is unable to recognize it (Warren et al.,
2006). Instead organisms dedicate specialized ‘suicide’ methyltransferases to recognize and repair
it (Moore et al., 1994). Similarly, on the ribosome, O6-mG causes miscoding by mispairing with
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U but only at the first position of the codon. At the second position, the adduct was found to reduce
peptide-bond formation by almost three orders of magnitude (Hudson and Zaher, 2015). Again,
these observations highlight not only the differences between the ribosome and DNA polymerases,
but also the position-dependent effects of these modifications on decoding.
N-alkyl adducts, in contrast to O-alkyl ones, tend to be more cytotoxic and less genotoxic
on DNA as they lead to stalled polymerases (Malvezzi et al., 2017). Whether these modifications
stall the ribosome during translation was unknown until recently. In particular, You and colleagues
examined the effect of three N-alkyl modifications on translation efficiency and fidelity using
bacterial and eukaryotic extracts (You et al., 2017). As expected, based on its deleterious effect on
base pairing, m1A was found to severely reduce protein-synthesis yield regardless of its position
within the codon (You et al., 2017). The severity of the effect, especially at the third position,
highlights the deleterious effect of the substitution on the codon-anticodon interaction.
Surprisingly, the modification appears to have no effect on the fidelity of translation. Interestingly,
m1G inhibits protein synthesis only when placed at the first and second position of the codon (You
et al., 2017). At the third position, the modification has no apparent effect on protein-synthesis
yield, which is consistent with the promiscuity of tRNA selection at this position. Why m1A and
m1G affect decoding disparately at the third position, even though the methyl group is added to
same N1 of the purine, can be explained by the introduction of a positive charge in the case of
m1A and not m1G. These observations suggest that, in addition to the effect on hydrogen-bonding
interactions, other parameters, like charge differences, need to be taken into account when
assessing how modifications might affect tRNA selection. Finally, N-alkyl modifications that do
not interfere with Watson-Crick-base-pairing interactions have a modest effect on protein17

synthesis yield and fidelity (You et al., 2017). These include “unintentional” modifications, which
are not known to occur naturally in mRNAs such as m2G, and “intentional” ones, which occur
naturally in mRNAs such as m6A (Hudson and Zaher, 2015), (You et al., 2017).

Ribosome-based-quality control of aberrant mRNAs that stall translation
As highlighted earlier, damage to mRNA, depending on its type, is highly detrimental to
its decoding capacity and unless dealt with could lead to the production of toxic protein products.
Even more detrimental is the ability of damaged mRNA to drastically affect ribosome homeostasis
through stalling. In particular, since multiple ribosomes typically occupy one mRNA during
translation, a single stalling event, such as the presence of a single 8-oxoG modification, could
lead to queuing of multiple ribosomes (Figure 2), sequestering them from the translating pool.
This in turn would lead to greatly diminished translation capacity for cells, especially those under
oxidative stress. Therefore, the inability of cells to recognize and resolve translational-stalling
events is detrimental to proteostasis and could even lead to disease development (Chu et al., 2009;
Ishimura et al., 2014). In this section, we discuss the role of the ribosome in recognizing and
targeting defective mRNAs for degradation.
Recent studies have identified conserved processes in eukaryotes that evolved to resolve
these stalling events and rescue stuck ribosomes (Brandman and Hegde, 2016; Shoemaker and
Green, 2012; Simms et al., 2017a) (Figure 3). In addition, these processes are coupled to the
degradation of the aberrant mRNA and incomplete peptide product. As a result, the ribosome
appears to be at the center of quality control of aberrant mRNAs and the encoded protein products
(Brandman and Hegde, 2016; Shoemaker and Green, 2012; Simms et al., 2017a). We note that
although these processes have almost exclusively been studied in the context of artificial reporters
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that harbor genetically-encoded-stalling sequences, one could easily infer that they are also likely
to be activated in response to chemically-modified mRNAs. Indeed, the inactivation of some of
these processes leads to the accumulation of damaged mRNA and renders cells sensitive to
chemical insults (Simms et al., 2014).
In eukaryotes, quality-control processes that are triggered by stalling events accomplish
three tasks to alleviate stalling-induced translational stresses: 1) degradation of the aberrant
mRNA, 2) degradation of the nascent peptide, and 3) ribosome rescue (Figure 3). mRNA
degradation proceeds through a process called no-go decay (NGD), which initiates with an
endonucleolytic cleavage of the mRNA (Doma and Parker, 2006; Tsuboi et al., 2012). Protein
degradation is mediated by a process termed ribosome-quality control (RQC), which involves
ubiquitination of the incomplete peptide and subsequent proteolysis by the proteasome (Bengtson
and Joazeiro, 2010; Brandman et al., 2012; Defenouillere et al., 2013). Ribosome rescue is carried
out by three factors: Dom34 in yeast (Pelo in mammals), Hbs1 and Rli1 (ABCE1 in mammals)
that bind the A site of the ribosome and catalyze the dissociation of the two subunits (Pisareva et
al., 2011; Shoemaker and Green, 2011; Shoemaker et al., 2010).
These three processes are triggered by the same originating signal of ribosome stalling, but
how this signal is propagated to activate them and coordinate these activities remained poorly
understood until recently. Initial clues came out of studies showing a ubiquitin E3 ligase (Hel2 in
yeast and Znf598 in mammals) is required for stalling (Letzring et al., 2013; Saito et al., 2015). In
particular, its deletion results in ribosomes reading through stall sequences (Sitron et al., 2017).
Hel2 was later found to add K63-linked-ubiquitin chains to a number of ribosomal proteins and
this activity requires the presence of the ribosome-bound factor Asc1 in yeast (or RACK1 in
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mammals) (Juszkiewicz and Hegde, 2017; Sundaramoorthy et al., 2017). Some of the first studies
of Hel2 suggested that it recognizes an unusual conformation that the ribosome adopts during
stalling (Matsuo et al., 2017). However, a later study by our group showed that ubiquitination by
the factor requires ribosomes to collide into each other, which is also critical for NGD to occur
(Simms et al., 2017b). Subsequent cryoEM structures from the Hegde, Ramakrishnan, Beckmann
and Inada groups provided a molecular rationale for these observations (Ikeuchi et al., 2019;
Juszkiewicz et al., 2018). Collided ribosomes provide an interface that can be recognized by the
E3 ligase to ubiquitinate its target proteins. In agreement with these observations, Znf598 and Hel2
appear to prefer higher-order structures of polysomes during their ubiquitination reactions (Ikeuchi
et al., 2019; Juszkiewicz et al., 2018).
How ubiquitination mediates the downstream events of NGD, RQC and ribosome rescue
is not fully understood. However, we are beginning to learn about how certain ribosomal proteins
ubiquitination contributes to these processes. In particular, in a recent study, Inada and colleagues
showed that ubiquitination is required for the activation of both NGD and RQC (Ikeuchi et al.,
2019). Deletion of HEL2 saves the aberrant mRNA and prevents the nascent peptide from
degradation. NGD, in contrast, is divided into two branches depending on the identity of the
ubiquitinated ribosomal protein (Ikeuchi et al., 2019). The first branch called the RQC-dependent
branch requires the ubiquitination of ribosomal protein uS10 (Ikeuchi et al., 2019). In this branch
of NGD, the cleavage occurs in the vicinity of the lead ribosome. The second branch of NGD,
whose efficiency depends on whether the first one takes place or not, is called RQC-independent
and it requires monoubiquitination of ribosomal protein eS7 by another E3 ligase, Not4, and
subsequent K63-ubiquitination by Hel2. In this branch of NGD, cleavage takes place well
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upstream of the lead ribosome (Ikeuchi et al., 2019) (Figure 3). These findings strongly suggest
cleavage of the mRNA is mediated by at least two endonucleases. How these ubiquitination
reactions recruit the endonucleases is currently unknown.
As stated before, NGD is initiated by endonucleolytic cleavage reactions in the vicinity of
stalled ribosomes (Figure 3). This leads to the production of at least two mRNA fragments: a 5’end one that lacks a polyA tail and is rapidly degraded by the cytoplasmic exosome, and a 3’-end
one that lacks a cap structure and is rapidly degraded by the major 5’-3’ exonuclease Xrn1 (Doma
and Parker, 2006; Tsuboi et al., 2012). The identity of the endonucleases remained unknown for a
long time, but in a very recent study, D’Orazio and colleagues identified the conserved factor Cue2
as one of the endonucleases that contributes to NGD (D’Orazio et al., 2019). Using a reversegenetic screen, overexpression of Cue2 was found to reduce the level of protein production from
a stalling reporter suggesting that it contributes to NGD. The overexpression screen was necessary
to identify Cue2’s activity because of the two branches of NGD and the potential existence of a
second endonuclease. In particular, in the absence of Cue2, NGD could still occur in a process that
depended on Xrn1 (D’Orazio et al., 2019). Only in the absence of Xrn1 does the Cue2-dependent
branch dominate (D’Orazio et al., 2019). Arguably, what makes Cue2 interesting is its domain
architecture. The factor contains CUE (coupling of ubiquitin to ER degradation) ubiquitin-binding
domains and putative-UBA (ubiquitin-associated domain) domains, which could allow it to bind
ubiquitin and hence be recruited to ubiquitinated-stalled ribosomes. Furthermore, the C-terminal
domain of the enzyme contains an SMR (small MutS related) hydrolase domain. Some SMRcontaining plant proteins exhibit an endonucleolytic activity. Indeed, D’Orazio and colleagues
showed conserved residues in this domain are important for NGD in vivo (D’Orazio et al., 2019).
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Perhaps most interesting about Cue2’s SMR domain is its likelihood to adopt a structure similar
to the bacterial initiation factor 3 (IF3) based on modeling studies. IF3 binds the ribosome near the
P and A site close to the mRNA-entry channel. In sum, Cue2 has ubiquitin-binding domains and
harbors an SMR domain with a putative endonuclease activity that could bind the ribosome near
where the mRNA would reside. Indeed, ribosome profiling by the same group showed the factor
to cleave mRNA in the A site of the collided ribosome (D’Orazio et al., 2019).
Ribosome rescue is most likely to proceed after the initial cleavage as the ribosome runs to
the end of the mRNA and ends up displaying an empty A site and has a peptidyl-tRNA in the P
site. As we shall see later dissociation of the two subunits needs to be completed for RQC to occur.
Two pieces of evidence suggest that rescue occurs after the initial cleavage. First, structural and
biochemical studies have shown a requirement for little to no mRNA downstream of the P site in
order for the dissociation reaction to take place efficiently (Pisareva et al., 2011; Shoemaker and
Green, 2011). The N-terminal domain of the GTPase Hbs1, which is required for the rescue
reaction, binds in the mRNA entry channel and would sterically clash with the mRNA if it were
present (Becker et al., 2011). Additionally, a steric clash between Dom34 and the mRNA would
exist, preventing both factors from binding unless the mRNA is cleaved (Hilal et al., 2016).
Second, deletion of Dom34 results in multiple secondary cleavage reactions that take place further
upstream of the initial stall sequence (Ikeuchi and Inada, 2016; Simms et al., 2017b). Hence,
inhibition of subunit dissociation leads to a ribosome pile up, which results in spreading of
ubiquitination by Hel2 and more cleavage reactions by Cue2 and the second unknown
endonuclease (Figure 3).
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Following ribosome rescue, the incomplete peptide attached to the peptidyl-tRNA remains
associated with the large-ribosome subunit (60S) (Figure 3). The peptidyl-tRNA-bound 60S
constitutes an unusual complex that is easily recognized by components of RQC (Brandman et al.,
2012; Defenouillere et al., 2013). The E3 ligase Ltn1 (Listerin in humans) recognizes this atypical
form of the 60S subunit and, in addition to preventing the reassociation of the 40S subunit, adds
K48-linked ubiquitin to the peptidyl-tRNA (Bengtson and Joazeiro, 2010; Brandman et al., 2012).
Additional specificity is afforded by Rqc2, which along with making contacts with the tRNA,
binds an interface on the 60S subunit that would otherwise be used to bind the 40S subunit (Figure
3). Rqc2 exhibits an unusual activity, for which it adds untemplated alanine and threonine residues
(Osuna et al., 2017; Shen et al., 2015). The role of this so-called CAT (C-terminal alanine
threonine) tagging is controversial. One group suggested that it is used to promote protein
aggregation, which in turn is used to signal stress (Choe et al., 2016). Another group suggested
that it is used to move the peptide outside the exit tunnel to place lysine residues of the nascentpeptide substrate near the active site of LTN1 (Kostova et al., 2017). In a more recent study, Sitron
and Brandman suggested that in addition to aiding Ltn1 in recognizing structured proteins, CAT
tails serve as a degradation signal for incomplete peptides as a failsafe for peptides that escape
Ltn1 (Sitron and Brandman, 2019). Regardless of the role of CAT tailing, the peptidyl-tRNA, once
ubiquitinated, needs to be released from the ribosome and presented to the proteasome. This is
accomplished by Vms1 in yeast (AZKF1 in mammals) (Figure 3). Initial data suggested that the
factor acts like a peptidyl hydrolase, hydrolyzing the ester bond between the peptide and the tRNA
(Verma et al., 2018). More recent biochemical data, however, showed that the factor instead
cleaves a phosphodiester bond in the acceptor stem of the tRNA, functioning as an endonuclease
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(Kuroha et al., 2018). Following this cleavage reaction, the ubiquitinated peptide is presented to
the proteasome for degradation by Cdc48 in a process that requires Rqc1 (Defenouillere et al.,
2013; Verma et al., 2013) (Figure 3). How the tRNA remnant is removed from the peptide is
currently unknown.
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Figure 3. Overview of ribosome-based-quality control of aberrant mRNAs in yeast.
Ribosomes stall on an aberrant transcript (such as a damaged one), resulting in ribosome
collisions. The unique structural feature of collided ribosomes is recognized by the E3 ligase Hel2
for ubiquitination of multiple targets, including uS10 and eS7 on the 40S subunit. The
ubiquitinated ribosomes are recognized by a number of factors, which are hypothesized to recruit
an unknown endonuclease to cleave the mRNA and initiate NGD. In a secondary branch of NGD,
Cue2 cleaves the mRNA in the A site of the collided ribosome. The cleaved transcript is degraded
by Xrn1 and the exosome. The resulting ribosomes are rescued by Dom34, Hbs1 and Rli1. The
incomplete peptide attached to the peptidyl-tRNA on the 60S subunit is recognized and
ubiquitinated by another E3 ligase Ltn1. Carboxy-terminal alanine and threonine residues (CAT
tails) are added to the nascent peptide by Rqc2 to help expose lysine residues to the active site of
Ltn1 and/or mark the nascent peptide for degradation in an Ltn1-independent manner. Released
from the ribosome by Vms1, the ubiquitinated polypeptides are presented to the proteasome for
degradation by Cdc48 as facilitated by Rqc1.
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Ribosome-independent recognition of damaged mRNA
As detailed above, the ribosome plays a critical role in recognizing aberrant mRNAs and
targeting them for degradation, which makes sense since it is the only machine that sees every
single mRNA. Nevertheless, it appears that organisms may have evolved secondary mechanisms
to recognize and degrade modified mRNA (Simms and Zaher, 2016; Wurtmann and Wolin, 2009).
The notion that certain RNA-binding proteins are able to recognize a single modification on an
RNA is best exemplified by the YTHDF class of proteins, which recognize m6A (Patil et al.,
2018). For example, YTHDF2 binds m6A-decorated mRNAs and delivers them to P bodies, where
they are hypothesized to be degraded (Dominissini et al., 2012; Wang et al., 2014). It should be
noted though, that this modification is not a damage mark, but instead serves a regulatory role for
gene expression (for review see (Liu et al., 2019; Roundtree et al., 2017; Yang et al., 2018)).
Some of the first studies aimed at identifying ribosome-independent factors that recognize
damaged adducts focused on 8-oxoG. These studies revealed that bacteria and eukaryotes possess
factors that bind 8-oxoG-containng mRNAs and target them for degradation. For instance, in
bacteria, the 3’-5’ exonuclease polynucleotide phosphorylase (PNPase) was reported to have a
preference for oxidized RNAs to target them for rapid degradation (Hayakawa et al., 2001; Wu et
al., 2009). In humans, the RNA-binding protein YB-1 displays a specificity for 8-oxoG-containing
mRNAs and is likely to promote their degradation (Hayakawa et al., 2002). In agreement with a
role for this factor in damaged-mRNA-quality control, its overexpression renders bacteria more
resistant to oxidative stress (Hayakawa et al., 2002). However, the protein is known to sequester
RNAs into stress granules, which could offer a protective environment from chemical insults
(Hayakawa et al., 2001). As a result, whether the protective phenotype induced by YB-1
overexpression is due to an mRNA-insulating or mRNA-quality-control activity is unknown.
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Regardless of how YB-1 functions in the quality control of damaged RNA, these observations
suggest that compartmentalization of RNA during stress is likely to serve as an important
mechanism for protecting it from chemical insults.
More recent studies, using 8-oxoG-containing RNAs as bait, identified a new class of
proteins that bind oxidized mRNA (Hayakawa et al., 2010). The most interesting quality-control
candidate to come out of this study was AUF1 (also called HNRNPD) (Ishii et al., 2015). Not only
does AUF1 bind 8-oxoG-containing mRNA specifically, but in its absence oxidized mRNAs are
stabilized, suggesting that the factor might be responsible for their degradation (Ishii et al.,
2015).The same group that identified a role for AUF1 in targeting oxidized mRNA for degradation
also identified another 8-oxoG-RNA-specific-binding protein PCBP1 (Ishii et al., 2018). In
contrast to AUF1, which recognizes RNAs with one 8-oxoG, PCBP1 recognizes heavily oxidized
RNAs. The factor does not promote the degradation of its target, but instead induces cell death.
Mutations in one of the two RNA-binding KH domains, which abolish 8-oxoG binding, suppress
the induction of apoptosis-related reactions, suggesting that its RNA-binding activity is required
for the induction of programmed cell death (Ishii et al., 2018). These observations highlight the
ability of cells to use damaged mRNA as a signal for stress. Interestingly, this PCBP1-mediated
response is only activated in the presence of heavily modified RNAs (Ishii et al., 2018), which in
turn only happens if the oxidative stress is excessive. Under these conditions, it would make sense
to induce apoptosis. Whether cells have evolved factors that recognize other types of modifications
such as alkylated ones to sense chemical insults and alert surveillance systems is currently
unknown.
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RNA repair
Until now our discussion has focused on quality-control pathways that degrade aberrant
mRNAs. The transient nature of the molecule makes the utilization of such processes appropriate.
However, as the synthesis of mRNAs requires energy, these degradative pathways are costly.
Therefore, pathways that could repair mRNAs would save cells energy and be evolutionarily
beneficial. It is worth noting that a precedent for this exists for repair of damaged proteins. Like
RNA, proteins are transient, and when damaged are typically degraded through proteasome action
or autophagy (Goldberg, 2003; Grune et al., 1997; Pickering and Davies, 2012; Vilchez et al.,
2014). Of the 20 canonical amino acids, cysteine and methionine are most susceptible to ROS.
Oxidation of methionine results in methionine sulfoxide (Stadtman et al., 2003), whose
accumulation may contribute to the progression of neurodegenerative disease (Schöneich, 2005).
The enzymes methionine sulfoxide reductases are able to repair oxidized methionine (BoschiMuller et al., 2008). Therefore, it would not be surprising if cells evolved pathways to repair RNA.
Although similar to DNA, RNA lacks a complementary strand and a homologous partner.
As a result, RNA-repair pathways may not use most of the mechanisms used for DNA repair,
which take advantage of unaltered information contained within the complementary strand or the
homologous chromosome. This leaves at least two direct-reversal pathways to potentially repair
RNA: 1) methyl-guanine-methyl transferases (MGMT), which repair O6-mG (Kaina et al., 2007),
and 2) the oxidative demethylases, which repair m1A and m3C (Dinglay et al., 1998; Jr et al.,
2003). Currently there are no reports that implicate the MGMT class of proteins in RNA repair
and given the suicide nature of these enzymes it is difficult to imagine why cells would utilize this
strategy to repair O6-mG-containing RNA. In contrast, the AlkB family of oxidative demethylases
are involved in tRNA modification (Fu et al., 2010). These natural-tRNA modifications, such as
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m1A and m3C, can also be products of damage, suggesting that these enzymes are capable of
repairing damage-induced adducts. This is beside the fact that many of the AlkB enzymes prefer
ssRNA (and ssDNA) as substrates in vitro (A. Alemu et al., 2016). This is especially true for the
founding member of the family, the bacterial AlkB, which is capable of reactivating alkylatedMS2 RNA phage in vivo (Jr et al., 2003; Ougland et al., 2004). The human homologue of AlkB,
hAlkB3, displays a similar substrate specificity towards ssRNA (Falnes, 2004; Jr et al., 2003),
suggesting that RNA repair is likely to be conserved. Perhaps the most convincing argument about
the existence of RNA-repair pathways and their utility for cellular fitness is the observation that
many RNA viruses encode Alkb-like proteins within their RNA genomes (van den Born et al.,
2008; Simms and Zaher, 2016). Given how compact the RNA genomes of these viruses are, this
suggests that the process of RNA repair is very important to maintain the integrity of the polymer.

mRNA damage and disease
In the previous sections, we discussed the susceptibly of RNA to damage and how it
impacts the chemical properties and function of the molecule. Naturally the next question is
whether these alterations have any profound effect on organismal fitness. In this section, we
discuss the connections between RNA damage and several disease states. Since an mRNA is
translated multiple times, and in some cases more than a thousand times, a damaged mRNA has
the potential of producing significant amounts of aberrant protein products. As defective protein
products are more likely to misfold and aggregate, damaged mRNAs would pose significant
challenges to tissues that are more sensitive to protein misfolding. As a result, neurons, with their
long-life span, appear to be the most vulnerable to RNA damage (Gandy, 2005). Indeed, more than
two decades ago, a link between neurodegeneration and RNA oxidation was uncovered
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(Nunomura et al., 1999). Since then many studies have shown that oxidized RNAs accumulate to
very high levels in neurons during neurodegeneration as well as through aging (Shan and Lin,
2006). In one of the initial studies, Nunomura et al. (Nunomura et al., 1999) demonstrated that
RNA oxidation is a distinct feature of neuronal vulnerability to oxidative stress, as samples from
brain tissue of Alzheimer’s disease (AD) patients accumulated high levels of 8-oxoG in both
cytoplasmic and nuclear RNA (Nunomura et al., 1999). A more recent study revealed that neuronal
mRNA oxidation in AD patients can reach as much as 50-70% for some transcripts, while the
percentage is less than 2% of the total mRNA pool of healthy individuals (Shan and Lin, 2006).
Aside from AD, the accumulation of 8-oxoG in cellular RNAs has been reported in several
neurodegenerative disorders (Bradley-Whitman et al., 2014; Chang et al., 2008; Ding, 2005;
Nunomura et al., 2002; Shan and Lin, 2006; Zhang et al., 1999). For instance, in Parkinson’s
disease (PD) patients, the presence of 8-oxoG can be observed in cerebrospinal fluid and serum,
and an increase in the levels of 8-oxoG was found in substantia nigra (SN) compared to other brain
regions (Kikuchi et al., 2002; Zhang et al., 1999). Highlighting the significance of RNA oxidation
for neurodegeneration, the levels of oxidized RNAs have the potential to be used as a diagnostic
marker for certain diseases. In particular, oxidized CuZnSOD mRNA can be used as an early preclinical feature of ALS (Chang et al., 2008). It should be noted that, given that a hallmark of many
neurodegenerative diseases is increased oxidative stress, the accumulation of oxidized RNA under
these conditions could be a side effect of the disease pathogenicity. A direct causal relationship
between oxidized mRNA and pathogenicity of neurodegenerative disease remains ambiguous
(Simms and Zaher, 2016) and should be the focus of future research. These are important avenues
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to explore, especially in light of a convincingly demonstrated causal connection between the
inability of cells to resolve stalled ribosomes and neurodegeneration (Ishimura et al., 2014).

Damage to non-coding RNAs and its effect on their functions
So far, the focus of our discussion has been on mRNA damage, but the bulk of the RNA in cells,
~95%, is non coding (Rosenow, 2001; Westermann et al., 2012). These RNAs carry out important
functions in the cell, which include translation, splicing, transcription, RNA-directed modification
and regulation of gene expression (Bushati and Cohen, 2007; Esteller, 2011). For instance, rRNA
and tRNA are essential for translation, and- given their long-lived nature- modifications that
interfere with their function could have drastic consequences on cellular homeostasis. Unlike
mRNA, studies addressing the effect of chemical damage to tRNA and rRNA on their function are
sparse. However, we note that unlike mRNAs, for which the majority of the nucleotides are seen
by the ribosome, changes to the majority of the nucleotides of rRNA would be expected to be
tolerated (Figure 2). Most of the functional sites of the rRNA are buried within the ribosome,
making them less accessible to reactive chemicals. Nucleotides on the surface, which are
accessible to modification, tend to be less conserved and are often functionally unimportant.
Nevertheless, recent studies by the Polacek group showed that the peptidyl-transferase center
(PTC) of the ribosome is susceptible to oxidation (Willi et al., 2018). Using atomic mutagenesis,
the authors were able to show that placing a single 8-oxoA within the PTC inhibits peptide-bond
formation, suggesting that oxidation of the ribosome could severely disrupt its function (Willi et
al., 2018). Equivalent studies on the effect of modification to tRNA are lacking. Nevertheless,
changes to a tRNA’s anticodon that do not affect the aminoacylation reaction but change the baseparing preference would be expected to cause significant miscoding (Figure 2). Interestingly,
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tRNAs harbor modifications that contain sulfur substitutions that are very sensitive to the redox
state of cells (Nawrot et al., 2011). Many of these reside in the anticodon, and their oxidation is
known to affect their base-pairing properties (Nawrot et al., 2011).
How cells cope with chemical damage to rRNA and tRNA is largely unknown. It is,
however, evident that cells have the ability to recognize defective rRNA and tRNA molecules. In
the case of rRNA, non-functional rRNA decay (NRD) targets defective ribosomes for rapid
turnover (Cole et al., 2009; LaRiviere et al., 2006). NRD has been studied in the context of
ribosomes harboring mutations in the peptidyl-transferase center (PTC) of the 25S rRNA and the
decoding center (DC) of the 18S rRNA. Interestingly, the process by which cells rid themselves
of defective small subunits is distinct from that used to degrade defective large subunits. For
example, 18S NRD is dependent on translation, whereas 25S NRD is not. Furthermore, 18S NRD
is intimately coupled to mRNA surveillance as it utilizes factors that are used during NGD. In
contrast, 25S NRD employs distinct factors and takes place prior to the assembly of the 80S subunit
in perinuclear foci (Cole et al., 2009; LaRiviere et al., 2006). Since 18S and 25S NRD recognize
defective ribosomes that are unable to carry out protein synthesis, it is tempting to speculate that
these processes are induced in response to chemically-damaged ribosomes. Future research should
be focused on exploring this potential connection and the utility of these processes in ridding cells
of oxidized, alkylated and cross-linked ribosomes.
Similar to rRNA, defective tRNA molecules are also subject to quality control that ensures
that they are rapidly degraded before they can participate in translation. In particular, eukaryotes
evolved the process of rapid-tRNA decay (RTD), which targets aberrant tRNAs (Chernyakov et
al., 2008; Whipple et al., 2011). RTD has been mainly studied in the context of misprocessed
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tRNAs especially those lacking important post-transcriptional modifications. These tRNAs are
subject to rapid decay by Rat1 in the nucleus and Xrn1 in the cytoplasm (Chernyakov et al., 2008;
Whipple et al., 2011). It is generally accepted that these factors are able to recognize changes to
the post-transcriptional-modification status of the tRNA through changes to its overall secondary
structure. As alkylation and oxidation of the tRNA nucleobases are likely to induce a profound
effect on the overall structure of the molecule, it is highly likely that RTD is also responsible for
recognizing chemical damage to tRNA molecules.
What about other classes of noncoding RNAs? Almost all of these require base-pairing to
carry out their function. Many of them are also long lived so that any changes that alter their
function would be expected to linger unless cells have pathways to deal with them. For example,
snRNAs are used by the spliceosome to identify splice-junction sites through base pairing (Will
and Luhrmann, 2011); changes to this class of RNAs is likely to have profound effects on splicing
and hence gene expression. Similarly, snoRNAs are used to guide 2’-O methylation and
pseudouridylation on many RNAs (Watkins and Bohnsack, 2012), and changes to their basepairing properties could affect the specificity of these reactions and likely be detrimental to the
function of the target molecule. As a-case-in point of the downstream effects of RNA
modifications to functional RNAs, Wang et al. showed that oxidation of a microRNA alters its
targets and induces apoptosis (Wang et al., 2015). How cells cope with chemical damage to these
classes of RNAs- be it snRNAs, snoRNAs and microRNAs- is unclear and whether they evolved
pathways to degrade/repair them should be the subject of future research.
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CONCLUDING REMARKS
As outlined here, we have been aware of the vulnerability of nucleic acids to chemical
insults for more than half a century. We have also known how this type of damage would alter
their chemical properties and interactions with other molecules. In particular, most modifications
affect the base-pairing potential of nucleic acids, which in turn is arguably their most important
feature. Interestingly, however, while DNA damage has been systematically studied for decades,
RNA damage in contrast has received little attention. Of course, the importance of maintaining
genomic integrity supersedes that of RNA, but that cannot fully justify this disparity. RNA plays
a central role in many fundamental biological processes and most of these depend on its ability to
base pair correctly. These include intermolecular ones like those between tRNA and mRNA during
translation, snRNA and pre-mRNA during splicing, and snoRNA and rRNA during RNA-guided
modification; but also, intramolecular ones that are responsible for maintaining the structural
integrity of complex molecules like the ribosome. It is not surprising then that RNA damage is
detrimental to cellular fitness and has been associated with many disease states.
Recent efforts from our group and others have focused on mRNA damage. These studies
have begun to highlight how damage to this molecule affects the efficiency and accuracy of protein
synthesis. We are also beginning to appreciate the role of the ribosome in detecting many damageformed adducts and triggering quality-control processes to degrade the damaged transcript. It is
also clear that ribosome-independent mechanisms are at play to degrade or repair damaged mRNA
that may escape recognition by the ribosome. This increased interest in how modifications affect
mRNA function should hopefully motivate others to look at other species in RNA biology.
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CHAPTER 2: Ribosome collision is critical
for quality control during no-go decay
Carrie L. Simms, Liewei L. Yan and Hani S. Zaher
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ABSTRACT
No-go decay (NGD) is a eukaryotic quality control mechanism that evolved to cope with
translational arrests. The process is characterized by an endonucleolytic cleavage near the stall
sequence, but the mechanistic details are unclear. Our analysis of cleavage sites indicates that
cleavage requires multiple ribosomes on the mRNA. We also show that reporters harboring stall
sequences near the initiation codon, which cannot accommodate multiple ribosomes, are not
subject to NGD. Consistent with our model, we uncover an inverse correlation between ribosome
density per mRNA and cleavage efficiency. Furthermore, promoting global ribosome collision in
vivo resulted in ubiquitination of ribosomal proteins suggesting that collision is sensed by the cell
to initiate downstream quality control processes. Collectively our data suggests that NGD and
subsequent quality control are triggered by ribosome collision. This model provides insight into
the regulation of quality control processes and the manner by which they reduce off target effects.
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INTRODUCTION
During protein synthesis ribosomes face obstacles that impede their movement along the
mRNA template (Brandman and Hegde, 2016; Simms et al., 2016). These obstacles include, but
are not limited to, stable secondary structures, stretches of inhibitory and rare codons, poly
lysine/arginine encoding mRNA and chemically damaged nucleotides (Doma and Parker, 2006;
Letzring et al., 2010; Simms et al., 2014; Tsuboi et al., 2012). These events of ribosomal arrest,
unless resolved, are detrimental to cellular homeostasis as they diminish the cellular concentration
of available ribosomes for translation. In eukaryotes, the mRNA-surveillance process of no-go
decay (NGD) evolved to degrade these defective mRNAs (Doma and Parker, 2006). The process
is characterized by an endonucleolytic cleavage; the resulting 5’ and 3’ fragments are rapidly
degraded by the cytoplasmic exosome and XRN1, respectively. Although the identity of the
endonuclease remains elusive, the ribosome appears to play a major role in specifying the NGD
targets as the initial cleavage reaction is dependent on translation (Doma and Parker, 2006; Tsuboi
et al., 2012). Furthermore, the process is intimately coupled to ribosome rescue and degradation
of the short protein products through a ribosome-associated complex (RQC) (Bengtson and
Joazeiro, 2010; Brandman et al., 2012; Shoemaker et al., 2010).
Ribosome rescue through disassembly of the two subunits is carried out by a ternary
complex of Dom34 (Pelota in mammals), Hbs1 and GTP (Pisareva et al., 2011; Shoemaker et al.,
2010; Shoemaker and Green, 2011). Dom34 and Hbs1 are homologs of the eukaryotic release
factors eRF1 and eRF3, respectively (Chen et al., 2010; Graille et al., 2008; Lee et al., 2007).
However, Dom34 lacks the catalytically important GGQ motif required for peptide hydrolysis as
well as the NIKS motif required for stop-codon recognition. As a result, in contrast to eRF1:eRF3mediated recycling, Dom34:Hbs1-mediated recycling results in a peptidyl-tRNA-bound 60S
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subunit (Shoemaker et al., 2010). Recent studies have shown that this atypical form of the 60S
subunit is recognized by the RQC (Chiabudini et al., 2012; Defenouillere et al., 2013; Shao et al.,
2015; Shao and Hegde, 2014; Shao et al., 2013; Shen et al., 2015; Verma et al., 2013). The complex
mediates the ubiquitination, extraction and rapid degradation of the incomplete nascent peptide. In
addition to ubiquitination of the nascent peptide, regulatory ubiquitination of ribosomal proteins
appears to take place on stalling ribosomes. In humans the E3 ligase ZNF598 ubiquitinates several
ribosomal proteins both in vitro and in vivo, and in the absence of the factor, stalling on polyA
sequences is significantly alleviated (Juszkiewicz and Hegde, 2017; Sundaramoorthy et al., 2017).
In yeast the equivalent E3 ligase HEL2 was shown to be important for stalling (Letzring et al.,
2013; Saito et al., 2015). Recent studies using ribosomal profiling have, however, argued that
HEL2 is not required for stalling but instead in its absence mRNA reporters are stabilized (Sitron
et al., 2017). Here, nonetheless, deletion of HEL2 results in increased ribosome occupancy (>
twofold) beyond the stall site. Therefore, emerging from all of these studies is a potentially critical
role for ribosomal protein ubiquitination in initiating quality control on stalled ribosomes.
Arguably much of the emphasis on NGD to date has focused on the identification and
characterization of trans factors that communicate with the ribosome during the process, namely
those that are required to initiate ribosome rescue and nascent-peptide degradation. Interestingly,
comparable studies on the role of the ribosome itself and especially its functional part in
recognizing NGD targets are sparse. Importantly, we do not have a clear mechanistic
understanding of the signals responsible for initiating the endonucleolytic cleavage. Additionally
it is unclear how the ribosome and the NGD machinery distinguish between defective mRNAs and
those that for instance intentionally stall translation to allow for proper protein localization.
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Discriminating between programmed pauses/stalls and those that are unwanted is paramount for
cellular homeostasis.
In this study we carried out a detailed characterization of the nature of the endonucleolytic
reaction using reporters in yeast. In an effort to gain mechanistic insights into the endonuclease
specificity, we mapped the 5’ fragments for a number of stalling reporters in the absence of SKI2.
In agreement with earlier reports (Chen et al., 2010; Doma and Parker, 2006; Tsuboi et al., 2012),
the 5’-fragment maps upstream of the stall. However, we were surprised to observe that the
majority of the sequence reads mapped well upstream of the stall site. These observations suggest
that multiple ribosomes are required to load on the mRNA for efficient NGD. Consistent with
these ideas, NGD-induced cleavage was not observed unless the stall site was greater than 105 nt
downstream of the start codon. Furthermore, mutations and reporters that result in a low ribosome
density on mRNA significantly reduce NGD efficiency. Finally, by genetically manipulating yeast
to have a mixed population of cycloheximide-resistant and -sensitive ribosomes, we globally
induced ribosomal collision through the addition of the antibiotic. Interestingly only under these
circumstances do we observe robust ubiquitination of ribosomal protein RPS3 in a HEL2dependent manner. These observations suggest that similar to the cleavage reaction ribosome
ubiquitination is associated with collision events and provides a mechanism by which HEL2
recognizes its substrate ribosomes. Collectively our data suggests that the trigger for quality
control following stalling is ribosomes colliding with each other.
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RESULTS
NGD results in multiple endonucleolytic cleavages that map well upstream of the stall site
A collection of reporters has been utilized by a number of groups to study NGD in
Saccharomyces cerevisiae by presenting a genetically-encoded translational block. We elected to
use a PGK1 reporter, initially engineered by Parker and colleagues, which expresses a stable stem
loop (SL) known to inhibit ribosome movement along the mRNA (Doma and Parker, 2006). We
also constructed two additional reporters, which contain a stretch of the inhibitory codons CGA
(PGK1-CGA12) encoding poly-Arg or AAA sequence (PGK1-AAA12) encoding poly-Lys; both of
these sequences have been well documented to inhibit translation and elicit NGD (Doma and
Parker, 2006; Kuroha et al., 2010; Letzring et al., 2010; Lu and Deutsch, 2008; Tsuboi et al., 2012).
As a negative control, we constructed a reporter with a polyU stretch (PGK1-UUU12) encoding
poly-Phe instead. As has been seen previously, all of the reporters that present a block to the
ribosome were found to produce shorter mRNA products in a ski2 background; these strains are
defective for 3’-5’ exonuclease activity by the cytoplasmic exosome (Anderson and Parker, 1998).
Also consistent with earlier reports, these products ran as smears on the gel suggesting that they
are heterogeneous in nature (Figure 1A). In the absence of XRN1 (Stevens, 1980), 3’-PGK1
fragments accumulated in the presence of the stalling reporters (PGK1-SL, PGK1-CGA12 and
PGK1-AAA12) (Figure 1B). Similar to the 5’ intermediates, the 3’ intermediates ran as
heterogeneous products on the gel.
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Figure 1. NGD reporters produce heterogeneous 5’ and 3’ fragments.
(A) Northern analysis of 5’ fragments accumulation from the indicated PGK1 mRNA reporters in
wild-type and ski2 strains. PGK1 indicates no additional sequence was added to the PGK1 ORF.
SL indicates a stem loop was inserted at position 1040 of the ORF; (CGA)12, (AAA)12 and (UUU)12
indicate the corresponding codons were inserted at position 950 of the ORF. (B) Northern analysis
of 3’ fragments accumulation in wild-type and xrn1 strains. The fragments were labeled as per
(Chen et al., 2010). Note that the asterisk depicts an endogenous endonucleolytic cleavage specific
for the PGK1 sequence. (C-F) Mapping sites of mRNA cleavage in cells expressing stalling
reporters. The 5’ ends of 3’ fragments from xrn1 cells were mapped relative to the stall site (C)
(data from Chen et al. 2010). (D-F) The 3’ ends of 5’ mRNA cleavage products from ski2 cells
expressing the indicated reporter were mapped relative to the stall site. Data is binned to 25 nt
increments.
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Although noted earlier by others (Chen et al., 2010; Doma and Parker, 2006; Tsuboi et al.,
2012), we were surprised by the extent of the smear length (> 500 nt) (Figure 1A). These
observations suggested to us three different scenarios: 1) The cleavage reaction is inefficient
relative to the elongation rate of the ribosome so that by the time cleavage initiates multiple
ribosomes had protected the mRNA; 2) The endonuclease requires multiple stacked ribosomes for
efficient cleavage; 3) Rescue of ribosomes behind the primary ribosome is relatively inefficient
resulting in secondary stalls that trigger more NGD cleavages.
To explore these different scenarios, we sought to map cleavage sites for the reporters using
RACE assays. Previous studies focused on mapping the 3’-fragments in the xrn1 background. In
Figure 1C we used the data reported by the Parker and Song groups (Chen et al., 2010) to plot the
number of reads from the (CGA)4 reporter as a function of their relative position from the stall site.
Consistent with the northern analysis, the 3’-fragments mapped to a broad region of the reporter
(~0-250 nt upstream of the stall site). In these experiments cDNA was prepared by ligating an
RNA oligo at the 5’ end of the mRNA and reverse transcribing using a primer that anneals
downstream of the stall sequence (Chen et al., 2010). As a result, secondary cleavage reactions
resulting from inefficient rescue are lost during this step since they do not possess the
complementary sequence for the RT primer, thus excluding the third scenario.
The corresponding 5’ fragments have not been mapped to single-nucleotide resolution and
are likely to provide further hints about the endonucleolytic reaction. We mapped these fragments
by first ligating an adenylated DNA oligo to the 3’ end. Following first-strand synthesis with a
primer complementary to the ligated oligo, the cDNA was amplified from the start of the PGK1
gene (eg. Figure S1A). Alignment of the resulting reads revealed some interesting clues about the
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cleavage reaction. In contrast to the 3’ fragments, for which most clustered within 200 nt of the
stall site, the 5’ fragments mapped to a broader region upstream of the stall site (Figure 1D)
suggesting that the 5’ fragments are subject to multiple cleavage reactions, presumably due to
inefficient recycling by Dom34 and Hbs1. In agreement with this proposal, inhibition of ribosome
rescue by deleting DOM34 leads to even more dramatic heterogeneity of the 5’-fragments (Figure
S1B) (Ikeuchi and Inada, 2016).
Mapping of the 5’-fragments for the SL and (AAA)12 reporters was largely consistent with
that for the (CGA)12 reporter. However, unlike the (CGA)12 reporter, for which the reads were
uniformly distributed across a broad region upstream of the stall site, the reads for the SL and
(AAA)12 reporters are clustered either 100-175 nt upstream of the stall (Figure 1E) or close to the
stall site (Figure 1F). These findings suggest that the endonucleolytic reaction is to a certain extent
dependent on the nature of stall. Some of these distinctions are likely to be rationalized by
differences in the precise location of where the ribosome stalls as well as the makeup of the polyA
sequence, especially given its slippery nature (Koutmou et al., 2015). These distinctions between
AAA- and CGA-mediated stalling are likely to be the result of subtle differences between bonafide-no-go decay and non-stop decay (NSD) (Frischmeyer et al., 2002; van Hoof et al., 2002).
Cleavage appears to takes place between stacked ribosomes
To gain further insight into the nature of the cleavage reaction, we decided to carry out
high-throughput sequencing to map the 5’-fragments from the NGD reporters in the ski2
background. Overall, three main characteristics of the cleavage reaction are readily discernable

56

Figure 2. Large scale sequencing reveals strong periodicity of cleavage sites.
57

(A) Plot of sequencing reads of 3’RACE products from ski2 cells expressing a (CGA)12 reporter.
Each point represents one read, mapped relative to the stall site. Inset shows a wider view of the
mapped data. (B) Plot of smoothed data from (A) reveals a strong periodicity in the location of
cleavage sites. Data was smoothed by using a 5-point quadratic polynomial. Peaks were assigned
by taking the derivative of the smoothed data and finding the + to - inflection point. (C) Graph
depicting the number of reads as mapped to the translation frame of the reporter. (D) Plot of the
distance between peaks in (B).

from our analysis. First, very few cleavage products map downstream of the stall site. We
mapped more than 7 × 106 reads to the (CGA)12 reporter with greater than 99.7% mapping
upstream of the stall site (Figure 2A). The first major peak of reads mapped at about -43-nt (likely
behind the secondary stalled ribosome). Second, we observe a predominant peak at 75 – 150 nt
upstream, depending on the identity of the stall sequence (Figure 2B, S2). Third, and arguably
most interesting, is the observation that cleavage takes place significantly in frame (Figure 2C,
S2). This latter observation is similar to what has been observed recently using ribosomal profiling
(Guydosh and Green, 2017) and suggests that the endonuclease is using the ribosome as a ruler.
Consistent with this proposal, smoothing of the (CGA)12 mapping data revealed a regular
oscillation of read peaks with a median period of 29-nt (Figure 2B, 2D) and a tight distribution
(standard deviation of 2.5-nt). The 29-nt periodicity has important ramifications for the nature of
the endonuclease as it suggests that the cleavage reaction takes place among stacked ribosomes.
This observation argues against the potential proposal that the heterogeneity of the cleavage
products is the result of secondary cleavage reactions as this would result in a 15-nt periodicity
instead; during secondary cleavage reactions ribosomes are expected to run to the end of the
message and hence protect only one half the length of an 80S footprint.
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For the SL and (AAA)12 reporters, we were able to map ~5 × 106 and ~ 4 × 106 reads to
their corresponding sequence, respectively (Figure S2). Interpretation of the mapping results,
however, was not as straightforward as for the CGA reporter, presumably due to imprecise stalling
on these sequences (Figure S2). This can be rationalized in light of earlier reports showing that
tandem CGA sequences present harder stalls relative to other motifs in yeast (Chen et al., 2010).
Notwithstanding, we also document a similar correlation between the cleavage reaction and frame
to that observed for the CGA reporter. Collectively our analysis suggests that cleavage on NGD
substrates is intimately coupled to the translational machinery and that the endonuclease may sense
stacked ribosomes to initiate its reaction.
Multiple stacked ribosomes are required for robust NGD
Perhaps one of the most important findings to come out of our sequencing efforts is the
observation that the primary cleavage is likely to take place well upstream of the stall site. This is
especially true for the SL reporter, for which the cleavage sites appear to cluster to regions >100
nt from the stall (Figure S2A). These results are in agreement with a model whereby multiple
stacked ribosomes are required to activate the endonuclease. To empirically provide support for
this proposal we constructed new PGK1 reporters that place the SL sequence at distances close to
the start codon, which allowed us to control a maximum number of ribosomes that can load onto
the reporter (Figure 3A). In particular we positioned the SL at 10, 22, 48, 60, 105, 135, 175, 200
and 1040 nts from the AUG
In agreement with our sequencing results, we only observe robust cleavage on reporters
having the SL at sites that are >135 nt from the start codon as evidenced by the accumulation of
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Figure 3. Endonucleolytic cleavage is not efficient on ribosomes that stall within 175 nt of
the start codon.
(A) Northern analysis of 5’ fragment accumulation in ski2 cells expressing a reporter with the
SL located at the indicated positions (relative to the start codon), performed on formaldehydeagarose (top) or denaturing PAGE (bottom). 5’ cleavage products are indicated by arrowheads.
(B) Northern blot of RNA from xrn1 cells expressing the same set of reporters as in (A)
performed on formaldehyde-agarose. 3’ cleavage products are indicated by arrowheads. (C)
Polysome profile, ethidium bromide-stained agarose gel, and northern blot from ski2 cells
expressing the indicated SL reporter. The band corresponding to endogenous PGK1 is labeled
PGK1 end. Blots in all panels were probed with an oligo complementary to the 5’UTR immediately
upstream of the AUG.
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the 5’-fragments in the ski2 background (Figure 3A). Although we can detect minimal cleavage
products in the SL10 through SL105 reporters, cleavage was more evident in the SL135 reporter and
was much stronger in the SL175 reporter. To rule out the possibility that the absence of cleavage
products in the reporters with SL close to the start codon is due to probing issues or due to possible
trimming by an unknown exonuclease, we looked at the accumulation of the 3’-fragments in the
xrn1 background. Similar to what we observe for the 5’-fragments, robust accumulation of the
3’-fragments was only detected for reporters expressing the SL at sites that are >105 nt from the
AUG codon (Figure 3B). The effect of its position within the ORF on cleavage efficiency was not
dependent on the identity of the stall. Indeed similar to the SL stall, cleavage efficiency was
significantly reduced for the CGA and AAA stalls when they were placed <105 nucleotides from
the initiation codon (Figure S3).
As NGD is fully dependent on translation (Doma and Parker, 2006), we next sought to
verify that reporters that are not subject to NGD are capable of associating with the ribosome. We
carried out polysome analysis on the SL60, SL135, SL175 and SL1040 mRNA reporters to assess their
distribution across the different ribosomal fractions. As expected the SL60 mRNA was found to
associate with monosomes and disomes, whereas the SL135 was found to associate with trisomes
and tetrasomes. The SL175 and SL1040 mRNAs, including their stabilized 5’-fragments due to the
ski2 background, could be detected in the heavier fractions of the polysomes (Figure 3C). We
note that the endogenous PGK1 mRNA, which migrates faster and can be detected with our probes,
was found to associate with the heavy fractions in all of our samples offering an internal control.
These observations suggest that although the SL60 reporter harbors a roadblock for translation and
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associates with ribosomes, it is not a good target of NGD. Collectively, our data argues that robust
endonucleolytic initiation of NGD requires multiple ribosomes to load onto the mRNA target.
Reduction of ribosome density inhibits NGD
Although our data so far suggest that ribosome collision is key for initiating NGD, the
mechanism by which this signal is communicated to the endonuclease is unclear. The L1 stalk of
the ribosome, which protrudes away from the ribosome facing the mRNA exit channel, is an
obvious candidate for sensing collision events. Structures of polysomes from human cells revealed
a likely interaction between the ribosome and the small subunit of the upstream neighboring
ribosome near the mRNA entry tunnel (Brandt et al., 2010). Furthermore, recent studies from the
Grayhack group showed that deletion of RPL1B, one of two genes that encodes ribosomal protein
L1 and is more highly expressed than its paralog RPL1A, allows for read through of inhibitory
CGA codons suggesting that it may play a role in NGD (Letzring et al., 2013). However, an
alternative possibility is that deletion of RPL1B is affecting overall ribosome homeostasis, by
reducing the levels of available 60S subunits. Indeed studies from multiple groups have
documented a profound relationship between ribosomal protein availability and ribosome
assembly. In particular, deletion of ribosomal protein paralogues has been shown to result in
defects in ribosome biogenesis (Ferreira-Cerca et al., 2005; Moritz et al., 1990; Mueller et al.,
1998; Rudra et al., 2007).
Before exploring the effect of the RPL1B deletion on ribosome homeostasis we sought to
assess its effect on the endonucleolytic reaction. Consistent with its effect on readthrough of
inhibitory codons (Letzring et al., 2013), we observe a significant reduction in 5’-fragment
accumulation from the PGK-SL reporter in the rpl1bski2 strain (Figure 4A). The disappearance
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of NGD intermediates can be rescued by reintroducing RPL1B on a plasmid suggesting that the
effect is due to the loss of RPL1B. To evaluate whether the effect of RPL1B deletion is due to
limiting levels of available ribosomes or altered ribosome composition, we isolated ribosomes
from wild-type as well as rpl1b cells and performed mass spectrometry to quantify the relative
levels of the ribosomal proteins. We measured almost identical stoichiometries of the near
complement of ribosomal proteins between the wild-type and the mutant strains (Figure 4B). In
particular, in the rpl1b strain, the level of RPL1 was found to be reduced by a modest 15% relative
to its parent (Figure S4). This confirms that the effects of RPL1B deletion on NGD cannot be
explained simply by altered ribosome composition and instead are likely due to changes in the
cellular concentration of ribosomes. The polysome profile of rpl1b provided support for this
model; the profile exhibited a significant reduction of polysomes relative to the 80S monosome
peak when compared to profiles from the wild type strain (Figure 4C). As expected, we observe a
gradual increase in polysome levels in the wild type strain whereas in the rpl1b strain an opposite
steep and immediate drop in polysomes levels was noted, indicating that ribosome density on
mRNAs is significantly reduced in the rpl1b strain. This in turn could explain the effect of the
deletion on NGD in a manner that is consistent with our collision-based model for triggering
cleavage; ribosome density and hence “traffic” has a profound impact on the likelihood of
ribosomes running into each other.
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Figure 4. Deletion of RPL1B reduces mRNA cleavage efficiency by lowering ribosome
density on mRNAs.
(A) Efficiency of mRNA cleavage is reduced in ski2 rpl1b cells compared to ski2 cells
expressing PGK1-SL. Cleavage activity is rescued by RPL1B expression from a plasmid
(pAG426-rpl1b). Cleavage products were quantified relative to the PGK1 full-length reporter (top
band on blot) and to SCR1 (bottom panel). % abundance compared to WT is shown. (B)
Quantification of ribosomal protein content from ribosomes for rpl1b versus wild type cells by
mass spectrometry. Values are relative ion counts  SD from three biological replicates. (C)
Polysome profiles from wild type and rpl1b cells. (D) Western blots of cell lysates from wild
type and rpl1b cells used to assess RPS9 levels. Quantification of RPS9 relative to PGK1 is
shown in the lower panel. Value is mean ±SD from three biological replicates. Full blots are shown
in Figure S3. (E) A phosphorimage of an SDS PAGE gel used to follow the incorporation of 35SMet in nascent proteins in wild type and rpl1b cells. Middle panel shows coomassie stained
samples used to assess the steady state levels of proteins. Bottom panel is a western blot of PGK1.
Radiolabeled proteins from two independent biological samples were quantified relative to the
steady state levels of PGK1 and the resulting plot is shown to the right. (F) A dual luciferase
reporter was used to assess readthrough on (CGA)4. Plot of normalized firefly luciferase relative
to Renilla luciferase expression from a control reporter and one containing a (CGA) 4 sequence in
wild type and rpl1b cells. (G) Western blot of cell lysates from WT and rpl1b cells expressing
the indicated PGK1 reporters. (H) Northern blot of RNA isolated from WT and rpl1b cells
expressing the indicated reporters. Cleavage products were quantified relative to the full PGK-stall
reporter (top band) or to SCR1 (bottom panel). The band corresponding to endogenous PGK1 is
labeled PGK1 end.
To provide further support for the effect of RPL1B deletion on ribosome homeostasis, we
looked at the relative level of another ribosomal protein as a proxy for gauging the cellular levels
of ribosomes. As predicted, the level of the small subunit ribosomal protein RPS9 is significantly
reduced in the rpl1b strain relative to wild-type cells (~30% reduction) as judged by western
blotting (Figure 4D). This apparent reduction in ribosome concentration was corroborated by
assessing the global rate of protein synthesis using

35S-methionine

incorporation. The rate by

which the radiolabel was incorporated into nascent proteins was observed to be ~fivefold slower
in the rpl1b strain relative to wild-type cells (Figure 4E). We note that, superficially, these
deficiencies in translation can rationalize the observed inhibition of cleavage; after all NGD is a
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ribosome-based surveillance mechanism. However, this rationale falls short of explaining that in
the absence of RPL1B we observe increased accumulation of full-length protein products from a
number of NGD reporters. We utilized a reporter similar to the one used by Grayhack and
colleagues (Letzring et al., 2013), for which a dual luciferase construct is interrupted with CGA
codons between the renilla and firefly luciferase coding sequences. In the absence of RPL1B, the
ratio of firefly- to renilla-dependent luminescence increased more than twofold (Figure 4F).
Similar effects of the deletion were seen with the PGK1 constructs; both the SL and (AAA)12
reporters produced > twofold more protein in the rpl1b strain (Figure 4G). These findings suggest
that although decreasing ribosome density per mRNA has an overall negative effect on translation,
it increases protein output on NGD reporters because it reduces the probability of ribosome
collision and hence cleavage efficiency.
The likelihood of elongating ribosomes running into each other, in principal, depends on
two parameters (assuming the elongation rate is similar): 1) the strength of the stall, which affects
the dwell time of the ribosome on the pause sequence, and 2) ribosome density, which affects the
arrival time of the ribosome behind the primary ribosome. We manipulated the first parameter by
presenting stall sites of varying strengths to the ribosome. Previous work suggested that stretches
of CGA and AAA codons present harder blocks to translation as compared to SL structures (Chen
et al., 2010). Indeed in our hands, we observe little to no full-length protein products from these
reporters, whereas we observe significant full-length protein product from the SL reporter (Figure
4G). In agreement with our model, the effects of RPL1B deletion on NGD efficiency was
completely dependent on the strength of the stall sequence. Cleavage was significantly inhibited
for the SL reporter but moderately inhibited for the (CGA)12 reporter and the (AAA)12 reporter
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(Figure 4H). These findings suggest that by increasing the stalling time, NGD becomes less
affected by ribosome density.
To provide further support for our model we deleted other ribosomal protein genes
encoding RPS26 and RPS28. Both are encoded by duplicated genes, and deletion of RPS28B
appears to impart defects on the biogenesis of the 40S as evidenced by accumulation of 18S rRNA
precursors in a ski2 rps28b strain (Figure S5) (Ferreira-Cerca et al., 2005). Similar to what we
observe for the rpl1b strains, the stoichiometry of ribosomal proteins in the 80S ribosomes was
largely unaffected in the rps26b and rps28b strains (Figure S5) as evidenced by mass
spectrometry analysis suggesting that ribosome composition is not compromised in these strains.
Consistent with our proposal, deletion of RPS28B inhibited NGD on the SL and, to a lesser
extent, on the (CGA)12 and (AAA)12 reporters (Figure 5A). In contrast deletion of RPS26B had
little effect on the accumulation of the 5’-fragments. This difference between the two deletions can
be easily rationalized by the severity of the RPS28B deletion relative to the RPS26B deletion. This
was evident in the polysome profiles, for which the rps28b strain exhibited a much more
pronounced peak for the 60S subunit relative to the rps26b strain (Figure 5B). Furthermore, in
contrast to the rps28b strain, the rps26b strain did not accumulate 18S rRNA precursor.
Corroborating these observations is the finding that the growth rate of the rps26b strain was only
slightly reduced, whereas that of the rps28b strain was significantly reduced (Figure S5).
Collectively our data on the ribosome mutants suggests that
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Figure 5. Reducing ribosome density by deletion of rps28b or by limiting initiation inhibits
NGD.
(A) Northern analysis of 3’ fragment accumulation in ski2 cells expressing the indicated reporters
and deleted for rpl1b, rps26b, or rps28b respectively. Cleavage products were quantified relative
to the full PGK-stall reporter or to SCR1. The band corresponding to endogenous PGK1 is labeled
PGK1 end. (B) Polysome profiles from ski2, ski2 rps26b, and ski2 rps28b cells. (C)
Western blot used to assess reporter protein expression downstream of the indicated 5’UTR for
either control PGK or (CGA)12. Cells were grown in the presence of glucose (-) to suppress
induction or in the presence of galactose (+) to induce reporter expression. (D) Northern blot
analysis of mRNA cleavage from reporters containing longer 5’UTRs.

NGD efficiency is to a large extent dictated by ribosome density as a result of its direct
consequence on the frequency of ribosome collision.
So far our analysis of the effect of ribosome density on cleavage focused on altering
ribosome homeostasis, which is likely to have pleiotropic effects on cellular fitness. In our next
set of experiments we focused our efforts on changing ribosome density per mRNA by modifying
the reporter itself. We reasoned that by significantly increasing the UTR length, resulting in
prolonged scanning by the small subunit, initiation rates should be reduced to an extent that can
considerably limit the number of elongating ribosomes on the reporter (analogous to highway onramp signals to manage traffic). In particular, we replaced the UTR of the PGK1 gene in our
control and (CGA)12 reporter with that of the RPO21 and SCH9 genes (516- and 454-nts,
respectively). As expected, increasing the length of the UTR led to a profound decrease in protein
synthesis; in particular whereas induction of the PGK1-UTR control reporter resulted in an
eightfold increase in PGK1 protein levels, induction of the RPO21- and SCH9-UTR reporters
resulted in a dismal twofold increase of protein levels (Figure 5C). As important, these experiments
also established that the addition of the long UTRs does not abrogate recognition by the translation
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machinery and the new reporters are translated, albeit inefficiently. We note that we did not
observe an effect on protein accumulation of the (CGA)12 NGD reporter, most likely because these
reporters do not produce significant amounts of protein regardless of the UTR sequence (Figure
5C). Nevertheless, in contrast to the PGK1-UTR NGD reporter, for which short abortive products
are observed, the reporters with the long UTRs failed to produce observable short protein products
suggesting that they are not subject to NGD. In agreement with these observations, we detected
little to no 5’-RNA fragments in the presence of the reporters that harbor the long UTRs (Figure
5D). These observations provide independent support for our model that cleavage is sensitive to
ribosome “traffic” on NGD targets.
Induction of global collision events is accompanied by ubiquitination of the ribosomal
protein RPS3
Two recent reports from the Hegde and Bennett groups (Juszkiewicz and Hegde, 2017;
Sundaramoorthy et al., 2017) provided evidence to support that monoubiquitination of a number
of ribosomal proteins is critical for resolving stalled ribosomes. Deletion of the E3 ligase ZNF598,
or introducing mutations to its ribosomal proteins targets allows for readthrough on polyA
sequences and inhibits downstream RQC events. In agreement with these proposals, deletion of
HEL2, the yeast orthologue of ZNF598, was also previously shown to result in a similar phenotype
(Letzring et al., 2013; Saito et al., 2015). Motivated by these observations, we sought to explore
whether ribosome monoubiquitination is also triggered by ribosome collision. To accomplish this,
we took advantage of the fact that substituting proline for glutamine at residue 56 (P56Q) of
ribosomal protein RPL42 (eL42) renders ribosomes resistant to cycloheximide (Roguev et al.,
2007; Shirai et al., 2010). Fortuitously, in yeast RPL42 is encoded by two paralogues, RPL42A
and RPL42B, and as a consequence mutating one should result in a mixed population of ribosomes
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with respect to cycloheximide sensitivity. Hence, addition of cycloheximide to these strains should
result in global ribosomal collision.
We initially set out to assess the relative expression of RPL42A and RPL42B in our strain.
However, since the protein sequence is identical we opted to use qRT-PCR with gene-specific
primers to assess their transcript levels. Both genes express to substantial levels (as compared to
taf10), with RPL42B expressing at approximately twice the levels of RPL42A (Figure 6A). With
this in mind, we chose to introduce the P56Q mutation to RPL42B as we hypothesized this will
lead to increased ribosome stacking upon cycloheximide addition. We also introduced the same
mutation to both genes to make a strain that is fully resistant to cycloheximide. As expected, a
strain carrying wild-type copies of both genes was very sensitive to cycloheximide, for which no
growth was observed when the antibiotic was added to concentrations higher than 160 ng/mL
(Figure 6B). A strain harboring mixed populations of ribosomes was slightly more resistant to
cycloheximide but overall sensitive; robust growth was observed at an antibiotic concentration of
160 ng/L. Finally a strain carrying P56Q-mutant copies of both genes was fully resistant to
cycloheximide even when the antibiotic was added to 10 g/mL.
Having established that the RPL42 strains display the expected sensitivity towards
cycloheximide, we next explored the effect of the antibiotic on ribosomal protein
ubiquitination. We focused our efforts on RPS3, which has been shown to be ubiquitinated
in response to stalling (Juszkiewicz and Hegde, 2017; Sundaramoorthy et al., 2017). Tagging
the endogenous RPS3 with a FLAG tag allowed us to follow its modification as a
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Figure 6. Ribosome collision is accompanied by ubiquitination of ribosomal protein RPS3.
(A) Bar graph showing the relative transcript levels of the RPL42A and RPL42B genes to
TAF10 as assessed by qRT-PCR. The values are the mean of three biological repeats with
error bars depicting the standard deviation. (B) Growth curves of the indicated strains in the
presence of the specified cycloheximide concentrations. (C) Western-blot analysis of RPS3
modification (assessed by anti-FLAG antibody) in the cycloheximide –sensitive, –mixed and
–resistant strains in the presence or absence of the antibiotic. Arrowheads point to bands
that appear in the presence of cycloheximide. (D) Western-blot analysis of anti-FLAG
immunoprecipitated protein under conditions as in (C). Arrowheads point to bands that are
enriched after cycloheximide treatment. (E) Western-blot analysis used to explore the effect
of HEL2 on the cycloheximide-dependent modification of RPS3 as well as appearance of
ubiquitinated protein products in the cycloheximide-mixed strain. (F) Western-blot analysis
used to follow RPS3 modification and appearance of ubiquitinated protein products as a
function of cycloheximide concentration. Antibiotic concentrations from left to right: 100,
33, 11, 3.7, 1.2, 0.41, 0.14, 0.045, 0.015, 0.0051 and 0.00 g/mL.
function of cycloheximide addition using western blotting. We note that tagging RPS3 with
the longer 3 × FLAG tag altered the modification pattern, suggesting that ubiquitination is
likely dependent on the context of the C-terminus of RPS3. As expected, in the absence of
cycloheximide we observe little to no modification of RPS3 regardless of the strain
background (Figure 6C). In agreement with our collision-based model, we only observe
robust modification of RPS3 upon addition of cycloheximide to the mixed-ribosome strain.
The appearance of a band that corresponds to a mass shift of ~8 kDa (Figure 6C) is consistent
with monoubiquitin being added to the protein as has been shown by others (Juszkiewicz
and Hegde, 2017; Sundaramoorthy et al., 2017). In support of these ideas, we also detect an
accompanying accumulation of ubiquitinated proteins as judged by anti-ubiquitin blotting.
The addition of ubiquitin to RPS3 was further confirmed by immunoprecipitation of the
protein (using anti-FLAG resin) and subsequent blotting for ubiquitin (Figure 6D).
Consistent with our earlier western blotting analysis (Figure 6C), substantial signal for
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ubiquitin was only observed for the mixed strain in the presence of cycloheximide.
Furthermore as expected, the modification was no longer detected when HEL2 was deleted
from the mixed-ribosome strain, and the accumulation of ubiquitinated proteins was also
absent (Figure 6E).
The observation that cycloheximide on its own does not result in modification of RPS3
suggests stalling on its own cannot activate the RQC pathway. Having said that, we reasoned
that modification of RPS3 should be observed in the wild-type strain by titrating
cycloheximide to a concentration where it no longer saturates ribosomes. In other words,
concentrations at which binding of the antibiotic is dynamic should lead to collision of
ribosomes since at any given point some ribosomes will be bound by the antibiotic whereas
others will not. We titrated cycloheximide from 100 g/mL down to 5 ng/mL and looked at
the modification of RPS3. As expected, no ubiquitination was observed at the high and low
concentrations of cycloheximide (Figure 6F). Instead, and in agreement with our model, we
observed appreciable modification of RPS3 when the antibiotic was added at intermediate
concentrations (0.13-3.7 g/mL or 0.45–13 M). Interestingly, these concentrations are
close to the measured KD values for cycloheximide binding to the eukaryotic ribosome
(Garreau de Loubresse et al., 2014; Schneider-Poetsch et al., 2010), and as such association
between the antibiotic and the ribosome is most dynamic. In summary, these findings on the
RQC pathway strongly suggest that ribosome collision is somehow detected by the E3 ligase
HEL2 to ubiquitinate certain ribosomal proteins.
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DISCUSSION
Quality control pathways are widespread and utilized by all organisms to ensure that
cellular homeostasis is maintained. These processes typically inspect the integrity of biological
polymers and respond through repair or degradation of the aberrant molecules. Failing to respond
rapidly is often deleterious as is evident in the case of DNA repair, for which defects in the
machinery’s response to DNA damage can result in cellular death or cancer (Jeggo et al., 2016).
On the other hand, these processes are energetically expensive and as a result should not be called
upon unless needed. Therefore, it is paramount that these processes distinguish between real targets
and their look-alikes. This is especially true for the mRNA surveillance pathway of no-go decay.
The process responds to stalled ribosomes on defective mRNAs, but there are many examples in
biology that take advantage of slow ribosomes to regulate gene expression. Chief among these is
SRP targeting of nascent peptides to the ER (Akopian et al., 2013), during which the ribosome
essentially comes to a complete stop before being moved to the ER membrane to resume
translation. These events do not appear to trigger NGD and the corresponding mRNAs are not
short lived. These observations can be readily rationalized by a model whereby SRP’s interaction
with the ribosome inhibits the action of the endonuclease. Our data, however, argues that SRP
targeting does not elicit NGD because stalling occurs during the synthesis of the N-terminus before
multiple ribosomes can stack on the mRNA. Furthermore, efficiency of NGD is directly correlated
to ribosome density suggesting that ribosome collision is key in transmitting the activation signal
to the endonuclease. It is important to note that under normal conditions, initiation rates have been
estimated to be at least 100 fold slower than elongation rates (Yan et al., 2016). As such, ribosome
collisions are not typically encountered during translation, making undamaged transcripts poor
NGD targets. In other words, ribosomes have to be exceptionally slow before cleavage is induced.
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This in turn can explain why elongation rates are capable of varying greatly, which is an essential
feature of translation that is required for proper protein folding and trafficking (Kim et al., 2015).
Our model is also supported by observations that upstream open reading frame (uORF)
sequences that stall the ribosome are not subject to NGD (Guydosh and Green, 2014). These
sequences tend to be extremely short and can only accommodate one ribosome and as a result
collision cannot take place on these mRNAs. Perhaps the most compelling support comes from
studies on the ribosome-associated factor ASC1 (RACK1 in humans); a factor that appears to play
a role during NGD. Deletion of ASC1 or mutations that affect its association with the ribosome
results in significant read through on inhibitory CGA codons, but only when these are located deep
inside the open reading frame (Letzring et al., 2013; Wolf and Grayhack, 2015). Deletion of the
factor has no effect on read through when the CGA codons are located near the initiation codon
(4th amino acid). Also, no cleavage products were observed in this reporter; in contrast robust
cleavage is observed for the internal reporter. It should be noted that the read-though effects are
not specific to ASC1 as deletion of other NGD factors such as HEL2 results in a similar phenotype
(Letzring et al., 2013).
At least two important and related questions come out of our studies reported here: 1) Why
are multiple ribosomes required for efficient NGD? 2) How does collision activate the
endonuclease? While our data does not directly answer these questions, one can propose multiple
scenarios to address them. For instance it is possible that the endonuclease associates with a small
fraction of ribosomes and is activated upon stalling through perhaps an atypical conformation of
the ribosome such as a rotated state. Although this scenario does not explain the precipitous drop
in cleavage efficiency when the SL was moved upstream from position 175 to 135 in the PGK176

SL reporter (Figure 3). One could also imagine that the endonuclease is activated through
oligomerization, which can be mediated through stacked ribosomes. A precedent for this is the
yeast IRE1 endonuclease. The protein mediates the unfolded protein response through
translational-coupled splicing of the transcription factor HAC1. Upon ER-stress, the protein
oligomerizes into a higher order structure that appears to be responsible for its final activation
(Korennykh et al., 2009).
Our collision model for NGD is corroborated by recent ribosomal profiling studies in
eukaryotes as well as bacteria, for which < 2 ribosomes are typically seen behind a primary stalling
ribosome. In yeast, the addition of 3-Amino-1,2,4-triazole (3-AT), an inhibitor of HIS3, results in
global stalling as evident by the accumulation of ribosomal footprints near histidine codons
(Guydosh and Green, 2014). In contrast, footprints for the trailing ribosomes did not appreciably
increase. This absence of an expected “traffic jam” (Mitarai et al., 2008) suggests that collisions
are readily resolved. We note that even under these global conditions of stalling, polysomes were
found to collapse predominantly to monosomes after the addition of RNase I (Guydosh and Green,
2014) suggesting that ribosomes are not in close proximity to each other. Similar observations
were also made in E. coli, when stalling is induced through amino-acid starvation (Subramaniam
et al., 2014).
Arguably the most compelling evidence for ribosome collision playing a critical role in
quality control came from our analysis on ribosomal protein ubiquitination as a consequence of
cycloheximide-induced stalling. It has been noted for a while now that addition of the antibiotic
stabilizes mRNAs on the ribosome (Jacobson and Peltz, 1996), which puts forward a conundrum:
the antibiotic elicits global stalling, yet it does not trigger NGD. This observation can be easily
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rationalized by a scenario whereby the antibiotic stabilizes a ribosome state that is not productive
for endonucleolytic cleavage. Our model, however, provides an alternative explanation for the
inability of the antibiotic to trigger NGD. Under normal circumstances, cycloheximide stalls every
translating ribosome and as a result collisions are avoided. Similar to its apparent lack of effect on
NGD, cycloheximide-induced stalling does not result in the ubiquitination of the ribosomal protein
RPS3. However, by introducing a mutation that results in a mixed population of cycloheximideresponsive ribosomes, RPS3 was modified upon the addition of the antibiotic (Figure 6). Under
these conditions, global collision events are more likely to occur, which explains the gain of
modification observed. In agreement with this, titrating cycloheximide to a range of concentrations
near its binding affinity to the ribosome also resulted in modification of RPS3. At these
concentrations binding of the antibiotic to the ribosome is dynamic and hence at any given point a
subset of the ribosomes will be arrested. These observations reconcile earlier observations from
the Weissman group (Brandman et al., 2012), which linked the RQC pathway to HSF1 induction.
In these studies, cycloheximide activated HSF1 only at low concentrations.
Finally, our data offers some clues about the identity of the endonuclease. Our
observations, as well as those of others, of the ~30-nt gaps between mapped cleavage products
suggest that it is ribosome associated (Guydosh and Green, 2017). Our proposal of activation
through ribosome collision offers an elegant mechanism for its regulation. Interestingly, as
cleavage takes place in between tightly packed ribosomes, for which the downstream cleavage by
our estimate occurs 10-15 nt inside the secondary ribosome, it is feasible that the ribosome itself
is the endonuclease. As many of the ribosomal proteins are duplicated in yeast, it is conceivable
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that this redundancy is responsible for the failure of many NGD- and NSD-based screens to
identify the enzyme (Kuroha et al., 2010; Letzring et al., 2013; Wilson et al., 2007).
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METHODS
Yeast strains and growth conditions
Cells were cultured at 30°C in either YPD or in defined media when expressing reporter plasmids.
Yeast knockout strains were made using standard PCR-based disruption techniques in the
background BY4741 (MATa (his3Δ1 leu2Δ0 met15Δ0 ura3Δ0). HIS3 and HYG cassettes were
amplified from plasmids pFAGa-6xGLY-FLAG-HIS3 (Funakoshi and Hochstrasser, 2009) and
pFA6a-HTB-hphMX4 (Tagwerker et al., 2006) respectively using oligos complementary to the
target insertion sites.
The RPL42B(P56Q):HIS strain was constructed by cloning the RPL42B coding sequence into the
AscI/BglII sites and the RPL42B UTR into the SacI site of pFA6a-6xGLY-FLAG-HIS3. The
P56Q mutation was introduced by site directed mutagenesis and the entire cassette was amplified
and transformed. The RPL42A gene was mutated by amplifying overlapping regions of the coding
sequence, incorporating the P56Q mutation. These products were fused using PCR and the
resulting cassette used to transform the RPL42B(P56Q):HIS.
Strains carrying mixed cycloheximide-sensitive ribosome populations were treated with 100
g/mL cycloheximide for 30 min prior to pelleting for protein isolation.
Plasmid construction
The plasmids encoding the PGK1 gene and PGK1-SL under control of the GAL1 promoter were
obtained from R. Parker (Doma and Parker, 2006). PGK1-(CGA)12, PGK1-(AAA)12 and PGK1(UUU)12 were made by annealing complementary oligos and ligating them to XbaI digested PGK1
plasmid. To make stem loop reporters with the stall sequence at different positions, the existing
XbaI site from PGK1 was removed and new sites added using site-directed mutagenesis. The stemloop sequence was made by annealing a partially self-complementary oligo and extending it with
Klenow enzyme. The resulting double stranded sequence was then digested with XbaI and ligated
to XbaI-digested plasmids. Plasmids with longer 5’UTRs were constructed by amplifying the
entire PGK1 control plasmid or PGK1-(CGA)12 plasmid from the ATG of PGK1 to the upstream
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BamHI site and inserting a PCR product with the 5’UTR of RPO21 or SCH9, using BamHI and
XhoI.
The (CGA)4 luciferase assay reporter was made using site directed mutagenesis to insert the
(CGA)4 sequence between the Renilla and Firefly luciferase genes in pDB688 (Salas-Marco and
Bedwell, 2005).
Northern blotting
Culture was grown overnight in a defined media (-Ura) in the presence of glucose. The culture was
washed twice in media containing 2% raffinose and 2% galactose, diluted to OD 0.1 in the same
media and allowed to grow to an OD of 0.5-0.8 to induce the gal-driven reporters. RNA was
isolated using the hot phenol extraction method followed by chloroform extraction and ethanol
precipitation. The samples were then phenol-chloroform extracted and ethanol precipitated a
second time. 2 g of total RNA was resolved on 1.2% formaldehyde agarose gel, followed by
transfer to positively-charged nylon membrane (GE Lifesciences) using a vacuum blotter (Biorad).
Nucleic acids were UV cross-linked to the membrane and baked at 80°C for 15 minutes.
Membranes were then pre-hybridized in Rapid-Hyb buffer (GE Lifesciences) for 30 minutes in a
hybridization oven. Radiolabeled DNA probe, which was labeled using polynucleotide kinase and
[-32P]ATP, was added to the buffer and incubated overnight. Membranes were washed with
nonstringent buffer (2 × SSC, 0.1% SDS) three times, in some cases followed by three washes in
stringent buffer (0.2 × SSC, 0.1% SDS), all at hybridization temperature. Membranes were
exposed to a phosphorimager screen and analyzed using a Biorad personal molecular imager.
Northern blots performed on denaturing PAGE were resolved on 6% PAGE in TBE/urea followed
by transfer to positively-charged nylon membrane using a semi-dry transfer apparatus (Biorad) in
0.5 × TBE. The membranes were then treated exactly as those used for denaturing agarose.
3’-RACE mapping of cleavage products
Total RNA samples were ligated to a short adenylated DNA oligonucleotide, 5'
rAppCTGTAGGCACCATCAAT/3ddC/ 3', using truncated T4 RNA ligase 2 (NEB). Following
reverse transcription with a primer complementary to the adaptor, the cDNA was amplified with a
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5’-primer that annealed at the start codon. The forward and reverse primers introduced BamHI and
XhoI restriction sites, respectively, which allowed us to clone the samples into pPROEX-htb
(Invitrogen).
Next generation sequencing libraries
Next generation sequencing libraries were prepared as above except the cDNA was amplified
using primers designed for the Illumina HiSeq platform that contain sequence complementary to
the adaptor and to position 585 of PGK1. This position was chosen based on results from our lower
resolution mapping experiments. Samples were then column purified to remove primers.
Polysomes analysis
Yeast cultures were grown to mid-log phase before cycloheximide was added to a final
concentration of 100 μg/mL. The culture was chilled by adding an equal volume of ice and
centrifuged at 4°C. Cells were then resuspended in polysome lysis buffer (20 mM Tris pH 7.5, 140
mM KCl, 5 mM MgCl2, 0.5 mM DTT, 1% Triton-100, 100 μg/mL cycloheximide, 200 μg/mL
heparin), washed once and lysed with glass beads using a FastPrep (MP Biomedical). Supernatant
from cleared lysate corresponding to 1 mg of total RNA was layered over a 10-50% sucrose
gradient and centrifuged at 37,000 rpm for 160 min in an SW41Ti (Beckman) swinging bucket
rotor. Gradients were fractionated using a Brandel tube-piercing system combined with continuous
absorbance reading at A254 nm. RNA was isolated using phenol/chloroform extraction in the
presence of 1% SDS followed by ethanol precipitation. The extraction/precipitation protocol was
repeated to clean up the RNA samples further. Fractions were resolved on 1.2% formaldehyde
agarose and analyzed by Northern blots as described above.
Luminescence and western blot
5-10 ml of exponentially growing culture (defined media –Ura) was collected. The cell pellet was
washed with TE and resuspended in 100-200 L of passive lysis buffer (Promega). Lysis was
accomplished by adding glass beads (~ 50 L) to the sample and vortexing 5 × for a minute each
time at high speed, with incubation on ice in between each interval. The lysate was clarified by
centrifugation and diluted 30 to 50 fold. Luminescence was measured using the Dual-Luciferase
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Reporter Assay System (Promega) on a Tecan plate reader equipped with an automated injection
system.
For western blot assays, proteins were isolated using the NaOH/TCA method and resuspended in
HU buffer (8 M Urea, 5% SDS, 200 mM Tris pH 6.8, 100 mM DTT). Proteins were resolved on
12% SDS PAGE gels and transferred to PVDF membranes using a semi-dry transfer apparatus
(BioRad). The membranes were blocked with milk in PBST for ~ 30 minutes at room temperature
followed by incubation with primary antibody overnight at 4°C. After washing with PBST, the
membrane was incubated with the appropriate HRP-conjugated secondary antibody for ~ 1hr at
room temperature before washing 3-4 × with PBST. Detection was carried out on a GE
ImageQuant LAS 4000 using the Pierce SuperSignal West Pico Chemiluminescent Substrate. The
following antibodies were used: rabbit anti-RPS9 (ab117861), and mouse anti-PGK1[22C5D8]
(ab113687) from Abcam; mouse anti-FLAG [M2] from Sigma-Aldrich; mouse anti-Ub [P4D1]
(sc-8017) from Santa Cruz; rabbit anti-eRF1 was a gift from R. Green (Eyler et al., 2013); goat
anti-mouse IgG HRP (31430) and goat anti-rabbit IgG HRP (31460) from Thermo Scientific.
In vivo 35S-met labeling
Cultures were grown overnight in YPD, washed twice, diluted to OD 0.2 in defined media (-Ura)
and allowed to grow to OD 0.6. Cells were then washed twice in media lacking methionine (-Ura,
-Met) and resuspended at OD 0.6. 35S-methionine was added to ~10 nM (0.2 mCi 35S-met) and
cells were collected at intervals from 8 to 40 minutes. An aliquot was taken prior to addition of
labeled methionine for T=0. Proteins were isolated using the NaOH/TCA method and resuspended
in HU buffer. Samples were separated on 12% SDS-PAGE, transferred to PVDF membrane and
exposed to a phosphorimager screen, followed by western blotting for PGK1 as a steady-state
control. Samples were also separated on a second gel for Coomassie staining.
Quantitative RT-PCR
Total RNA from yeast cells was isolated following the hot phenol method (Kohrer and Domdey,
1991). cDNA was generated with M-MuLV reverse transcriptase (Promega) from 1ug of total
RNA that was treated with DNaseI (Themo Fisher Scientific) using a random hexamer for priming.
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Quantitative RT-PCR was conducted using iTaq Universal SYBR Green Supermix (BIO-RAD)
with ~50 ng of cDNA. Relative fold change was obtained by following the Ct method. Gene
expression was normalized to the expression level of the taf10 gene.
Yeast sensitivity assay
The sensitivity assay was carried out as described here (Toussaint and Conconi, 2006). In brief,
yeast cells were grown to mid-log-phase (OD600 of 0.5-0.7). Cells were collected, washed and
resuspended in YPD to a final density of OD 0.8. 5 ul of the cell suspensions were added to 195
ul of YPD with CHX at various concentrations, from 0-10 g/mL. All samples were prepared in
biological triplicates as well as technical duplicates in 96-well polystyrene microplates. The plate
was incubated at 30°C with shaking on a microplate scanning spectrophotometer (Biotek). Cell
density was monitored every 10 min over 24-48 h at 600nm.
Immunoprecipitation with anti-FLAG resin
Yeast cells were grown to mid-log phase (OD600 of 0.5-0.7). Cycloheximide was added at 100
ug/mL to one half of the culture and cells collected after an additional 30 minutes. Cells were
washed once and resuspended in lysis buffer (50 mM Tris-HCl, pH 7.4; 150 mM NaCl; 1 mM
EDTA, 1% Triton), then lysed with glass beads using a FastPrep (MP Biomedical).
Resin (Anti-FLAG M2 affinity gel, Sigma) was prepared by rinsing in TBS twice, washing three
times with 0.1 M Glycine HCl, pH 3.5, and washing 5 times in TBS. Lysate was added to the
washed resin and allowed to incubate for 4 hours at 4°C while rotating. Resin was collected by
brief centrifugation and proteins were eluted using SDS loading buffer. DTT was added to the
samples following the elution step and proteins were analyzed by western blotting.
Tandem mass spectrometry
Approximately 50 µg ribosomes were denatured in 8M urea in a total volume of 100 µl. Proteins
were then reduced in the presence of 10 mM dithiothreitol at room temperature for 1 hour, and
alkylated in the dark in the presence of 50 mM 2-iodoacetamide at room temperature for a further
1 hour. Excess alkylating agent was then quenched with 50 mM dithiothreitol for 5 minutes at
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room temperature, and the sample was diluted with 900 µl of 25 mM ammonium bicarbonate to
reduce the urea concentration to below 1.5 M. Proteolytic digestion was then initiated by adding
0.5 µg of sequencing grade modified porcine trypsin (Promega), giving a total protein to trypsin
ratio of approximately 30:1, and the samples were incubated overnight at 37°C. Peptides then were
vacuum dried in a Speed Vac™ centrifugal evaporator (Savant Instruments, model number
SUC100H) to a final volume of approximately 250 µl, acidified with 10% trifluoroacetic acid
(TFA) until the pH was less than 3, then desalted and concentrated on a 100 µl Bond Elut™ OMIX
C18 pipette tip (Agilent Technologies), as according to the manufacturer’s instructions. The
sample was eluted in 50 µl of 75% acetonitrile, 0.1% acetic acid, then dried and resuspended in 50
µl 5% acetonitrile, 0.1% formic acid. Nano-scale liquid chromatography (LC) separation of tryptic
peptides was performed on a Dionex Ultimate™ 3000 Rapid Separation LC system (Thermo
Scientific). The protein digests were loaded onto a 1 μl nanoViper™ sample loop (Thermo
Scientific), and separated on a C18 analytical column (Acclaim® PepMap™ RSLC C18 column,
2 μm particle size, 100 Å pore size, 75 µm x 15 cm (Thermo Scientific)) by the application of a
linear 2 hour gradient from 1.8% to 32% acetonitrile in 0.1% formic acid, with a column flow rate
set to 250 nl/min. Analysis of the eluted tryptic peptides was performed online using a Q
Exactive™ Plus mass spectrometer (Thermo Scientific) possessing a Nanospray Flex™ Ion source
(Thermo Scientific) fitted with a stainless steel nano-bore emitter operated in positive electro-spray
ionisation (ESI) mode at a capillary voltage of 1.85 kV. Data-dependent acquisition of full MS
scans within a mass range of 380-1500 m/z at a resolution of 70,000 was performed, with the
automatic gain control (AGC) target set to 1 x 106 , and the maximum fill time set to 100 ms. High
energy collision-induced dissociation (HCD) fragmentation of the top 15 most intense peaks was
performed with a normalized collision energy of 28, with an intensity threshold of 2 x 105 counts
and an isolation window of 3.0 m/z, excluding precursors that had an unassigned, +1, +7 or +8
charge state. MS/MS scans were conducted at a resolution of 17,500, with an AGC target of 2 x
105 and a maximum fill time of 100 ms. Dynamic exclusion was performed with a repeat count of
2 and an exclusion duration of 8 seconds, while the minimum MS ion count for triggering MS/MS
was set to 4 x 103 counts. The resulting MS/MS spectra were analyzed using Proteome
Discoverer™ software (version 2.0.0.802, Thermo Scientific), which was set up to search the S.
cerevisiae proteome database, as downloaded from www.uniprot.org/proteomes (ID number
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UP000002311). Peptides were assigned using SEQUEST HT (Eng et al., 1994), with search
parameters set to assume the digestion enzyme trypsin with a maximum of 2 missed cleavages, a
minimum peptide length of 6, precursor mass tolerances of 10 ppm, and fragment mass tolerances
of 0.02 Da. Carbamidomethylation of cysteine was specified as a static modification, while
oxidation of methionine and N-terminal acetylation were specified as dynamic modifications. The
target false discovery rate (FDR) of 0.01 (strict) was used as validation for peptide-spectral
matches (PSMs) and peptides. Proteins that contained similar peptides and which could not be
differentiated based on the MS/MS analysis alone were grouped, to satisfy the principles of
parsimony. Label-free quantification as previously described (Silva et al., 2006) was performed in
Proteome Discoverer™ with a minimum Quan value threshold of 0.0001 using unique peptides,
and “3 Top N” peptides used for area calculation. All samples were injected in duplicate, and the
resulting values were averaged.
QUANTIFICATION AND STATISTICAL ANALYSIS
High throughput sequencing analysis
Single read HiSeq 2500 sequencing was performed by the Genome Technology Access Center
(GTAC) at Washington University. Quality of Raw data was analyzed using the Fastx toolkit
(http://hannonlab.cshl.edu/fastx_toolkit/index.html), followed by trimming using cutadapt
(Martin, 2011) and aligned to our reference reporter sequence using NovoAlign
(http://www.novocraft.com/).
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ABSTRACT
During translation, an mRNA is typically occupied by multiple ribosomes sparsely distributed
across the coding sequence. This distribution, mediated by slow rates of initiation relative to
elongation, ensures that they rarely collide with each other, but given the stochastic nature of
protein synthesis, collision events do occur. Recent work from our lab suggested that collisions
signal for mRNA degradation through no-go decay (NGD). We have explored the impact of
stalling on ribosome function when NGD is compromised and found it to result in +1
frameshifting. We provide multiple lines of evidence to suggest that +1 frameshifting is induced
through ribosome collision. For instance, efficient +1 frameshifting does not occur unless the stall
sequence is placed beyond ~20 nucleotides from the initiation codon, suggesting that it requires
multiple ribosomes to load onto the mRNA. Furthermore, we observe a positive correlation
between ribosome density and frameshifting efficiency. For programmed frameshifting no such
correlation was observed, suggesting that they exploit a distinct mechanism for recoding. In a welldefined bacterial system, we find that frameshifting at a stall sequence within the downstream gene
of a polycistronic mRNA depends on the translation of the upstream gene and hence collisions. As
a result, it is tempting to speculate that NGD, in addition to its role in mRNA-quality control,
evolved to cope with stochastic collisions events to prevent deleterious frameshifting events.
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INTRODUCTION
At any point during protein synthesis, a single mRNA is typically occupied by multiple
ribosomes (Warner et al., 1963). Biochemical assays, as well as computational studies, have shown
ribosomes to be thinly distributed across transcripts, rarely coming in close proximity to one
another (Brandt et al., 2010, Brandt et al., 2009, Kennell and Riezman, 1977, Kierzek et al., 2001,
Siwiak and Zielenkiewicz, 2013). This sparse distribution is the result of at least two distinct
mechanisms. The first involves vastly differential translation-initiation and -elongation rates. In E.
coli, the rate of initiation has been estimated to be in the range of ~1 codon s -1 (Mitarai et al., 2008),
whereas that of elongation has been measured to be ~20 codons s -1 (Sorensen and Pedersen, 1991).
The second mechanism involves the apparent clustering of rare codons near the start codon (EyreWalker and Bulmer, 1993, Tuller et al., 2010), which has been hypothesized to slow down early
elongating ribosomes, acting like a ramp and hence ensuring that ribosomes do not collide into
each other downstream (Dobrzynski and Bruggeman, 2009). Despite these mechanisms, modeling
studies suggest that ribosome collisions are inevitable given the stochastic nature of translation
(Mitarai et al., 2008). Collisions are predicted to slow down the lagging ribosome significantly,
which would, in turn, increase the likelihood of additional collisions and subsequent ribosome
pileups. These effects can be minimized by decreasing the stability of the mRNA, but this comes
at a cost of reduced protein output per mRNA. It has been estimated that, for a codon-optimized
lacZ mRNA, which is translated an average of 30 times in E. coli, stochastic collisions lengthen
the translation time by 5% compared to an mRNA that is translated once (Mitarai et al., 2008).
These models suggest that not only do ribosome collisions occur frequently, even on codonoptimized mRNAs, but that they are costly, slowing down protein synthesis overall.
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Ribosome collisions have been best studied in the context of defective mRNAs that stall
ribosomes. More specifically, mRNAs harboring stable secondary structures, inhibitory codons,
internal polyA sequences, damaged nucleobases and ones that encode for peptides that interact
with the exit tunnel of the ribosome are all well documented to dramatically inhibit translation
(Brandman and Hegde, 2016, Simms et al., 2016). These mRNAs activate the processes of no-go
decay (NGD) and ribosome-associated-quality-control (RQC) to rapidly degrade the defective
mRNAs and the incomplete nascent peptide (Bengtson and Joazeiro, 2010, Doma and Parker,
2006). NGD is initiated through an endonucleolytic cleavage- by an unknown enzyme- upstream
of the stall site, exposing the mRNA for the exonucleolytic action of Xrn1 and the exosome (Doma
and Parker, 2006, Tsuboi et al., 2012). RQC requires the action of a number of factors that
recognize a peptidyl-tRNA-bound large subunit (Brandman et al., 2012, Defenouillere et al.,
2013). Briefly, the E3 ligase Ltn1 (Listerin in mammals) adds K48-linked-ubiquitin chains to the
peptide (Bengtson and Joazeiro, 2010). Following release by Vms1 (ANZF1 in mammals)(Verma
et al., 2018), the ubiquitinated peptide is recognized by the adaptor protein Cdc48 and presented
to the proteasome for degradation (Defenouillere et al., 2013, Verma et al., 2013). In addition to
RQC and NGD, dissociation of the stalled ribosomes into their respective small and large subunits
by Dom34/Hbs1/Rli1 ensures that they are rescued to be utilized for new bouts of translation.
Ribosome rescue, NGD and RQC are all dependent on the action of the E3 ligase Hel2 (Znf598 in
mammals) (Matsuo et al., 2017, Garzia et al., 2017, Juszkiewicz and Hegde, 2017,
Sundaramoorthy et al., 2017). The factor ubiquitinates various ribosomal proteins through K63linked chains and deletion of the factor inhibits all of the processes associated with ribosome
stalling.
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Until recently, an important question for the field was: how are these stalls recognized; in
other words, how does Hel2 distinguish stalled ribosomes from slow ones? Initial models
suggested that stalled ribosomes adopt a distinct conformation that is recognized by the E3 ligase
(Matsuo et al., 2017). While this model was tempting, it lacked mechanistic insights into how this
conformation could be attained. Instead, a more appealing model emerged recently that describes
the factor recognizing collided ribosomes resulting from stalls. A major basis of this model, as put
forward by our group, is the observation that ribosomal-protein ubiquitination by Hel2 is
significantly increased when global ribosome collisions are induced (Simms et al., 2017). Recent
studies from the Hegde, Ramakrishnan, Inada and Beckman groups provided important structural
support for this model; collided ribosomes form an interface on the small subunits that bring
together the target ribosomal proteins for ubiquitination by Hel2 (Ikeuchi et al., 2019, Juszkiewicz
et al., 2018). Further biochemical characterization of these reactions showed the factor to prefer
higher-order structures of ribosomes, i.e. polysomes. Analysis of Hel2 binding to RNA in vivo
revealed that, although it binds most mRNA species, binding to the initial 150-nt of the coding
sequence is significantly depleted, suggesting that it requires multiple ribosomes to initiate quality
control (Winz et al., 2019). This is consistent with the observation that NGD is only robust when
the stall sequence is >100 nt from the initiation codon (Simms et al., 2017). Therefore, it appears
that eukaryotic cells have evolved a pathway to recognize and respond to ribosome collisions,
suggesting that they are detrimental to cellular homeostasis if they go unresolved.
Analogous biochemical studies on replication and transcription have revealed that DNAand RNA-polymerases often collide with each other resulting in so-called “conflicts” (GarciaMuse and Aguilera, 2016). These “conflicts” are especially problematic for replisome integrity
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thus necessitating mechanisms for their resolution (Azvolinsky et al., 2009, Merrikh et al., 2011).
To this end, DNA-damage-response factors are able to sense these collision events, and in most
cases remove the RNA polymerase (Poli et al., 2016, Tehranchi et al., 2010, Tuduri et al., 2009).
Failure to resolve collided polymerases has been shown to be associated with genomic instability
(Prado and Aguilera, 2005, Helmrich et al., 2013). In contrast to replication, the consequences of
unresolved collision events during translation is poorly understood. In particular, whether they
could modify the decoding properties of the ribosome, and especially frame maintenance, is
unknown.
This potential connection between mRNA-quality control and frame maintenance is
consistent with the observation that deletion of asc1 (RACK1 in mammals), which is a key factor
in RQC (Kuroha et al., 2010, Brandman et al., 2012) and is predicted to act upstream of hel2
(Juszkiewicz and Hegde, 2017, Sundaramoorthy et al., 2017, Matsuo et al., 2017, Sitron et al.,
2017), leads to +1 frameshifting in yeast (Wolf and Grayhack, 2015). However, a connection
between frame maintenance and ribosome collision has not been explored. Equally important is
the fact that stochastic ribosome collisions are predicted to be frequent and are likely to activate
Hel2. Indeed, we have previously shown that increasing stochastic collisions by addition of subinhibitory concentrations of cycloheximide leads to robust ribosomal protein ubiquitination by
Hel2 (Simms et al., 2017). These observations beg the question of whether ribosome-based-quality
control evolved to cope with stochastic collision events that would otherwise lead to frameshifting.
Here we show, using various reporters in yeast as well as a well-defined in vitro bacterial
translation system, that collisions result in +1 frameshifting. In yeast, inhibition of NGD was found
to be accompanied by a significant increase in +1 frameshifting. We further show that efficient +1
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frameshifting does not occur unless the stall sequence is placed beyond ~20 nucleotides from the
initiation codon, suggesting that it requires multiple ribosomes to load onto the transcript.
Furthermore, we observe a positive correlation between ribosome density and frameshifting
efficiency. No such correlation was observed for programmed frameshifting, suggesting that they
exploit a distinct mechanism for recoding. In agreement with our model that ribosome collisions
induce +1 frameshifting we find that, in a well-defined bacterial system, frameshifting on a stall
sequence within the downstream gene of a polycistronic mRNA depends on the translation of the
upstream gene and hence, collisions. In conclusion, our data strongly suggest that collisions are
detrimental to frame maintenance and that NGD is likely activated frequently on regular mRNAs
to resolve stochastic collision events.
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RESULTS
Inhibition of NGD leads to +1 frameshifting
As collisions activate NGD and are accompanied by the rapid degradation of the mRNA
(Simms et al., 2017), their effect on ribosome function could only be studied in the absence of
pathway activity. We have recently reported that the entry tunnel residues of ribosomal protein
Rps3 (Figure 1A, 1B) are important for the endonucleolytic cleavage reaction (Simms et al., 2018),
thus providing us a means to examine frameshifting in the context of inhibited NGD. To probe
frameshifting in these variant yeast strains, we utilized a dual luciferase reporter (Salas-Marco and
Bedwell, 2005), for which the downstream firefly luciferase (FL) coding region is in different
frames relative to the upstream renilla luciferase (RL) coding region, either -1, in frame, or +1
(Figure 1C). Stalling on this reporter was promoted through the addition of inhibitory CGA codons
between the two genes (Letzring et al., 2010). The ratio of FL luminescence to that of RL was used
to measure the amount of frameshifting that occurred. We note that since this reporter is a
translational fusion any effects of the mutations on the RNA stability, and hence its levels, should
be minimized. Indeed, qRT-PCR analysis using primers specific to the FL region and the RL one
showed that the mutations in RPS3 as well as in ASC1, known to affect NGD, have little to no
effect on the RNA ratio of the two reporters (Figure S1).
On a reporter containing AGA codons, which are synonymous for CGA codons but do not
cause stalling, mutation of Rps3’s entry tunnel residues had no discernable effect on relative FL
expression levels. In contrast and as expected, FL expression was significantly reduced (to 31 ±
15%) in wild type cells carrying the reporter with in-frame CGA codons. Interestingly, in the
presence of the Rps3 mutations the relative FL expression was further reduced (to 13 ± 9.2%),
presumably due to increased frameshifting when stalling occurs. Consistent with this idea, direct
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measurements using frameshifting reporters showed that in the presence of CGA codons, +1
frameshifting is significantly higher relative to that seen in the presence of AGA codons. In
particular, the relative FL expression was measured to be 0.16 ± 0.1% and 1.0 ± 0.2% for the
(AGA)4+1 and (CGA)4+1 reporters, respectively. Including the Rps3 mutations increased
frameshifting a further fivefold (to 5.3 ± 1.2%) on the (CGA)4+1 reporter (Figure 1C). To provide
further support for this observed effect of the mutations on frameshifting, we also tested 4 more
sequences that were previously identified by the Grayhack group to promote frameshifting in the
absence of Asc1 (Gamble et al., 2016, Wang et al., 2018). On two of these sequences, namely
(CGACCG)3+1 and (AGAATT)3+1, the mutations in the entry tunnel increased frameshifting,
albeit to a lesser extent than that observed on the CGA codons (Figure 1D). This suggests that
collision-induced +1 frameshifting occurs in the absence of functional NGD.
As expected, the mutations did not promote frameshifting on codons that do not induce
stalling and also did not promote -1 frameshifting (Figure S2). Furthermore, the Rps3 mutations
had no effect on programmed frameshifting efficiency, as assessed using a construct that had the
frameshifting sequence from the Ty1 transposable element (Figure 1D). This particular
programmed frameshifting construct was chosen due to its simple sequence requirement of a 7-nt
motif and high frameshifting efficiency (Belcourt and Farabaugh, 1990). Western analysis
corroborated these results and revealed that the mutations increase +1 frameshifting specifically
on the (CGA)4+1 reporter, but not on the Ty1 one (Figure S3). These findings suggest that since
programmed frameshifting likely occurs in a collision-independent manner, inhibition of NGD is
inconsequential. Similarly, the mutations do not promote nonsense and missense types of
miscoding as assessed by constructs that replace the active site Lys residue of the firefly luciferase
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(K529) (Kramer and Farabaugh, 2007) by other amino acids or a stop codon (Figure 1E). In these
constructs, firefly luminescence reports on the frequency of the ribosome misreading the mutated
codon as a Lys. Collectively, our data supports the notion that, when NGD does not occur,
ribosomes undergo +1 frameshifting at a stall; it appears that other aspects of decoding are not
affected.

Figure 1. Mutation of Rps3’s entry tunnel residues increases +1 frameshifting on stalling
sequences.
A) Overview of the structure of the eukaryotic small ribosomal subunit complexed with mRNA
and P-site tRNA (PDB ID 5AJ0). The mRNA entry tunnel, encompassing residues from Rps3 and
Rps2, is highlighted as well as the proximity of Rack1 (Asc1 in yeast) and its interaction with
Rps3. B) A close up view of the entry tunnel, where the ribosome makes the most intimate contacts
with the mRNA (in orange). Rps3 and Rps2 are shown in dark and light magenta, respectively,
101

other ribosomal proteins are shown in green, whereas the rRNA is depicted in cyan. C) The
R116A; R117A mutations increase +1 frameshifting on CGA codons. The architecture of the dualluciferase reporter is shown on top; the XYZ indicates the different nucleotides that were inserted
in the linker region between the two coding sequences. An additional adenosine (A) was added for
the +1 frameshifting reporters. Relative luminescence of firefly luciferase (FL) to that of renilla
luciferase (RL) from the indicated reporters in the wild-type and mutant Rps3 strains is plotted.
The readings were normalized to those measured from the non-stalling (AGA)4 reporter. Asterisk
denotes a significant difference between wild type and mutant rps3 for (CGA)4+1 (p<0.005). For
comparison, p=0.096 for the (AGA)4+1 reporter. D) The Rps3 mutations promote frameshifting
on previously-described stalling sequences. Bar graphs of the normalized luminescence ratio (to
the original reporter with no insertion between the two reporters) for the indicated reporters in the
wild-type and Rps3-mutant strains. E) The Rps3 mutations have little to no effect on programmed
frameshifting. Normalized ratios of FL luminescence to that of RL for a reporter harboring the
Ty1 transposon frameshifting site in wild-type and rps3 strains. F) The entry tunnel mutations do
not affect missense and nonsense miscoding. Normalized luminescence ratios for reporters, which
have the active-site FL Lys residue (K529) mutated to the indicated amino acid. In all cases, the
mean + SD of at least three biological repeats is plotted.

Entry tunnel residues of Rps2 do not affect frameshifting
Alongside Rps3, the mRNA entry tunnel of the ribosome encompasses residues of Rps2
(Figure 1B), namely K119, E120, Q94, R95, suggesting that the protein may also play a role in
frame maintenance. However, previous data from our group showed mutations in this region of
Rps2 to have no observable effect on mRNA cleavage during NGD (Simms et al., 2018).
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Consistent with their apparent lack of effect on NGD, these mutations did not change frameshifting
efficiency on the (CGA)4+1 reporter (Figure S4). Furthermore, the RPS2 mutations did not alter
the increased levels of frameshifting observed in the rps3 (R116A; R117A) background. These
observations suggest that Rps3 plays an especially important role in frame maintenance beyond its
role as a constituent of the helicase domain of the ribosome. In agreement with this notion, genetic
screens by the Culbertson and Grayhack groups identified a separate mutation in Rps3 (K108E),
which promotes efficient +1 frameshifting (Hendrick et al., 2001, Juszkiewicz et al., 2018, Wang
et al., 2018). This mutation also caused increased frameshifting on our (CGA)4+1 reporters (Figure
S4) lending additional support to the idea that Rps3 plays a general role in preventing unwanted
+1 frameshifting.

Asc1/RACK1 promotes frame maintenance independently of Rps3
To examine the potential contribution of other NGD components, we introduced the Rps3
mutations into yeast backgrounds that affect the pathway, but none were found to alter the observed
increased levels of frameshifting seen in the Rps3 mutant alone (Figure 2A). Furthermore, in
addition to Rps3, the ribosome-associated factor Asc1 (human RACK1) has been documented to
affect multiple facets of NGD and ribosome-quality control (RQC) of nascent peptides during
stalling (Ikeuchi and Inada, 2016, Letzring et al., 2013, Sitron et al., 2017, Wolf and Grayhack,
2015). Most relevant to our studies is the observation that in yeast its deletion results in increased
frameshifting on CGA codons (Wolf and Grayhack, 2015); furthermore, the protein interacts with
the C-terminal end of Rps3 on the ribosome (Ben-Shem et al., 2011). Hence, it is possible that the
increased frameshifting we observe in the presence of the Rps3 mutations are due to Asc1-specific
defects. We addressed this by introducing mutations to Asc1 (R38D and K40E) known to greatly
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reduce its association with the ribosome (Coyle et al., 2009). As has been reported earlier for the
asc1 deletion (Wolf and Grayhack, 2015), these mutations enhanced frameshifting on our
(CGA)4+1 construct to 5.8 ± 0.18%. In the presence of the Rps3 mutations alone, the observed
occurrence of frameshifting was 13.7 ± 0.9%, and surprisingly, when combined with the asc1
mutations we observe a compounding effect, resulting in 36.0 ± 2.4% frameshifting, suggesting
that the factors may, at least in part, contribute to NGD independently (Figure 2B). This is
consistent with structural and biochemical studies showing that Asc1 interacts with Rps3 away
from the entry tunnel (Ben-Shem et al., 2011), and that mutations of Rps3’s entry-tunnel residues
do not affect the interaction between Asc1 and the ribosome (Simms et al., 2018). The same
mutations appear to have little to no effect on +1 frameshifting on polyA sequences, presumably
because frameshifting on these sequences results in the same sequence in the A site and does not
alleviate stalling (Figure S5). Similarly, frameshifting on reporters harboring other stretches of
positively-charged amino acids was not affected (Figure S5).
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Figure 2. +1 frameshifting does not depend on NGD components but is correlated with
ribosome density.
A) Deletion of NGD factors does not alter the effect of the Rps3 mutations on frameshifting.
Normalized ratios of FL luminescence to that of RL for the (CGA) 4+1 reporter in the indicated
strains. B) The effects of Rps3 mutation on frameshifting are additive with mutations in Asc1. The
bar graph shows the normalized luminescence ratios for the (CGA) 4+1 reporter in the indicated
strains. In the double mutant (rps3; asc1), frameshifting efficiency is nearly 40%. C) Bar graph of
normalized FL/RL luminescence ratios for the indicated reporters in wild-type and rpl1b strains.
D) Similar to first dataset in C). Deletion of rpL1b results in decreased +1 frameshifting. In all
cases, the mean + SD is plotted from at least three biological replicates, normalized to values for
the (AGA)4 reporter.
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Ribosome density is correlated with +1 frameshifting
Our analysis suggests that there is a correlation between NGD inhibition and increased +1
frameshifting, but the underlying mechanism is unclear. We suggest that in the absence of efficient
cleavage of the aberrant mRNA, an increase in collision events, which go unresolved, results in a
steric clash between ribosomes. Consequently, this somehow causes the leading ribosome to move
out of frame, which in turn alleviates stalling (the P-site codon changes from the inhibitory CGA
one to GAC). A prediction of this model is that frameshifting should be correlated to ribosome
density. Earlier work by our laboratory has shown that reducing cellular ribosome concentrations
by depleting ribosomal proteins strongly inhibits NGD (Simms et al., 2017). This in turn results in
readthrough of CGA codons. It is important to note that the mechanism by which reduction of
ribosome density inhibits NGD –decreased collision events– is different from the one induced by
the rps3 mutations –increased collision events–; hence their effects on frameshifting should also
be divergent. In complete agreement with our model, deletion of one of the two genes that encode
ribosomal protein Rpl1 (rpl1b) decreased frameshifting by fourfold (from 2.8 ± 0.17% to 0.7 ±
0.15%) (Figure 2C, 2D). Deletion of rpl1b has a dramatic effect on ribosome concentrations, but
not its composition, that is apparent in polysome profiles of the deletion strain; a marked decrease
in the amount of polysomes indicates a reduction in the density of ribosomes on mRNAs (Simms
et al., 2017). Interestingly, this relationship between ribosome density and “unwanted” +1
frameshifting is in direct contrast to what we know about programmed frameshifting, for which
slowed translation is a major determinant for increased recoding (Kawakami et al., 1993).

+1 frameshifting increases at greater distances from the initiation codon
To further probe the mechanism for collision-induced frameshifting, we placed the
frameshifting site (the inhibitory CGA codons) at various distances from the initiation codon. The
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rationale behind these experiments is that at distances close to the initiation codon, the stalling
sequence would prevent multiple ribosomes from loading onto the transcript, precluding collisions.
Indeed, we observe no increase in frameshifting relative to the wild-type strain in the rps3 and
asc1 mutants, unless the stalling sequence is placed at least 22 nts from the initiation codon (Figure
3A). The efficiency of frameshifting increases as the stalling sequence moves farther from the
initiation codon, consistent with the idea that loading multiple ribosomes behind the primary
stalled ribosome increases frameshifting. This pattern was by and large independent of the rps3
mutations; we observe a very similar dependence on stalling-sequence placement in the K108E
mutant (Figure S6), which is also in agreement with data reported by Wolf and Grayhack (2015).
Although programmed frameshifting also appears to be dependent on the frameshifting site, there
was no obvious correlation between distance from start site and frameshifting efficiency. For Ty1,
we observe equivalent efficiencies for constructs harboring the site between 3 and 83 nt from the
start codon, but frameshifting significantly increases when it was placed at position 429 (Figure
3B). For the programmed frameshift sequence EST3, frameshifting efficiency was higher for
position 3 relative to positions 22 and 83, but significantly increased for position 429 (Figure S6).
These observations, again, highlight the important distinctions between programmed and
“unwanted” frameshifting.
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Figure 3. Frameshifting on CGA inhibitory codons depends critically on the position of the
stalling sequence and is likely to require multiple ribosomes to load onto the mRNA.
A schematic of the reporter indicates the dual-luciferase-fusion reporter together with a GFP
reporter under a constitutive promoter that is oriented opposite to the luciferase reporter. The
frameshifting site (fs) was placed at different positions throughout the renilla coding sequence. A)
Frameshifting only occurs on reporters that have the fs site placed at least 22 nucleotides from the
initiation codon. Ratios of FL luminescence to GFP fluorescence for the indicated reporters,
normalized to values obtained using the wild-type strain, obtained in the presence of the rps3
(R116A; R117A), asc1 (R38D; K40E) and the double mutation are plotted. B) Similar to A), but
the (CGA)4+1 fs sequence was substituted with the (programmed fs) Ty1 transposon sequence. In
all cases, the mean + SD of at least three biological repeats is plotted.

+1 frameshifting correlates with the efficiency of gene expression
Next, we sought to change ribosome density specifically on our frameshifting reporters
without affecting overall ribosome homeostasis. We reasoned that by modifying the 5’-UTR
sequence, we should be able to change initiation efficiency and hence ribosome density. In the first
approach, we introduced stem loops of various lengths in the 5’-UTR of the reporters; these should
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slow or inhibit scanning by the small subunit during initiation (Hinnebusch et al., 2016). These
reporter plasmids, in addition to having the dual luciferase gene to measure frameshifting, harbor
a gene that encodes sf-GFP (Pedelacq et al., 2006). Both genes are under constitutive promoters.
As a result, the ratio of renilla luminescence to GFP fluorescence reports on translation efficiency
of the reporters with the different stem loops; and that of firefly luminescence to the renilla one
reports on frameshifting. As expected, the introduction of the stem loops reduced the expression
of renilla luciferase by as much as four orders of magnitude and this reduction correlated well with
the equilibrium constant of unwinding for the stem loops (Figure 4A). Importantly, the level of
frameshifting correlated well with gene expression, and presumably ribosome density, regardless
of the mutation. For the rps3; asc1 mutant, we measured an R value of 0.84; for the rps3(K108E),
we measured an R value of 0.79 (Figure 4B, 4C and Figure S7). Therefore, initiation efficiency,
and likely ribosome density, is a good predictor for frameshifting efficiency.
As a second approach for this collision model, we introduced different natural yeast 5’UTRs into our frameshifting reporter. In total, we generated 22 reporters with 5’-UTRs that span
a broad length (30 to 829 nucleotides), which we expected to have drastic effects on initiation
efficiency and hence gene expression (Hinnebusch et al., 2016). We measured ratios of renilla
luminescence to GFP fluorescence (our measure for translation efficiency) that were more than an
order of magnitude different among the different UTRs. Likewise, frameshifting efficiency varied
by more than fivefold among the different reporters (Figure 4D, 4E and Figure S7). Most pertinent
to our model, however is the observation that, similar to our stem-loop reporters, the amount of
frameshifting we observed was found to correlate tightly with gene expression, with R values of
0.71 and 0.79 for the rps3; asc1 and rps3(K108E) mutants, respectively. Similar to what we
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documented for the stem-loop reporters, no correlation between translation efficiency and
frameshifting was observed for programmed Ty1 frameshifting (Figure 4F). The results for asc1
may highlight differences in its role with respect to frameshifting as it correlates with gene
expression in the stem loop experiments, but not in the UTR ones (Fig. S7). It may also be due to
our choice of strain – we observe lower frameshifting efficiencies with the R38DK40E mutations
than are reported for the asc1 deletion strain (Wolf and Grayhack, 2015). Collectively, our use of
reporters with disparate initiation rates suggests that translation efficiency, and hence ribosome
density, contributes significantly to “unwanted” frameshifting.
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Figure 4: Efficiency of stalling-induced frameshifting correlates with gene expression.
A schematic of the reporter, which harbors the fs site between RL and FL coding sequence, is
shown on top. Stem loops of various lengths were introduced in the UTR of the dual-luciferase
gene. A) Plot of the ratio of RL luminescence relative to GFP fluorescence versus the equilibrium
constant of unwinding of the stem loops. The equilibrium constants were calculated from G
values determined by mfold (Zuker, 2003). B) A plot of luminescence ratios (RL/FL), which
reports on fs efficiency, against that of RL luminescence to GFP fluorescence, which reports on
gene-expression, in the rps3; asc1 double mutant. C) Similar to B, but in the rps3 K108E mutant.
D) A schematic of the reporter is shown on top. It is similar to the one shown in A, but instead of
stem loops various native yeast UTRs were introduced upstream of the dual-luciferase gene. The
plot is similar to B) but uses the UTR reporter set. E) Similar to C), with UTR reporter set. F) A
schematic of the reporter used to assess the effect of gene-expression efficiency on programmed
fs is shown. The reporter is similar to that used in D) but harbors the Ty1 fs sequence between RL
and FL instead of the stalling (CGA)4+1 sequence. The plot shows FL/RL luminescence ratios
versus RL luminescence divided by GFP fluorescence. Note the lack of correlation between the
two. In all cases, the mean + SD of at least three biological repeats is plotted.

Collision is required for +1 frameshifting-dependent gene expression in vitro
To address the collision model more directly, we chose to use the bacterial reconstituted
PURE system (NEB) because of the polycistronic organization of genes in bacteria. This allowed
us to generate mRNA reporters consisting of two genes with overlapping coding sequences. In
particular, the initiation codon of the downstream gene resides within the coding region of the
upstream one, and translation of its full-length product depends on an early frameshifting event
(poor stop-codon context with CCC UGA coding for Pro-STOP at codon 7 from the start codon)
(Gurvich et al., 2003). In other words, translation of this gene in isolation would allow for a
maximum of one ribosome to load before the frameshift site is encountered. As a result, if
frameshifting is dependent on ribosome collision, then the translation of the downstream gene
should be dependent on the translation of the upstream gene. As a positive control, we generated
a reporter for which translation of the downstream gene does not depend on frameshifting (Figure
5A). In both cases, the upstream gene contains sequences that encode cysteine, whereas the
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downstream one does not and, as expected, translation of the upstream gene, which contains an Nterminal-HA tag, was dependent on cysteine for both reporters. In the absence of cysteine, the
amount of protein products as assessed by western blotting decreased by ~twofold (Figure 5B).
This incomplete inhibition of synthesis of the upstream product is likely due to partial deacylation
of the tRNAs in the reaction mix. Regardless, synthesis of the downstream protein products, as
assessed by western blotting against the C-terminal-Flag tag, differed between the two reporters.
For the positive-control reporter, depletion of cysteine had little to no effect on its translation
(Figure 5B). This was expected as the downstream gene does not encode cysteine residues. In
contrast and in agreement with our prediction, for the frameshifting reporter we observed a
~twofold reduction of protein produced for the downstream gene in the absence of cysteine. This
suggests that its synthesis depends on translation of the upstream gene, since the downstream
protein does not contain any cysteine residues, and therefore it is likely that collisions from
ribosomes translating the upstream gene are required to induce frameshifting on the downstream
gene. Not only do these observations add support for ribosome collisions playing an important role
in promoting frameshifting, but they also suggest that the mechanism is conserved, occurring in
bacteria as well as in eukaryotes.
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Figure 5. Collisions result in frameshifting in a reconstituted bacterial system.
A) A schematic of the reporters used to assess the effect of collisions on frameshifting. The
reporters are bicistronic, with the initiation codon of the downstream gene residing within the
upstream gene. The first ORF codes for an N-terminal HA tag as well as cysteine residues
throughout. ORF 2 codes for a C-terminal FLAG tag and no cysteine residues; it is in the +1 frame
relative to the upstream gene. For the collision reporter, the downstream gene has a stop codon in
a poor context (CCC TGA) and requires a frameshift to translate the C-terminal FLAG. B)
Western-blot analysis of in vitro translation reactions with the indicated reporters in the presence
or absence of cysteine. Synthesis of the upstream protein, assessed by probing with HA, is more
robust in the presence of cysteine. Synthesis of the downstream protein from the collision reporter
is twice as abundant in the presence of cysteine, and hence the synthesis of the upstream protein.
Arrowhead indicates the band for the downstream product.
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DISCUSSION
The ability of the ribosome to precisely and repetitively move three nucleotides at a time
during the elongation phase of protein synthesis is an indispensable feature of the translation
machinery. This maintenance of reading frame ensures that the genetic code is faithfully
deciphered. To this end, frameshifting errors are among the most deleterious ones, especially when
compared to missense errors, as they result in peptide products that bear no resemblance to the
intended protein. Precise translocation, and hence the prevention of frameshifting, is not an easy
task given the multiple coordinated movements of the mRNA, tRNA and the ribosomal subunits
that must occur (Noller et al., 2017). After peptidyl transfer, the peptidyl-tRNA residing in the A
site must move to the adjacent P site. Initially, the acceptor stem of the tRNA moves from the A
site to the P site of the large subunit, while the anticodon stem remains in the A site of the small
subunit, forming the so-called “hybrid” state (Moazed and Noller, 1989). Following EF-G (eEF2)
binding, GTP hydrolysis and Pi release, full translocation of the tRNA to the P site of the ribosome
is completed (Brilot et al., 2013, Pulk and Cate, 2013, Ramrath et al., 2013, Tourigny et al., 2013,
Voorhees and Ramakrishnan, 2013, Zhou et al., 2013, Zhou et al., 2014, Belardinelli et al., 2016,
Noller et al., 2017). During this process, multiple interactions between the tRNA-mRNA complex
and the ribosome must be disrupted, and new ones established. Multiple elements of the ribosome,
translation factors and the tRNA contribute to these interactions and hence the precision of the
translocation process. Indeed, mutations in the tRNA, mRNA and the ribosome that alter some of
these interactions have been shown to modulate translocation mechanics and accuracy (Atkins and
Bjork, 2009).
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The P-site tRNA, through its interaction with the mRNA codon, appears to play an
important role in reading frame maintenance (Baranov et al., 2004). More specifically, the
likelihood of the tRNA anticodon to transiently dissociate and establish new out-of-frame basepairing interactions is governed by the energetics of binding to the P-site codon. In addition to
tRNA-mRNA interactions, stalling plays a major role in promoting frameshifting. This is mainly
dictated by the nature and availability of the A-site ligand (Farabaugh et al., 2006). For example,
during RF2-programmed frameshifting in bacteria, the efficiency of frameshifting at the poorly
decoded RF2-specific UGA stop codon is significantly impacted by the concentration of cellular
RF2 (Craigen and Caskey, 1986). Finally, frameshifting is heavily influenced by structural
impediments upstream or downstream of the ribosome. Using RF2-programmed frameshifting as
an example again, this impediment is provided by a Shine-Dalgarno sequence upstream that has
been hypothesized to base pair with the rRNA, pulling the mRNA out of frame (Marquez et al.,
2004, Devaraj and Fredrick, 2010).
Here we provide compelling evidence that, if left unresolved, ribosomes colliding behind
the primary stalled one provide the necessary structural element for efficient frameshifting. To
look at unintended frameshifting, we chose the CGA codon and yeast as a model system. The
wobble adenosine nucleotide, as decoded by inosine on the anticodon, provides the necessary weak
interaction in the P site, which presumably allows for dissociation and reassociation of the tRNA.
The presence of an adjacent slowly-decoded CGA codon in the A site lends the additional
requirement of stalling for efficient frameshifting (Letzring et al., 2010). Our data suggests that
these two requirements are not sufficient for frameshifting to occur. Ribosome queuing is needed
to complete the requirements, similar to those noted for programmed frameshifting.
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Previous data from our group as well as others have shown ribosome collisions to activate
the process of NGD (Simms et al., 2017, Juszkiewicz et al., 2018, Ikeuchi et al., 2019), which
results in the endonucleolytic cleavage of the mRNA and hence resolving collisions. Consistent
with our collision-induced frameshifting model, inhibition of the cleavage reaction by introducing
mutations to the ribosomal protein Rps3 in the entry tunnel increases frameshifting significantly.
This agrees with data from the Grayhack group that showed deletion of the NGD/RQC factor Asc1
also results in significant frameshifting (Wolf and Grayhack, 2015). Here, we too show that
mutations of Asc1 that disrupt its interaction with the ribosome promote frameshifting. Ribosomeassociated Asc1 appears to be important for the recruitment of the E3 ligase Hel2 (Juszkiewicz
and Hegde, 2017, Sundaramoorthy et al., 2017, Matsuo et al., 2017, Sitron et al., 2017), which
adds K63-linked ubiquitin chains on collided ribosomes (Ikeuchi et al., 2019). Deletion and
mutation of Asc1 have been documented to inhibit NGD-associated cleavage of the mRNA and
downstream ribosome rescue by Dom34/Hbs1/Rli1 (Ikeuchi and Inada, 2016). Asc1 likely senses
collided ribosomes and somehow communicates that information to Hel2. In its absence,
ribosomes pile up behind the primary stalled one and cause it to move out of frame. Interestingly,
previous work also from the Grayhack group has suggested that the ribosome associated protein
Mbf1 is recruited to stalled ribosomes where, together with Rps3, they may act as bumpers,
preventing adjacent ribosomes from colliding (Wang et al., 2018).
Although there are previous reports of a relationship between frameshifting and NGD, the
connection between frameshifting and ribosome collision, and the underlying mechanics have not
been explored prior to the work presented here. We provide various pieces of evidence to support
a direct influence of ribosome queuing on frameshifting efficiency. For instance, reducing the
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cellular concentration of ribosomes, which decreases their density on mRNA and hence their
likelihood of collision, lowered frameshifting by more than threefold (Figure 2D). Furthermore,
when the stalling sequence is placed near the initiation codon, so that a maximum of one ribosome
can occupy the mRNA before encountering the stall site, we observe little to no increase in
frameshifting as a result of NGD inhibition. The correlation between ribosome density and
frameshifting efficiency is bolstered by our observation that alteration of ribosome loading onto
the mRNA by modulating initiation efficiency impacted frameshifting by almost an order of
magnitude (Figure 3). We document a significantly positive correlation between translation
efficiency, and hence ribosome loading, and frameshifting (Figure 3). It should be noted that in
these experiments, ribosome density was only altered on our reporters without globally affecting
translation. Finally, and perhaps the strongest piece of supporting evidence comes from our
experiments in a reconstituted bacterial translation system. Here we observe that frameshifting on
the downstream gene of a polycistronic mRNA depends critically on the ability of ribosomes to
translate the upstream gene and collide with the ribosomes stalled on the downstream one (Figure
5). Collectively through the use of various reporters and genetic manipulations in yeast as well as
a high-resolution in vitro bacterial translation system, we provide data that strongly suggest that
ribosome collisions result in +1 frameshifting.
Given that ribosome collisions are likely to happen during translation under normal
conditions, it should not be surprising that a mechanism for reducing their impact on cellular fitness
may have evolved. In conclusion, we propose a mechanism for collision-induced frameshifting
(Figure 6), whereby the behind ribosome translocates along the mRNA until it reaches the stalled
ribosome at which point the mRNA is stretched completely. Under normal conditions, this triggers
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cleavage and downstream events of NGD. Under conditions where cleavage is inhibited, the
behind ribosome is free to pull on the mRNA –since its A-site codon is competent –exerting force
on the fully-stretched RNA, resulting in slippage by the stalled ribosome causing it to frameshift.

Behind ribosome
pulls on mRNA

X

Stall

Lead ribosome
frameshifts
Figure 6. A model for collision-induced frameshifting.
In this model the colliding, behind ribosome pulls on the mRNA resulting in its slippage from
the A site of the lead, stalled ribosome.

Not only does this study add critical insights into frame maintenance and its relationship
to mRNA-quality control processes, but also suggests that ribosomes are able to change the
decoding properties of their neighboring ones. While there has been a wealth of studies that have
looked at the role of RNA structure and sequence on frameshifting (Farabaugh et al., 2006), this
study may be the first to look at the ribosome itself acting in trans to affect the decoding properties
of another ribosome. Beyond adding new mechanistic details into the role of trans factors in
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promoting frameshifting, our findings suggest that this is a widespread phenomenon that cells need
to deal with, especially given that ribosome collisions are predicted to occur frequently. As a result,
it is tempting to speculate that NGD, in addition to its primary role in mRNA-quality control
(Simms et al., 2016), evolved to cope with stochastic collisions events that are bound to take place
occasionally and, if left unresolved, result in deleterious frameshifting events. At a minimum our
data reveals a profound connection between an mRNA surveillance mechanism and maintaining
the integrity of the decoding process.
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METHODS
Yeast strains
Yeast strains were cultured in YPD or defined media (when expressing reporter plasmids)
at 30°C. Strains carrying mutations were constructed using standard PCR-based recombination
techniques in the background BY4741 (MATa (his31 leu20 met150 ura30). Strains used in
this study are included as Supplemental Table 1.
The RPS2 mutant strains were generated by cloning a PCR fragment encoding RPS2LEU2-rpS2 3’UTR into the BamHI/XbaI sites in pPROEX-Htb. Point mutations in RPS2 were
introduced by site directed mutagenesis, the entire region PCR amplified and the resulting
fragment used for transformation of target yeast strains. RPS3 (K108E) strains were made in the
same manner, except a HIS3 gene was used to tag RPS3 and the PCR product was cloned into
pPROEX-Htb using BamHI and XhoI sites. The HIS3 and LEU2 coding regions were amplified
from plasmids pFA6a-6xGLY-FLAG-HIS3 and pAG415 respectively(Alberti et al., 2007,
Funakoshi and Hochstrasser, 2009). pAG415-GPD-ccdB was a gift from Susan Lindquist
(Addgene plasmid # 14146; http://n2t.net/addgene:14146).
Plasmids
The Renilla-Firefly dual luciferase reporter was constructed from plasmid pDB688(SalasMarco and Bedwell, 2005) using site-directed mutagenesis to insert various sequences between
the two coding regions. These included the CGA and AGA codon repeats (with an extra A in the
+1 constructs), and the Ty1 and EST3 fs sequences. The Lys 529 constructs were built similarly,
with mutations introduced into the firefly luciferase gene.
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The GFP-dual luciferase reporter was assembled from overlapping PCR products; the GPD
promoter sequence from pAG415 driving GFP(Wolf and Grayhack, 2015) in one orientation, with
a dual luciferase frameshifting cassette positioned in the opposite direction and driven by a PGK1
promoter. In the first set of constructs, frameshifting sequences ((CGA) 4+1, Ty1, or EST3) were
inserted into the Renilla luciferase gene by PCR amplifying the entire plasmid and re-ligating using
AgeI sites that were included in the primer oligos. For experiments with constructs containing
various stem loop or 5’ UTR sequences, PCR fragments were cloned into BglII sites downstream
of the PGK1 promoter or AscI/SbfI sites, respectively.
The in vitro fs constructs were designed with two overlapping coding regions, derived from
sequences for E. coli InfA and DHFR, and the dsDNA templates were obtained from IDT.
All plasmid constructs and DNA oligos used in this study are included as Supplemental Table 2.
Luminescence Assays - Dual Luciferase Reporters
5-10 ml of exponentially growing culture (defined media –Ura) was collected. The cell
pellet was washed with TE and resuspended in 100-200 µL of passive lysis buffer (Promega).
Lysis was accomplished by adding glass beads (~ 50 µL) to the sample and vortexing 5 × for a
minute each time at high speed, with incubation on ice in between each interval. The lysate was
clarified by centrifugation and diluted 30 to 50-fold. Luminescence was measured using the DualLuciferase Reporter Assay System (Promega) on a Tecan plate reader equipped with an automated
injection system.
Luminescence Assays - GFP + Dual Luciferase Reporters
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Overnight cultures were grown to saturation in 0.5 mL media in 96-well deep well plates,
diluted 1:100 into 1 mL media and grown to OD ~ 0.5-0.8. Cells were then pelleted, washed once
with sterile water and pelleted again. 25 L of 1 mg/mL zymolase in buffer [50 mM Tris-Cl (pH
7.5); 10 mM MgCl2; 1 M sorbitol; 30 mM DTT] was added per well, shaken briefly to mix, and
incubated at 37C for 30 minutes. Cells were lysed by adding 250 L 1X Passive Lysis Buffer
(Promega) and shaking vigorously for 10 minutes. After brief centrifugation, 50 L of lysate was
added to each well of a 96-well plate. GFP fluorescence was measured using a Tecan plate reader
(485 nM excitation/530 nM emission) immediately followed by luminescence measurement using
the Dual Luciferase Reporter Assay system (Promega).
For all luciferase reporter assays, experiments were run in triplicate and the data was
analyzed and plotted using Graphpad Prism.
Quantitative RT-PCR.
Total RNA from different yeast cells was isolated following the hot phenol method. cDNA was
then generated with M-MuLV reverse transcriptase (Promega) from 2ug of total RNA that was
treated with DNase 1 (Themo Fisher Scientific). Quantitative RT-PCR was conducted by using
iTaq Universal SYBR Green Supermix (BIO-RAD) with ~50ng of cDNA. Relative fold change
was obtained by following the Ct method between the RL and FL PCR products.
In vitro translation assays
Assays were performed using the PUREexpress in vitro protein translation kit (NEB),
according to the manufacturer’s protocol.
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Western blotting
Proteins were isolated using NaOH/TCA and were resuspended in HU buffer (8 M Urea,
5% SDS, 200 mM Tris pH 6.8, 100 mM DTT). Proteins were resolved on 12% SDS PAGE gels
and transferred to PVDF membrane using a semi-dry transfer apparatus (BioRad). Membranes
were blocked in 5% milk/PBST for ~ 30 minutes at room temperature followed by incubation with
primary antibody overnight at 4°C. After washing with PBST, the membrane was incubated with
the appropriate HRP-conjugated secondary antibody for ~ 1hr at room temperature before washing
3-4 × with PBST. Detection was carried out on a GE ImageQuant LAS 4000 using Pierce
SuperSignal West Pico Chemiluminescent Substrate. The following antibodies were used: mouse
anti-FLAG [M2] from Sigma-Aldrich; HA-probe antibody, Y-11 (Santa Cruz, sc-805), AntiRenilla Luciferase Antibody, clone 1D5.2 (milipore, MAB4410), Anti-Firefly Luciferase antibody
(Abcam, ab21176) rabbit anti-eRF1 was a gift from R. Green(Eyler et al., 2013); goat anti-mouse
IgG HRP (31430) and goat anti-rabbit IgG HRP (31460) from Thermo Scientific.
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CHAPTER 4: Oxidation and alkylation
stresses activate ribosome-quality control
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ABSTRACT
Oxidation and alkylation of nucleobases are known to disrupt their base-pairing properties
within RNA. It is, however, unclear whether organisms have evolved general mechanism(s) to
deal with this damage. Here we show that the mRNA-surveillance pathway of no-go decay and
the associated ribosome-quality control are activated in response to nucleobase alkylation and
oxidation. Our findings reveal that these processes are important for clearing chemically modified
mRNA and the resulting aberrant-protein products. In the absence of Xrn1, the level of damaged
mRNA significantly increases. Furthermore, deletion of LTN1 results in the accumulation of
protein aggregates in the presence of oxidizing and alkylating agents. This accumulation is
accompanied by Hel2-dependent regulatory ubiquitylation of ribosomal proteins. Collectively, our
data highlight the burden of chemically damaged mRNA on cellular homeostasis and suggest that
organisms evolved mechanisms to counter their accumulation.
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INTRODUCTION
The mRNA-surveillance pathway of no-go decay (NGD) is a eukaryotic ribosome-based,
quality-control mechanism that targets transcripts stalled on ribosomes during translation . Much
of the mechanistic details of NGD have emerged from a wealth of studies using yeast as the
model(Doma and Parker, 2006; Passos et al., 2009; Shoemaker and Green, 2011; Shoemaker et
al., 2010; Tsuboi et al., 2012), but the process appears to be highly conserved and employs a
homologous set of factors in most other eukaryotes. In particular, when ribosomes stall upon
encountering a defective mRNA, three key events occur: (i) the defective transcript is degraded
rapidly; (ii) the stalled ribosomes are rescued; and (iii) the incomplete-nascent peptides are
subjected to proteolysis. RNA breakdown is accomplished by at least two pathways; a primary
route that involves the major 5’-3’ exonuclease Xrn1 and a secondary route triggered through an
endonucleolytic cleavage of the bound transcript upstream of the stalled ribosome(Bengtson and
Joazeiro, 2010; Brandman et al., 2012; Defenouillere et al., 2013; Doma and Parker, 2006;
D’Orazio et al., 2019; Pisareva et al., 2011; Shoemaker and Green, 2011; Shoemaker et al., 2010;
Tsuboi et al., 2012). Endonucleolytic cleavage generates an uncapped 3’-fragment and a
deadenylated 5’-fragment, which are rapidly turned over through the exonucleolytic actions of
Xrn1 and the exosome, respectively. As a result of this cleavage, ribosomes translating the 5’fragment run to the end of the mRNA, hence displaying an empty A site, which in turn marks them
for the dissociating activity of Dom34/Hbs1/Rli1(Pisareva et al., 2011; Shoemaker and Green,
2011; Shoemaker et al., 2010). The splitting action of Dom34/Hbs1/Rli1 leaves a peptidyl-tRNAbound large ribosomal subunit that is recognized by the ribosome-associated-quality-control
(RQC) process(Brandman et al., 2012; Defenouillere et al., 2013). RQC engages a number of
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factors to recognize the incomplete-nascent peptide, release it from stalled ribosomes, and deliver
it to the proteasome for breakdown. The ubiquitin-protein ligase (E3) Ltn1 plays a key role during
this process by adding K48-linked polyubiquitin chains to the nascent peptide while bound to the
60S subunit as a peptidyl-tRNA adduct(Bengtson and Joazeiro, 2010; Brandman et al., 2012).
Following release of the ubiquitylated peptide by the nuclease Vms1(Izawa et al., 2017; Kuroha
et al., 2018; Verma et al., 2018; Yip et al., 2019; Zurita Rendón et al., 2018), the free species is
recognized by the Cdc48-Ufd1-Npl4 disaggregase complex for final presentation to the
proteasome(Defenouillere et al., 2013; Shao et al., 2013; Verma et al., 2013, 2018).
Although NGD and RQC are initiated by the same signal - a stalled ribosome - how
activation of the two processes is coordinated and, more specifically, how quality-control factors
recognize and are recruited to ribosomes stalled on aberrant mRNAs remained largely unclear until
recently. The discovery that ribosomal proteins are ubiquitylated during stalling and that the trigger
for this modification is collided ribosomes shed new light on the activation events surrounding
NGD and RQC(Juszkiewicz and Hegde, 2017; Matsuo et al., 2017; Saito et al., 2015;
Sundaramoorthy et al., 2017). In yeast, the E3 ligase Hel2 has been shown to be a critical effector;
it adds K63-linked polyubiquitin chains onto stalled ribosomal proteins, especially those within
the small subunit. Accordingly, its deletion alleviates stalling and increases the production of fulllength-protein products from reporters engineered to stall(Brandman et al., 2012; Kuroha et al.,
2010; Letzring et al., 2013; Sitron et al., 2017). Hel2 appears to recognize collided
ribosomes(Ikeuchi et al., 2019a; Juszkiewicz et al., 2018), which are expected to arise during
stalling given that most mRNAs are occupied by multiple ribosomes such that collisions with
lagging ribosomes are inevitable if downstream ribosomes stop translating. Subsequent
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ubiquitylation of stalled ribosomes provides the signal for the degradation of the aberrant mRNA,
as either deletion of Hel2 or the introduction of mutations that prevent ribosomal protein
ubiquitylation stabilizes the aberrant transcript(D’Orazio et al., 2019; Ikeuchi et al., 2019a; Simms
et al., 2018). In this capacity, Hel2 is considered to be a master regulator that connects NGD and
RQC.
NGD and RQC have been studied almost exclusively in the context of artificial reporters
that were genetically engineered to harbor roadblocks that stop ribosomes from translating. These
blocks include: stable-RNA-secondary structures such as long stem loops, internal polyA
sequences, stretches of rare codons, inhibitory codon pairs, and sequences encoding peptides that
interact with the exit tunnel of the ribosome(Arribere and Fire, 2018; Chen et al., 2010; Doma and
Parker, 2006; Guydosh and Green, 2017; Letzring et al., 2013; Tsuboi et al., 2012). While studies
employing these reporters have been instrumental in unraveling the key mechanistic details related
to NGD and RQC, the utility of these processes and their activation in response to different
biological cues remain unclear.
We previously showed that mRNAs harboring 8-oxoguanosine (8-oxoG) stall translation
in an in vitro reconstituted translation system, suggesting that oxidized mRNAs are targeted for
NGD(Simms et al., 2014). Furthermore, many alkylative adducts, especially those with a modified
Watson-Crick face that are predicted to interrupt base-pairing during tRNA selection, also stall
translation(You et al., 2017). In addition, unwanted modification of nucleic acids, especially in the
context of DNA damage, has been well documented to occur as a result of nucleobase reactivity
with endogenous and exogenous agents(Cadet and Wagner, 2013; Yan and Zaher, 2019). One
example is reactive oxygen species (ROS) that generate nucleobase adducts with altered base133

pairing properties(Neeley and Essigmann, 2006; Sampoli Benítez et al., 2013). The adduct 8-oxoG
is of particular note given its abundance, due to the inherent reactivity of guanosine with ROS(Lü
et al., 2010; Simms and Zaher, 2016), as well as its proclivity to adopt a syn conformation capable
of Hoogsten-type basepair interactions with adenosine(Sampoli Benítez et al., 2013). Conversely,
alkylating agents can modify the nitrogen and oxygen atoms of the nucleobases(Sedgwick, 2004).
Some of these modifications, including N1-methyladenosine (m1A), N1-methylguanosine (m1G)
and N3-methylcytosine (m3C), are cytotoxic when present in DNA as they block replication and
hence are predicted to stall translation(Larson et al., 1985; Simms and Zaher, 2016).
While the above observations imply that cells have evolved pathways to recognize
damaged mRNA and rapidly degrade it, the mechanistic details are not fully appreciated. Because
transcripts that harbor damaged adducts are likely to stall translation, we hypothesize that damaged
mRNA is subject to NGD while the encoded peptide is cleared by a RQC mechanism. Here, we
tested this hypothesis and showed that both processes are activated by alkylation and oxidative
stress to rapidly degrade chemically-modified mRNAs and the resulting aberrant peptides encoded
by them. Collectively, our data suggest that NGD and RQC evolved coordinately to cope with
adduct-mediated ribosome stalling and highlight the potential burden of chemically-modified
mRNAs on cellular homeostasis.
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RESULTS
Xrn1 deletion leads to oxidized and alkylated adducts in mRNA
During NGD, regardless of the pathway involved, the aberrant mRNA is degraded by Xrn1(Doma
and Parker, 2006; Tsuboi et al., 2012) . Deletion of this factor is known to stabilize not only a fulllength NGD reporter transcript but the cleaved 3’ fragment as well(Tsuboi et al., 2012). We
reasoned that if damaged mRNA is subject to NGD, then deletion of XRN1 should increase the
levels of modified nucleotides in the mRNA pool such as the oxidation product 8-oxoG. We
previously used competitive ELISAs to show increased levels of 8-oxoG in xrn1 yeast
cells(Simms et al., 2014). As this method is not sufficiently sensitive or quantitative, we used here
two more analytical methods, namely electrochemical detection (ECD) (Fig. 1a) coupled with
HPLC(Park et al., 1992) and LC-MS to better quantify the adduct(Su et al., 2014). Total RNA was
isolated from wild-type and mutant cells and subjected to two rounds of poly-dT purification to
enrich for poly-A RNA (Fig. 1 and Supplementary Fig. 1a). Total RNA and mRNA-enriched
samples were then treated with P1 nuclease and the resulting nucleotides were dephosphorylated
to nucleosides using calf-intestinal phosphatase (CIP) before analysis. Consistent with previous
reports(Shen et al., 2000), we measured under normal conditions a ratio of 8-oxoG to G of 4 x 105

and 3.7 x 10-5 in total RNA by ECD and LC-MS, respectively. As expected, this ratio did not

change in xrn1 cells (Fig. 1b and Supplementary Fig. 1b, c). However, when poly-A RNA was
specifically analyzed, the ratio of 8-oxoG to G increased by more than twofold when XRN1 was
deleted (Fig. 1b and Supplementary Fig. 1c), suggesting that oxidized mRNA is selectively prone
to Xrn1-mediated quality control.
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Figure 1. Oxidized and alkylated mRNAs accumulate in the absence of Xrn1.
a, A representative HPLC-ECD chromatogram used to quantify the concentration of 8-oxoG in
our samples. b, Bar graphs showing the ratio of 8-oxoG to G in total and polyA RNA in presence
and absence of Xrn1. c, Bar graphs showing that the ratio of 8-oxoG to G in total and polyA RNA
significantly increases when 4-NQO is added to growing yeast cells. d, Bar graphs demonstrating
the ratio of the indicated alkylation adducts relative to their respective unmodified nucleoside in
polyA RNA in the presence and absence of Xrn1. e, Same as d, but in the absence and presence
of MMS. In all cases, Bars represent the average (±SD) of at least three independent biological
replicates. Source data are provided as a Source Data file.
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To add further support for our model that damaged mRNA in general is selectively targeted
for degradation, we analyzed specific alkylative damage marks, including m1A, m1G and m3C,
which are known to disrupt base pairing(Larson et al., 1985; Simms and Zaher, 2016), as well as
N7-methylguanosine (m7G), which does not disrupt base pairing. After processing of the RNA,
the modified nucleosides were quantified by sensitive LC-MS methods(Su et al., 2014) that can
detect 3.5-8.8 fmol of nucleoside (Supplementary Fig. 1e, f). Similar to our observations with 8oxoG, deletion of XRN1 significantly increased levels (2-3 fold) of the alkylative adducts known
to disrupt Watson-Crick base pairing within mRNA (m1A, m1G, and m3C), while a more modest
increase (~1.5 fold) was seen for m7G that does not modify Watson-Crick base pairing (Fig. 1d).
As expected, deletion of XRN1 has little to no effect on the levels of these modifications in total
RNA given their natural presence in rRNA and tRNA (Supplementary Fig. 1g). Collectively, the
data agreed with our model that modified mRNAs, for which base pairing with tRNAs could be
significantly disrupted, are subject to quality control with Xrn1 playing a critical role in their
prompt degradation.

Oxidizing and alkylating agents increase modifications in mRNA
Our initial findings implicated Xrn1 in rapidly degrading chemically-damaged mRNAs.
We expect NGD to be responsible for this process whereby modified mRNAs are recognized by
ribosomes, which in turn recruit downstream factors required for RNA degradation and RQC
activation. To provide support for this model, we initially focused on increasing the levels of
damaged mRNAs in yeast, which would allow us to assess whether different components of the
quality-control pathways are activated. We took advantage of several damaging agents known to
modify nucleic acids, including the UV-mimic 4-nitroquinoline 1-oxide (4-NQO) which generates
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ROS and hence the oxidation of G(Arima et al., 2006; Kohda et al., 1986), and methyl
methanesulfonate (MMS) which alkylates RNA via SN2-reactive species that modify the exocyclic
oxygen and nitrogen atoms within the nucleobase(Lawley, 1974). As expected, the addition of 4NQO at 5 g/mL for 30 minutes led to a greater than 10-fold increase of 8-oxoG in polyA-RNA,
but no significant increase in total alkylated bases (Fig. 1a, c, Supplementary Fig. 1i). Similarly,
the addition of MMS at 0.1% for 30 minutes produced a 30-fold, 160-fold and 50-fold increase of
m1A, m3C, and m7G in polyA-RNA, respectively, but no significant changes to the level of total
8-oxoG (Fig. 1e, Supplementary Fig. 1d). We noted that the basal levels of these modified
nucleosides in total RNA, were much higher given their natural presence in rRNA and tRNA
species(Boccaletto et al., 2018). As a result, the addition of MMS led to only a modest increase in
their levels (Supplementary Fig. 1h). Regardless, our findings revealed that the addition of 4-NQO
and MMS causes the widespread accumulation of damaged nucleotides in the mRNA, which in
turn should pervasively stall ribosomes.

4-NQO and MMS increase ubiquitylation of nascent peptides
During RQC, the peptidyl-tRNA bound to the 60S subunit is recognized by Ltn1, which
adds K48-linked polyubiquitin chains to the nascent peptide before its extraction by Cdc48 and
presentation to the proteasome for degradation(Defenouillere et al., 2013; Verma et al., 2013). We
reasoned that if 4-NQO increased the accumulation of 8-oxoG within mRNA, which in turn would
stall ribosomes, a hyper-accumulation of ubiquitylated nascent peptides upon addition of the
chemical would be observed. The levels of these peptides should increase when Cdc48 is
inactivated and decrease without Ltn1. As CDC48 is an essential gene in yeast; we opted to use a
temperature-sensitive allele for the analysis(Verma et al., 2013). To specifically assess
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ubiquitylation of nascent peptides, we used puromycin, a ribosomal A-site mimic that reacts with
peptidyl tRNAs on the ribosome and terminates protein synthesis, to label nascent peptides.

Figure 2. Ubiquitinated-nascent peptides accumulate in the presence of the oxidizing agent
4-NQO.
a, A schematic showing the experimental setup used to assess the amount of nascent peptides in
the ubiquitinated pool. After the addition of 4-NQO, cells are harvested, lysed and puromycin is
added to react with stalled ribosomes. TUBE beads are then used to bind ubiquitinated proteins.
The purified proteins are separated using SDS-PAGE and probed with anti-puromycin antibody.
b, Western-blot analysis of the input and TUBE-bound samples in the absence and presence of 4NQO for the wild-type, cdc48-ts, ltn1 and cdc48-ts;ltn1 cells. Note the signal for puromycin in
the input sample is faint relative to that for ubiquitin. Black lines compare the WT sample in the
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absence of the drug to that in its presence at the permissive temperature. Red lines compare wildtype cells to the cdc48-ts ones in the presence of the drug under the restrictive conditions. Blue
line compare the cdc48-ts to cdc48-ts;ltn1 cells at the restrictive temperature.
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Ubiquitylated forms of these peptides were then enriched for using Ubiquilin 1 Tandem UBA
(TUBE2) beads and quantified by immunoblotting with anti-puromycin antibodies (Fig. 2a).
As expected, the addition of 4-NQO increased the amount of puromycylated peptides in
the ubiquitylated pool regardless of the strain background (Fig. 2b). While shifting wild-type cells
from the permissive to the restrictive temperature had no observable effect on the accumulation of
ubiquitylated and puromycylated nascent peptides after 4-NQO treatment, they were dramatically
increased at the restrictive temperature when ts-cdc48 cells were used (Fig. 2b). This increase was
also accompanied by an increase in the total levels of ubiquitylated peptides, as expected given the
general role of Cdc48 in maintaining protein homeostasis(Berner et al., 2018). By contrast,
deletion of LTN1 from these cells almost completely abolished the effects of 4-NQO on the
accumulation of ubiquitylated-nascent peptides (Fig. 2b). This effect was not specific to oxidative
damage, as the addition of MMS produces similar outcomes and leads to accumulation of
puromycylated-ubiquitinated peptides (Supplementary Fig. 2). Taken together, these observations
suggest that the addition of either 4-NQO or MMS stalls translation and activates RQC, which
increases ubiquitylation of nascent peptides by Ltn1 via a route also involving CDC48.

Alkylating and oxidizing agents lead to protein aggregation
Given that our data implicated Ltn1 in clearing incomplete-nascent peptides arising from
chemically-induced mRNA damage, we speculated that in ltnΔ cells, these peptides misfold and
aggregate, which in turn would recruit chaperones. To visualize this potential aggregation, we
exploited fusions of mCherry to the yeast-specific disaggregase HSP104(Chernova et al., 2017),
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Figure 3. The addition of damaging agents leads to the accumulation of Hsp104-mCherry
foci in the absence of Ltn1 and Hel2.
a, Representative images of the indicated cells in the absence and presence of MMS. Shown are
brightfield, mCherry and DAPI signals. Scale bar is 10 m. b, Bar graph showing the
quantification of cells with >1 focus in the presence of the specified drugs for WT and ltn1 cells.
c, Similar to b, using WT and hel2 cells. d, Bar graph used to show the consequence of a
cycloheximide pretreatment on the effect of MMS on foci formation. In all cases, the average foci
count of at least three biological repeats is plotted with the error bars representing the standard
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deviation around the mean. For each biological repeat, > 120 cells were counted. Source data are
provided as a Source Data file.
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and to the Ssa1 and Ssa3 chaperones, which are members of the HSP70 family, to look for
chaperone-specific foci by fluorescence microscopy of wild-type and ltn1 cells grown under
normal conditions or in the presence of oxidizing agents, alkylating agents, and translation
inhibitors. Discernable foci of Ssa1- and Ssa3-mCherry were not observed under all conditions
tested, suggesting that they do not help yeast cope with chemical-induced RNA damage
(Supplementary Fig. 3a,b). More specifically, the lack of foci in ltnΔ backgrounds suggested that
these factors play little to no role during ribosome stalling.
Conversely, distinct foci decorated with Hsp104-mCherry were seen in more than 10% of
wild-type cells when treated with the alkylating and oxidizing agents MMS, 4-NQO and MNNG,
versus only 2% for untreated cells (Fig. 3a,b). Some of these Hsp104-dependent foci were likely
generated by direct damage to the protein pool by these chemical agents. To resolve this
possibility, we analyzed ltnΔ cells, which specifically acts on ribosomes to target nascent peptides
during RQC, to sort out whether these foci arose by stalling-mediated production of incomplete
peptides. Indeed, loss of Ltn1 increased the number of cells with Hsp104-mCherry foci from ~10%
to 40-60% in the presence of the damaging agents (Fig. 3b). Hence, the effect of the chemical
agents on the properties of mRNA was much more pronounced relative to their effect on protein,
which in turn impacts its translation. In addition to Ltn1, the deletion of Hel2, which acts upstream
and is required for RQC activation, led to a dramatic increase in the number of cells with Hsp104mCherry foci in the presence of damaging agents (Fig. 3c).
Consistent with the idea that these aggregates contain nascent peptides evading RQC,
inclusion of the translation inhibitor cycloheximide prior to MMS treatment caused the loss of
these Hsp104-decorated foci (Fig. 3d). In particular, the number of ltn1 cells with foci decreased
144

from ~25% to ~5%, which was close to those measured in the absence of any drugs, suggesting
that active translation is required for forming Hsp104 foci. Notably, these foci appear distinct from
P bodies(Swisher and Parker, 2010), as we saw no co-localization of Hsp104-mCherry with the Pbody marker Dcp2-GFP (Supplementary Fig. 3c). Our data suggest that Hsp104 is recruited to
aggregated nascent peptides generated during damaged-mRNA-induced stalling when RQC is
overwhelmed or incapable of ubiquitylating them for subsequent proteasome removal.

Damaging agents trigger ribosomal-protein ubiquitylation
As mentioned above, ribosomal protein ubiquitylation by Hel2 is a key signal for mediating
the downstream events of NGD and RQC during stalling(Ikeuchi et al., 2019a; Juszkiewicz et al.,
2018; Matsuo et al., 2017; Simms et al., 2017). Hel2 recognizes an interface between the small
subunits of collided ribosomes and adds K63-linked poly-ubiquitin chains to a number of core
ribosomal subunits, including uS10, uS3, and eS7(Ikeuchi et al., 2019a; Juszkiewicz et al., 2018;
Matsuo et al., 2017). To address whether damaging agents also induce ribosomal protein
ubiquitylation, we added MMS, MNNG and 4-NQO to growing yeast cultures and assessed the
level of protein ubiquitylation in total lysate and in purified ribosomes. Interestingly, while
alkylating and oxidizing agents only subtly increased the overall level of ubiquitylation, they
triggered robust ribosomal protein ubiquitylation as measured by immunoblotting with antiubiquitin antibodies (Fig. 4a). By contrast, the addition of the antibiotics cycloheximide and
hygromycin, which both arrest translation at high concentrations and thus prevent ribosome
collisions, triggered marginal ribosome ubiquitylation (Fig. 4a). To confirm that the ubiquitylation
pattern we observe in the presence of 4-NQO reflected ribosomal protein ubiquitylation and not
that of nascent peptides, we treated the lysates with puromycin,
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Figure 4. Ribosomal proteins are ubiquitinylated by Hel2 in the presence of damaging
agents.
a, Western-blot analysis of ubiquitinated proteins in total lysates and ribosome fractions in the
presence of the indicated compounds. b, Release of nascent peptides by puromycin does not affect
the ubiquitination pattern of proteins in the ribosome fraction. Right panel is a western analysis of
the puromycylation reactions under the indicated conditions. Left panel is a western analysis of
ubiquitination of ribosome-enriched fraction in the presence and absence of puromycin upon the
addition of 4-NQO. c, Western-bot analysis showing that the ubiquitination of ribosomal proteins
after MMS addition is completely inhibited when HEL2 is deleted. d, Western-blot analysis used
to assess the relative amount of ubiquitinated ribosomal proteins in the presence of 4-NQO when
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eIF4E, and hence initiation, is inactivated. Lines compare WT and cdc33-ts cells in the presence
of 4-NQO at the restrictive temperature. e, Sucrose-gradient fractionation of lysates obtained from
endogenous HEL2: 3 ✕ FLAG tag yeast cells in the absence and presence of 4-NQO. The traces
follow the absorbance at 254 nm, below the traces is the western-blot analysis of the fractions
using anti-FLAG antibody. f, Heat map showing scaled ubiquitination footprints of ribosome and
ubiquitin-derived peptides in response to 4-NQO. The samples were digested with trypsin and
enriched for diGly, prior to tandem MS analysis. Two independent biological replicates are shown
and the modified lysine residues are indicated to the right of the ribosomal protein name. The
peptides are organized based on their origin and subsequently ranked by their response to 4-NQO.
g, Bar graph showing the relative abundance of ubiquitin (eS31) and different ubiquitin chains. hk Bar graphs showing the relative abundance of corresponding ribosomal proteins (on the left) and
diGly modified peptides (on the right) in the absence and presence of 4-NQO (In all cases n=2, 
SD). l-m, Western-blot analysis used to follow the ubiquitination of depicted ribosomal proteins
in the presence of the indicated compounds. A C-terminal FLAG tag was added to the
chromosomal copy of ribosomal protein genes. Source data are provided as a Source Data file.

which would release nascent peptides prior to ribosome enrichment. This puromycin pre-treatment
had no discernable impact on the ubiquitylation of the ribosome-enriched samples (Fig. 4b).
Therefore, the increased ubiquitylation upon exposure to oxidation and alkylation agents most
likely reflected direct modification of ribosomal proteins.
We next sought to confirm that this pattern of ribosome ubiquitylation was distinct from
those known to arise during oxidation and ER stress by assessing its dependence on E3s associated
with RQC and nonfunctional ribosomal RNA decay (Fig. 4c, Supplementary Fig. 4a,b). Here, we
analyzed the level of ribosomal ubiquitylation after treatment with MMS in the presence and
absence of either Hel2, Mms21, or Rtt101, the latter two of which are known to function during
non-functional ribosome decay(Fujii et al., 2009; Sakata et al., 2015). A complete loss of ribosomal
ubiquitylation was only observed in hel2Δ cells (Fig. 4c, Supplementary Fig. 4a,b), supporting the
idea that damaging-agents-induced ubiquitylation depends on translation of the aberrant mRNA.
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Complementing these cells with a plasmid-borne HEL2 restored ubiquitylation to normal levels,
whereas an empty vector did not (Supplementary Fig. 4c). Using an antibody specific for ubiquitin
internally linked through K63, we confirmed that the ubiquitin chains bound to ribosomal proteins
were mostly connected via this lysine (Supplementary Fig. 4c), in agreement with the specificity
of Hel2 for K63 polyubiquitylation.
We next showed that ribosomal protein ubiquitylation depends on active translation using
two different approaches. For the first approach, we exploited an eIF4E temperature sensitive allele
(cdc33-ts4-2) to suppress translation initiation. Whereas shifting wild-type cells to the restrictive
temperature had little effect on 4-NQO-induced ribosomal protein ubiquitylation, shifting the
cdc33-ts4-2 cells to the restrictive temperature greatly reduced this modification (Fig. 4d). For the
second approach, we used abrupt glucose deprivation to induce ribosome runoff and examined
how this starvation affected ribosomal protein ubiquitylation. As shown in Supplementary Fig. 4d,
ribosome runoff prior to 4-NQO addition almost completely inhibited ribosomal proteins
ubiquitylation, implying that ribosomes must be actively translating for nucleobase-damaging
agents to trigger their ubiquitylation.

Hel2 associates with polysomes in the presence of stress
To demonstrate that Hel2 is recruited to ribosomes upon the addition of oxidizing and
alkylating agents, we investigated the association of this E3 with polysomes under different
conditions. To facilitate detection by immunoblot assays, the endogenous HEL2 gene was tagged
with a C-terminal FLAG epitope. The samples were crosslinked with formaldehyde to stabilize
any transient interactions prior to sucrose-gradient fractionation of polysomes. As expected, Hel2FLAG was predominately with the light fractions and appears not to be recruited efficiently to the
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ribosomes. In the presence of 4-NQO and MMS, Hel2 predominantly associated with the polysome
fraction (Fig. 4e). Since Hel2 is documented to recognize collided ribosomes, these observations
suggest that alkylating and oxidizing agents generate ribosome collisions., which together with the
accumulation of ubiquitylated ribosomal proteins (Fig. 4a, b), implies that alkylating and oxidizing
agents activate Hel2 through ribosome stalling.

Characterization of ubiquitin-modified-ribosomal proteins
To interrogate the dynamics of ribosome ubiquitylation in response to RNA damaging
agents, we use a quantitative-proteomic approach to measure ubiquitylation that combined
diglycine (diGly)-modified immuno-affinity enrichment followed by tandem MS to follow sitespecific ubiquitin additions onto individual ribosome proteins(Kim et al., 2011). MS/MS analysis
of individual peptides from the diGly-peptide-enriched pool revealed that the ubiquitylation status
of individual proteins within both the large (60S) and small (40S) subunits was altered upon 4NQO treatment (Fig. 4f). The majority of proteins displaying increased ubiquitylation in the
presence of 4-NQO were located on the 40S subunit (Fig. 4f), while the majority of proteins
displaying a decreased ubiquitylation in the presence of 4-NQO were located on the 60S subunit
(Fig. 4f) (Supplementary Table 1).
Given that the nature of the internal linkage used for polyubiquitylation can have a dramatic
effect on downstream events(Silva and Vogel, 2015), we further characterized by MS/MS the
dynamics of polyubiquitylation linkages during the 4-NQO treatment. Interestingly, while the total
amount of ubiquitin bound to purified ribosomes remained unchanged after 4NQO treament, the
peptide derived from ubiquitins internally linked via K63 increased dramatically (>10 fold) (Fig.
4g). By contrast, the peptide derived from ubiquitins internally linked via K48 increased only
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moderately (1-3 fold) in the presence of the compound (Fig. 4g). Finally, we identified several
lysine residues on the ribosomal proteins that are highly ubiquitylated as a result of 4-NQO
treatment. These proteins include: K212 on uS3, K8 on uS10, K83 on eS7B, and K33 on uS5 (Fig.
4h-k). We further validated the ubiquitination events on uS3, uS10, eS7 and, uS5 by
immunoblotting (Fig. 4l,m, Supplementary Fig. 4f,g).

DNA damage does not elicit ribosomal protein-ubiquitination
To provide further support for our model that MMS, MNNG and 4-NQO activate RQC
through their modification of RNA and not DNA, we examined the effect of agents that specifically
target DNA on ribosomal protein ubiquitylation. In particular we tested: cisplatin (an inter-strand
crosslinker), camptothecin (a topoisomerase I inhibitor), bleomycin (induces DNA-strand breaks),
mitomycin C (DNA crosslinker), etoposide (a topoisomerase II inhibitor) and hydroxyurea
(depletes the dNTP pool)(Vesela et al., 2017). As expected, the addition of all of these agents did
little to increase the ubiquitylation state of ribosomal proteins and uS3. At the same time, they all
elicited a DNA-damage response to various extents as assessed by phosphorylation of H2AX
(accumulation of H2AX) (Fig. 5a). This is similar to what has been observed in mammalian cells,
for which the additions of etoposide, mitomycin C, and cisplatin were not found to impact
ribosome ubiquitylation(Higgins et al., 2015).
Interestingly, the only drug that induced appreciable ubiquitylation of ribosomal proteins
– at least as compared to MMS, MNNG and 4-NQO – was cisplatin, which had been documented
to crosslink ribosomes(Melnikov et al., 2016), suggesting that it also affects translation and
activates RQC (Fig. 5a). Indeed, addition of cisplatin at high concentrations was accompanied by
moderately increased ribosomal protein ubiquitylation (Fig. 5b). Thus, we
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Figure 5. Agents that strictly compromise the integrity of DNA do not lead to ribosomalproteins ubiquitination.
a, Western-blot analysis of ribosomal-protein ubiquitination and uS3 in the presence of the
indicated compounds. Phosphorylation of H2AX was used to assess the activation of the DNAdamage response. b, Western-blot analysis of ribosomal-proteins ubiquitination as a function of
increasing cisplatin concentrations. c, Western-blot analysis of ribosomal-protein ubiquitination
and H2AX phosphorylation as a function of time after the addition 4-NQO. Note ribosomal protein
ubiquitination is observed only after 5 minutes of incubation and saturates at the ten-minute mark.
In contrast, -H2AX signal appears not to near saturation after 45 minutes of incubation. Source
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data are provided as a Source Data file.concluded that activation of RQC by damaging agents
results from their impact on RNA properties and not their influence on DNA metabolism.

To assess the cellular response to the presence of damaging agents through ribosomal
protein ubiquitylation, we examined these modifications as a function of time upon the addition of
4-NQO. Interestingly, we detected the accumulation of ubiquitylated ribosomal proteins within 5
min of treatment with the response saturated by 10-min. In contrast, the accumulation of H2AX
was not saturated after 45 min of incubation (Fig. 5c). These observations indicate that RNA is
modified faster than DNA, with subsequent ribosome stalling and activation of RQC occurring
shortly thereafter.

Yeast lacking NGD and RQC components are sensitive to damage
Thus far, our analyses have focused on the details of RQC activation in response to
damaging agents through their impact on RNA, but whether the inability to do so diminishes
cellular fitness remained unclear. To examine whether failure to activate RQC renders cells
sensitive to oxidizing and alkylating agents, we tested if yeast strains harboring mutations in
various components of NGD and RQC would recover poorly from oxidation and alkylation stress.
Briefly, cells were treated with 1 g/mL 4-NQO and 0.1% MMS for 30 min, washed with
prewarmed fresh medium, and then monitored continuously for growth (Fig. 6a). In the absence
of any treatment, we observed little to no difference in lag time or growth rate among the strains,
as assessed by the first derivative of growth curves (Fig. 6b). Upon a 4-NQO challenge, hel2;
rps3-R116, R117A; dom34; and ski2 strains had significantly increased lag times relative to the
wild-type cells (Fig. 6b), while the lag time was unchanged in the hsp104 strain (Supplementary
Fig. 5). Interestingly, ltn1 cells actually displayed a faster recovery as revealed
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Figure 6. Mutations in NGD and RQC components render cells sensitive to 4-NQO and MMS
addition.
a, Top is a plot of OD600nm over time of the indicated strains after a mock treatment or a 30-minute
challenge with 4-NQO (1 g/mL) or MMS (0.1 % MMS). Bottom is a plot of the first derivative
of the data on top to calculate the instantaneous growth rate and the corresponding lag time needed
to reach the maximum rate. Data was collected in technical duplicates from three biological
replicates. b, A bar graph showing the determined lag time from a. The mean of three biological
replicates is plotted and the error bars represent the standard deviation. p-value from two-way
ANOVA test is indicated. Source data are provided as a Source Data file.

153

by its lag time of 7.5 hr relative to 9 hr for wild type, but the additional deletion of HSP104 from
these cells significantly increased the recovery time (Fig. 6b, Supplementary Fig. 5). These
observations suggest that in the absence of Ltn1, Hsp104 clears misfolded nascent peptides that
fail to be ubiquitylated by this E3. Deletion of both factors then renders the cells sensitive to
nascent peptides that accumulate from stalled translation of damaged mRNA. We note that
treatment of NGD- and RQC-defective cells with the drugs for 30 min showed no differences in
cellular death relative to wild-type as assessed by spot assays (Fig. 6c), suggesting that the defects
we saw in growth rate were indeed caused by increased lag time post treatment. Collectively, our
data implies that NGD and RQC play an important role in coping with chemical insults that alter
the chemical properties of RNA.

One 8-oxoG adduct in the coding sequence destabilizes mRNAs
Until now, our analysis has focused on the effect of mRNA alkylation and oxidation on the
activation of NGD and RQC using compounds that target RNA indiscriminately, which likely
impacts bases throughout the RNA strand, resulting in the formation of a plethora of adducts in
various locations on the RNA(Simms et al., 2014; Vågbø et al., 2013). As a result, we sought to
examine how the presence of one disruptive adduct might influence turnover of an mRNA. We
opted to use HEK293 cells instead of yeast, because that allowed us to use electroporation to
efficiently deliver in-vitro-generated mRNAs to these cells. Briefly, a short RNA containing an 8oxoG was chemically synthesized and ligated to an in-vitro-transcribed mRNA, whose end was
healed with a hammerhead ribozyme (Fig. 7a,b). The resulting RNA was polyadenylated using
polyA polymerase and capped with vaccinia capping enzyme in the presence of [-32P]-GTP,
which allowed us to monitor the fate of capped mRNAs specifically.
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Figure 7. The presence of one 8-oxoG adduct in the ORF of an mRNA leads to accelerated
rate of decay in HEK293 cells.
a, Schematic showing the steps used to make mRNA reporters with 8-oxoG in the ORF. b,
Ethidium-bromide-stained PAGE gel used to follow the construction of the mRNA showing that
they migrate as would be predicted based on their size. c, Microscope images of HEK293 cells
electroporated with capped and uncapped eGFP mRNA used to assess electroporation efficiency.
Shown are the brightfield, and GFP- and DAPI-fluorescence signals. d, Northern analysis to
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measure the decay of the indicated reporters and the control GFP mRNAs post electroporation.
Reporters were visualized directly by exposing the nylon transfer to a phosphorimager screen. GFP
and GAPDH were visualized using a radio-labeled DNA probe. At the bottom is the ethidiumbromide stained agarose gel. The half-lives were determined from duplicates ( SD).

Two constructs were generated with only one difference: one that harbored 8-oxoG in the ORF
and another that positioned the adduct in the 3’-UTR (Supplementary Table 2). The former was
expected to be subject to NGD, whereas the latter was not. As a control, we also co-electroporated
a capped and polyadenylated eGFP mRNA, which allowed us to measure electroporation
efficiency, found to be >90% (calculated between 92 – 96% across three experiments) (Fig. 7c).
To confirm that in-vitro-generated mRNAs, like those synthesized in vivo are efficiently
targeted by mRNA-surveillance pathways, we also engineered a control construct without a
translation stop codon. This “no-stop” reporter also contained a polyA tail whose translation by
the ribosome should target the RNA for non-stop decay (NSD). Indeed, when these mRNA
reporters were electroporated into HEK293 cells, the control mRNA decayed with a half-life of
~5.3 hr, whereas the non-stop NSD version turned over rapidly with a half-life of <1 hr
(Supplementary Fig. 6a). Having established that RQC processes appear capable of targeting
mRNAs synthesized in vitro, we electroporated the 8-oxoG-ORF- or UTR-containing mRNAs into
HEK293 cells and followed their turn over (Fig. 7d). In agreement with our hypothesis that
mRNAs containing 8-oxoG in the coding region are subject to NGD, we measured a half-life of
~2.1 hr for the ORF-modified transcript versus ~4.3 hr for the UTR-modified one (Fig. 7d).
Similarly, a control-stop mRNA reporter, which replaced the 8-oxoG where the ribosome is
expected to stall with a stop codon, decayed with a half-life of 7 hr (Supplementary Fig. 6b). We
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note that these differences in half-lives are similar to what others have reported for NGD reporters
with stalling sequences(Doma and Parker, 2006; Saito et al., 2013). Furthermore, the
undistinguished half-life for the eGFP mRNA of ~3.5 - 4 hr among the experiments confirmed that
the differences we observe in the half-lives between the two reporters was caused by inherent
differences between the two mRNAs and no other experimental factors. Taken together, our results
strongly indicate that translation and hence the ribosome itself plays an important role in governing
the stability of adduct-containing mRNAs.
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DISCUSSION
All organisms rely on quality-control mechanisms to deal with defective biological
molecules. In addition to inherent mistakes that occur during the generation of these molecules,
chemical agents can alter them following synthesis(Drabløs et al., 2004; Sohal and Weindruch,
1996). Nucleic acids are especially vulnerable to such insults given the inherent reactivity of the
oxygen and nitrogen atoms of the nucleobases(Wurtmann and Wolin, 2009). Two classes of
endogenous and exogenous damaging agents that are particularly deleterious include reactive
oxygen species (ROS) and alkylating agents(Cadet and Wagner, 2013; Drabløs et al., 2004; Neeley
and Essigmann, 2006). Endogenous ROS arise as byproducts of mitochondrial respiration and their
levels are significantly influenced by cellular metabolism(Murphy, 2009). For instance, tissues
with high-energy demands such as neurons accumulate higher levels of ROS(Itoh et al., 2003;
Lebon et al., 2002). In addition to endogenous ROS, cells become exposed to exogenous agents
that can increase ROS levels, include ionizing radiation, ultraviolet light, pollutants, and many
toxins(Wurtmann and Wolin, 2009). Similarly, alkylating agents appear endogenously, with the
universal-methylating agent S-adenosyl methionine (SAM) being one of the most
abundant(Hoffman et al., 1980). SAM reacts with nucleic acids in vitro to form various modified
bases(Rydberg and Lindahl, 1982). As examples of exogenous alkylating agents,
chemotherapeutics such as cyclophosphamide, streptozotocin, and temozolomide are known to
target RNA in addition to DNA(Bellacosa and Moss, 2003). It should come as no surprise then
that oxidized and alkylated mRNA molecules accumulate in vivo(Nunomura et al., 1999; Shan and
Lin, 2006), but whether cells are impacted is not immediately evident.
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Given the transient nature of mRNA, it was once assumed that damage is of little
consequence. However, the discovery that cells evolved multiple pathways to cope with defective
mRNAs has significantly altered this view(Simms and Zaher, 2016; Wurtmann and Wolin, 2009).
Furthermore, we have also known for some time that the abundance of oxidized RNA is correlated
with various neurodegenerative diseases(Nunomura et al., 2007), suggesting that cells have
evolved pathways to deal with chemically-damaged mRNA. These ideas are bolstered by findings
that the genomes of almost all organisms and some viruses encode dealkylases involved in RNA
repair(Jr et al., 2003).
First hints about quality-control pathways capable of degrading chemically-damaged
mRNAs came from studies showing that oxidized mRNAs turn over faster relative to undamaged
versons(Hofer et al., 2005). The mechanism(s) by which these mRNAs are selectively recognized
were not immediately obvious(Simms et al., 2014); mainly because the effects of the modified
bases on mRNA function was unknown. In the past few years, we and a number of other groups
have begun to dissect the effects of modified bases on protein synthesis using in vitro
approaches(Hudson and Zaher, 2015; Simms et al., 2014; You et al., 2017). Interestingly, while
some of the adducts behave as expected based on their structure and the equivalent studies on DNA
replication (for example, m1A severely inhibits protein synthesis(You et al., 2017)), others have
revealed unexpected effects on ribosomes. Of particular note is 8-oxoG, which mispairs with A
during DNA replication by adopting the syn conformation, but on ribosomes severely inhibits
protein synthesis, presumably because of its failure to adopt the syn conformation in the decoding
center(Simms et al., 2014). These findings suggested that chemically-damaged mRNA triggers
NGD and the associated RQC. In agreement with this scenario, we recently showed that 8-oxoG
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mRNAs accumulate in the absence of XRN1 in yeast and associate with polyribosomes(Simms et
al., 2014). These findings suggest that oxidized mRNAs are subject to NGD, and subsequent
degradation of the 3’-fragment by Xrn1(Doma and Parker, 2006; Tsuboi et al., 2012). Here, we
expanded on these observations and provide evidence that other chemically-modified bases
including m1A, m3C and m1G accumulate in mRNA, when XRN1 is deleted (Fig. 1d). As alluded
to earlier, all of these adducts are either known or predicted to stall protein synthesis by severely
disrupting Watson-Crick base pairing . While these findings do not directly demonstrate that
damaged mRNA is subject to NGD, they are consistent with the notion.
Typically, studies on damaged RNA have largely relied upon treating cells or bulk RNA
with chemically modifying agents to assess their effect. To take a more precise look at how
oxidizing agents impact mRNAs and their translation, we undertook a novel approach, using sitespecifically modified mRNAs to assess whether mammalian cells recognize and remove these
transcripts from the translating pool. By introducing a single 8oxo-G modification to either the
ORF or the 3’ UTR, we could measure significant differences in mRNA half-life; the mRNA
harboring the modification in its ORF was degraded twice as fast as one with the modification in
its UTR (Fig. 7). This faster degradation implied that cells not only recognize damaged mRNA,
but exploit the translating ribosome to identify it and target it for breakdown, likely through NGD.
To provide further support for our model that NGD and RQC help cells cope with damaged
mRNAs and the derived defective protein products, we took advantage of chemicals capable of
modifying nucleic acids. In particular, we used both the alkylating agents MMS and MNNG, and
the oxidizing agent 4-NQO. Indeed, we showed using LC-MS/MS that the addition of MMS to
yeast induced an order of magnitude increase in the alkylative adducts m1A and m3C in mRNA
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(Fig. 1e), while the addition of 4-NQO led to a dramatic increase in RNAs harboring 8-oxoG (Fig.
1c). Given the strong increase in these damage marks, we predicted that accumulation of the
damaged transcripts would induce widespread ribosome stalling. By examining labelled
ubiquitylated nascent peptides, we provided compelling evidence indicating that alkylative and
oxidative stress activates RQC. First, the addition of MMS and 4-NQO was accompanied by an
increase in ubiquitylated puromycylated peptides (Fig. 2b, Supplementary Fig. 2), suggestive of
an increase in ribosome-associated quality control of nascent peptides. Interestingly, the addition
of damaging agents had little to no effect on the total levels of ubiquitylated peptides (Fig. 2b),
suggesting that the drugs do not significantly affect full-length proteins, at least at the drug
concentrations used. Second, inactivation of Cdc48 via the ts-cdc48 allele induced a dramatic
increase in ubiquitylated puromycylated peptides (Fig. 2b). Cdc48 functions within the ubiquitin
system, where it extracts defective proteins from complexes and delivers them to the
proteasome(Defenouillere et al., 2013). In addition to its involvement in RQC, the CDC48 has
role(s) in other quality control processes, including ERAD and autophagy(Ju et al., 2009; Neuber
et al., 2005; Schuberth and Buchberger, 2005; Watts et al., 2004). Notably, our observations that
Cdc48 inactivation in the presence of MMS, MNNG, or 4-NQO leads to increased levels of
ubiquitylated peptides that are also puromycylated (Fig. 2b) suggests that the compounds
appreciably alter mRNA translation. Third, deletion of LTN1, the E3 responsible for ubiquitylating
nascent peptides during RQC, suppresses the effects of cdc48-ts in the presence of alkylating and
oxidizing stress and greatly reduced the amount of puromycylated peptides to normal levels (Fig.
2b, Supplementary Fig. 2). Collectively, these findings suggest that not only is mRNA
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exceptionally susceptible to chemical insults, but also that resulting chemical modifications
significantly impact its translation.
While the above observations highlight the potential deleterious effect of chemical
modification to the function of mRNA, they do not necessarily show that this alteration is
sufficiently adverse to influence cellular fitness. However, our findings that cells lacking Ltn1
accumulate protein aggregates in the presence of chemical agents, as visualized through Hsp104foci (Fig. 3), shows that mRNA damage could indeed reduce cellular proteostasis. We are not the
first group to report that Hsp104-containg foci coalesce in the presence of damaging agents(Ford
et al., 2019; Hanzén et al., 2016; Jacobson et al., 2017), however this accretion was attributed to
damage to DNA and not to RNA. Furthermore, the relationship between these foci, chemical
damage, and RQC has not been explored previously. Thus, we identified an unappreciated role for
Hsp104 in stalling-associated-protein defects as a potential failsafe for RQC. In agreement with
this model, removal of LTN1 or HSP104 singly did not make yeast sensitive to damaging agents,
but the combined elimination of both factors rendered the cells sensitive (Supplementary Fig. 5).
It has been well established that ribosomal ubiquitylation is required for ribosome RQC
and ribosome rescue as translational stalls in both yeast and mammalian cells(Ikeuchi et al., 2019a;
Juszkiewicz et al., 2018; Matsuo et al., 2017; Sundaramoorthy et al., 2017). Our observations that
damaging agents induce ubiquitylation of ribosomes supports our hypothesis that these compounds
cause translational stresses through stalling (Fig. 3,4). Recent cryoelectron microscopy (cryo-EM)
studies provided convincing evidence that the two 40S subunits on collided ribosomes form a
unique interface that discriminates stalled from active ribosomes and provides a potential binding
site for Hel2(Ikeuchi et al., 2019a; Juszkiewicz et al., 2018). Given its ability to stall ribosomes, it
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is not surprising that 40S subunit ubiquitylation is particularly robust after 4-NQO treatment (Fig.
4f). Previous proteomics studies identified ubiquitylation events on specific lysine residues within
stalled yeast ribosomes during RQC induction, including lysines on uS3 (K212), uS10 (K8) and
eS7A/B(Matsuo et al., 2017; Sugiyama et al., 2019). We hypothesize that damaging agents such
as 4-NQO cause the ribosome to stall and subsequently elicits a similar ribosome ubiquitylation
pattern. In agreement, our MS analyses show that all of the lysines that are ubiquitylated upon
stalling are similarly targeted in the presence of 4-NQO (Fig. 4f). For example, the previouslyidentified-stalling target on uS5 (K33) is highly ubiquitylated in the presence of 4-NQO (Fig. 4k,
Supplementary Fig. 4g). In agreement, uS5 is located on the interface between two collided 40S
subunits close to uS3 in the entry tunnel, and was identified as a possible regulatory response to
the accumulation of unfolded proteins in yeast(Higgins et al., 2015).
While both K48- and K63-linked polyubiquitylation on ribosomes have been reported
during RQC(Matsuo et al., 2017), Hel2-mediated K63-linked polyubiquitination is required for
both NGD-induced mRNA degradation, and subunit dissociation and 18S non-functional rRNA
decay(Ikeuchi et al., 2019a; Sugiyama et al., 2019). The observation that Hel2-dependent-K63linked ubiquitylation is highly enriched upon 4-NQO treatment reinforces the critical role of the
RQC pathway in coping with RNA damage (Fig. 4g). K63-linked polyubiquitin chains play an
essential role in signal amplification processes for various cellular stress responses, including DNA
repair and nuclear factor κB (NF-κB) activation (Oh et al., 2018). Its role in signaling has recently
expanded to translation as it was reported that K63-linked ubiquitylation of ribosomal proteins
activates multiple downstream quality control pathways, and the modification by Hel2 provides a
platform for the interaction of ribosomes with other E3s or regulatory components(Ikeuchi et al.,
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2019b; Matsuo et al., 2017; Sugiyama et al., 2019). Combined with the prevalence of damaging
adducts in mRNA in the absence of Xrn1 (Fig. 1d), the activation of Hel2-mediated ribosomal
ubiquitylation might have evolved to resolve the translational stresses induced by mRNA damage.
Finally, the observation that ribosomal proteins ubiquitylation appears faster than H2A.X
phosphorylation(Löbrich et al., 2010) offers two notions: 1) RNA damage occurs on a much faster
time scale relative to DNA damage, 2) stalling of translation appears sooner than changes to DNA
metabolism (for instance changes to replication). The former implication is reinforced by the
chemical nature of RNA relative to DNA; RNA, and specifically mRNA, are relatively proteinfree and single-stranded, thus rendering the nitrogen and oxygen atoms of the Watson-Crick face
of the nucleobase vulnerable to chemical attack(Simms and Zaher, 2016). The latter implication
suggests a potential avenue for how cells respond to chemical insults; that organisms, in principle,
utilize ribosome stalling and the associated ribosomal ubiquitylation to mount a protective
response before DNA becomes damaged.
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METHODS
Yeast strains and plasmid constructs
Yeast strains used in this study are listed in Supplementary Table 3. Unless otherwise
stated, yeast cells were grown at 30°C in YPD media. Deletion, mutant and chromosomally-tagged
yeast strains were constructed in the BY4741 background (MATa; his31; leu2 0; met150;
ura3 0) with PCR-based disruption techniques. Plasmids used are listed in Supplementary Table
4. Unless otherwise stated, MMS, MNNG, 4-NQO, cycloheximide and hygromycin were added to
final concentrations of 0.1%, 20 g/mL, 5 g/mL, 100 g/mL and 200 g/mL, respectively. DNAdamaging agents of cisplatin, camptothecin, bleomycin, mitomycin C, etoposide and hydroxyurea
were added to final concentrations of 250 g/mL, 30 g/mL, 60 g/mL, 2.6 mM, 1 mg/mL and
100 mM, respectively. Cells were incubated with drug for 30 minutes, unless stated otherwise.
Oligonucleotide sequences are listed in Supplementary Table 5.
Quantification of RNA modifications by LC-MS/MS
Yeast cells were grown overnight in YPD. The cultures were then diluted to OD 0.05 in
the same media and grown to OD 0.5-0.8. When indicated, cultures were treated with damaging
agents for 30 min. RNA was isolated using the hot-phenol extraction method (Simms et al., 2017).
Two rounds of polydT pulldown were used to enrich mRNAs. Total RNA (1 µg) and Poly(A)
mRNA (0.1 µg) were digested by nuclease P1 (10 Units) at 50°C for 14-16 hr. Following the
addition of Tris pH 7.5 to a final concentration of 100 mM to adjust the pH, calf intestinal alkaline
phosphatase (CIP, NEB) was added (2-2.5 Units) and the reaction was incubated at 37°C for an
additional 1 hr to convert nucleotide 5’-monophosophates to their respective nucleosides. The
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RNA samples were diluted to 30-50 μL and filtered (0.22 μm pore size). 10-15 μL of the sample
was used for LC-MS/MS. Briefly, nucleosides were separated on a C18 column (Zorbax Eclipse
Plus C18 column, 2.1 x 50mm, 1.8 Micron) paired with an Agilent 6490 QQQ triple-quadrupole
LC mass spectrometer using multiple-reaction monitoring in positive-ion mode. The nucleosides
were quantified using the retention time of the pure standards and the nucleoside to base ion mass
transitions of 268.1 to 136 (A), 244.1 to 112 (C), 284.2 to 152 (G), 245.1 to 113 (U), 300 to 168.1
(8-oxoG), 282.2 to 150 (m1A), 298 to 166 (m1G), 258 to 126 (m3C), 282.1 to 150 (m6A), 298 to
166 (m7G). Standard-calibration curves were generated for each nucleoside by fitting the signal
intensities against concentrations of pure-nucleoside preparations. The curves were used to
determine the concentration of the respective nucleoside in the sample. The A, G, and C standards
were purchased from ACROS ORGANICS; U was purchased from TCI America. m7G, m1G and
m3C were purchased from Carbosynth, m6G and m6A were purchased from Berry’s Associates,
and m1A was from Cayman Chemical Company. The unmodified nucleosides were quantified
using the UV-Vis absorbance data that was recorded by a diode-array detector (DAD). The
modification level on the nucleosides was calculated as the ratio of modified to unmodified. Data
were analyzed using Excel (Microsoft) and Prism 7 (Graphpad) software.
Polysome analysis
Yeast cells were grown to mid-log phase before cycloheximide (CHX) was added to the
indicated concentration. The cultures were chilled on ice and centrifuged at 4°C. Cells were then
resuspended in polysome lysis buffer (20 mM Tris pH 7.5, 140 mM KCl, 5 mM MgCl2, 0.5 mM
DTT, 0.1% Triton-100, CHX to the indicated concentration, 200 g/mL heparin), washed once
and lysed with glass beads using a FastPrep-24 (MP Biomedical). Supernatants from cleared
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lysates corresponding to 0.5-1 mg of total RNA were layered over a 10%–50% sucrose gradient
and centrifuged at 35,000 rpm for 160 min in an SW41Ti (Beckman) swinging bucket rotor.
Gradients were then fractionated using a Brandel tube-piercing system combined with continuous
absorbance reading at 254 nm.
Western-blot analysis
Cells were grown to mid-log-phase and treated with chemicals. The total lysates were
harvested with ice cold lysis buffer (150 μl of 1.85 M NaOH, 7.5% beta-mercaptoethanol) and
55% trichloroacetic acid. Lysates were then pelleted and resuspended in an appropriate volume of
HU buffer (normalized to the number of cells harvested). HU buffer is composed of 8M urea, 5%
SDS, 200 mM Tris pH 6.8, 1 mM Ethylenediaminetetraacetic acid (EDTA), bromophenol blue,
100 mM DTT. Proteins were separated by SDS-PAGE and analyzed by immunoblotting. The
following antibodies were used: mouse anti-ubiquitin HRP (Santa Cruz, Cat#: sc8017; 1:2,000 v/v
dilution), mouse anti-FLAG (Sigma; Cat#: F1804; 1:5,000 v/v dilution), mouse anti-puromycin
(Millipore, Cat#: MABE343; 1:5,000 v/v dilution), rabbit anti-uS4 (Rps9) (Abcam,
Cat#:ab117861; 1:5,000 v/v dilution), rabbit anti-phospho-Histone H2A.X (Cell Signaling, Cat#:
ab11174; 1:3,000 v/v dilution), anti-ubiquitin (K48-linked-ubiquitin chains) (Cell Signaling, Cat#:
4289s; 1:3,000 v/v dilution, linkage-specific k48), anti-ubiquitin (K63-linked-ubiquitin chains)
(Cell Signaling, Cat#: ab179434; 1:3,000 v/v dilution, linkage-specific k63), and rabbit antieRF1(Eyler et al., 2013) (1:2000 dilution). Secondary antibodies of goat anti mouse IgG (Thermo
Scientific, Cat#: 31430) and goat anti rabbit IgG (Thermo Scientific, Cat#: 31460) were used at
(1:10,000 v/v dilution).
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To examine the ubiquitination on ribosomes, yeast cells were first harvested and washed
with ice-cold polysome-wash buffer (20 mM Tris pH 7.5, 140 mM KCl, 5 mM MgCl2, 5 mM
DTT). Cell pellets were then resuspended in 200-500 µL of polysome-lysis buffer [100 µg/mL
Heparin, 1 mM Pheylmethylsulfonyl fluoride (PMSF), 20 mM Tris pH 7.5, 140 mM KCl, 5 mM
MgCl2, 5 mM N-ethylmaleimide (NEM), 5 mM DTT]. Cells were homogenized by FastPrep-24
(MP Biomedical #116004500) with 200-500 µL of glass beads (Sigma, acid-free, Ø 425-600µm,
#G8772-500G) at 4ºC. Cells were processed at top speed for 1 min with 1 min resting on ice for 5
cycles. Cell debris was removed by pelleting at 15,000  g for 10 min at 4°C. Ribosome enriched
fractions were pelleted over a 0.5 mL sucrose cushion (1.1 M sucrose, 20 mM Tris-HCl pH 7.5,
500 mM NH4Cl, 0.5 mM EDTA, 10 mM MgCl2, 5 mM NEM, 1 mM PMSF) by centrifugation at
287,000 g for 2 hr at 4°C in an MLA rotor. Ribosomes were resuspended in 15-30 μl of RNasefree water. The concentration of ribosomes was measured using absorbance at 260 nm, and an
appropriate volume of HU buffer was added (normalized to ribosome concentration).
UBA purification and subsequent analysis of puromycylation
Overnight cultured cells were inoculated into 50 mL of fresh media to an OD 600 nm of 0.05
and incubated at 30°C. At OD ~0.6, 4-NQO and MMS were added and cells incubated for an
additional 30 minutes. Cells were harvested by centrifugation and washed 3 times with wash buffer
(20 mM Tris pH 7.5, 140 mM KCl, 5 mM MgCl2 and 10 mM NEM). Cell pellets were flash frozen
and stored at -80°C. Frozen cell pellets were resuspended in 200 L of lysis buffer [20 mM Tris
pH 8.0, 140 mM KCl, 5 mM MgCl2, 200

g/mL heparin, 5 mM NEM, 0.5 mM DTT and protease

inhibitor complete (ThermoFisher)]. Cells were lysed using glass beads using a FastPrep and the
resulting lysate clarified twice by centrifugation at 20,000 g for 10 minutes at 4°C. Absorbance
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was measured at 260 nm to estimate total RNA concentration. A total of 500 g was diluted to 100
L in lysis buffer, puromycin added to a final concentration of 2 mM and the reaction was
incubated at 30°C for 1 hr. Following the incubation, a 10-L aliquot was added to 10 L of HU
buffer for input. The remaining volume was added to 20 L UBA beads (BostonBiochem, #AM130), which were prewashed with 20 mM Tris-HCl pH 7.5, 5 mM NEM, 0.1% NP40. The total
volume was adjusted to 1 mL with the prewash buffer and lysates were incubated with beads for
1 hour at 4°C. The beads were washed 5  with wash buffer [25 mM Tris, pH 7.5, 150 mM NaCl,
0.2% NP40] followed by collection over a spin column in wash buffer without detergent. 50

L

of HU buffer was added, heated briefly before loading on 8 or 10% SDS-PAGE gels. After transfer,
western-blotting on the input and UBA-bound samples was conducted as described above.
Fluorescence microscopy
Yeast cells expressing Hsp104-mCherry or Dcp2-GFP were fixed with 4%
paraformaldehyde post-treatment for 15 min. Cells were then centrifuged and resuspended in 0.1
M KPO4 pH 7.5, 1.2 M sorbitol, and sonicated briefly prior to mounting for fluorescence
microscopy. Samples were imaged on a Nikon Eclipse E600 upright microscope at 60  using
OpenLab software (Improvision) through a Retiga EX charge-coupled-device (CCD) camera (QImaging). Image quantification was done using ImageJ software.
Yeast-sensitivity assay
Yeast cells in biological triplicates were back-diluted from overnight culture and were
treated with various damaging agents at mid-log-phase (OD600 of 0.5-0.7) for 30 min(Toussaint
and Conconi, 2006). The cells were then washed twice and resuspended in YPD media to a final
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density of OD 0.8. 5 μL of cell suspensions were added to 195μl of YPD in 96-well non-treated
polystyrene microplates, in technical repeats. The plates were incubated at 30°C with shaking, and
cell density was monitored every 10 min over 24-48 hours at 600 nm on a microplate scanning
spectrophotometer (Biotek PowerWave XS2).
Peptide preparation for mass spec analysis
Yeast cell lysis and peptide digestion was performed as follows. Specifically, 3 L of midlog cells were treated with various chemicals for 30 min at 30°C. Cells were then pelleted, washed
and resuspended in 5 mL of lysis buffer [20 mM Tris-HCl pH7.5, 140 mM KCl, 10 mM MgCl2,
0.5 mM DTT, 5 mM NEM, 1 mM PMSF]. Cells were lysed by FastPrep-24 with glass beads (top
speed for 1 min with 1 min resting on ice for 5 cycles). Debris was pelleted at 15,000  g for 10
min at 4°C and the lysates were clarified twice at 30,000  g for 20 min at 4°C. The ribosome
fraction from the lysate was enriched twice by centrifuging over a sucrose cushion (1.1M sucrose,
20 mM Tris-HCl pH 7.5, 500 mM NH4Cl, 0.5 mM EDTA, 10 mM MgCl2, 5 mM NEM, 1 mM
PMSF) at 107,100  g for 16 hr at 4°C in a Ti-45 rotor. The polysome enriched fraction was
resuspended in 10 mL RNase free water and then incubated with 0.1 M NaOH at 37°C for 30 min.
Protein concentration was determined by Bradford assay. Proteins were precipitated with 10%
trichloroacetic acid (TCA) at 4°C for 16 hr. Samples were then centrifuged at 10,000 x g for 15
min at 4°C. Pellets were washed with cold acetone and then resuspended in 8 M urea, 5 mM NEM,
1 mM PMSF. The samples were reduced for 1 hour with 1/25 volume of 200 mM DTT in 25 mM
NH4HCO3. Alkylation was performed by the addition of 200 mM chloroacetamide in 25 mM
NH4HCO3 for 1 hour at room temperature (RT) in the dark. The samples were then quenched by
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adding the same volume of reducing agent as the chloroacetamide and incubated at RT for 5 min.
The urea concentration was adjusted to 1M using 25 mM NH 4HCO3, pH > 8. Proteins were
digested first by LysC protease (Wako Chemicals USA, #NC9223464) at a protein ratio of 1:250
(w/w) for 4 hr at 37°C. Lysate were further digested using Trypsin (Pierce Trypsin Protease
#90057) at a protein ratio of 1:50 (w/w) at 37°C for 16 hr. The digestion was quenched by adding
trifluoroacetic acid (TFA) to a final concentration of 1%. The precipitate in the sample was
removed by centrifuging at 3,000  g for 5 min. The peptides were desalted by Sep-Pak C18
purification. Pre-enrichment samples were collected at the end of the elution step. Peptides were
then dried.
K-ε-GG peptide immunoprecipitation for LC-MS/MS
K-ε-GG peptide immunoprecipitation was performed using the PTMScan UbiquitinRemnant Motif (K--GG) Kit (#5562, Cell Signaling Technology) as per the standard protocol.
Following the final elution of the protocol, peptides were cleaned using Millipore Ziptips
(Millipore Sigma #Z720070), dried and stored at -20°C until LC-MS analysis.
Tandem mass spectrometry analysis
The sample was resuspended in 17 µl 5% acetonitrile, 0.1% formic acid. Nano-scale liquid
chromatography (LC) separation of tryptic peptides was performed on a Dionex Ultimate™ 3000
Rapid Separation LC system (Thermo Scientific). Of the digests, 4 µl was loaded onto a 20 μl
nanoViper™ sample loop (Thermo Scientific), and separated on a C18 analytical column
(Acclaim® PepMap™ RSLC C18 column, 2 μm particle size, 100 Å pore size, 75 µm x 25 cm
(Thermo Scientific) by the application of either a linear-2-hour gradient from 2% to 32%
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acetonitrile in 0.1% formic acid for the analysis of the ribosome enriched samples and a linear-2hour gradient from 4% to 36% acetonitrile for the analysis of subsequent glygly enrichment, with
a column flow rate set to 250 nL/min.
Analysis of the eluted tryptic peptides was performed online using a Q Exactive™ Plus
mass spectrometer (Thermo Scientific) possessing a Nanospray Flex™ Ion source (Thermo
Scientific) fitted with a stainless steel nano-bore emitter operated in positive electro-spray
ionisation (ESI) mode at a capillary voltage of 1.9 kV. Settings that differed for detecting glygly
enriched peptides are shown in brackets. Data-dependent acquisition of full MS scans within a
mass range of 380-1500 m/z at a resolution of 70,000 was performed, with the automatic gain
control (AGC) target set to 3  106, and the maximum fill time set to 200 ms. High-energy
collision-induced dissociation (HCD) fragmentation of the top 15 (8) most intense peaks was
performed with a normalized collision energy of 28, with an intensity threshold of 4  104 (1.3 
104) counts and an isolation window of 3.0 m/z, excluding precursors that had an unassigned, +1,
+7 or +8 charge state. MS/MS scans were conducted at a resolution of 17,500, with an AGC target
of 2  105 and a maximum fill time of 100 ms (300 ms). Dynamic exclusion was performed with
a repeat count of 2 and an exclusion duration of 30 seconds, while the minimum MS ion count for
triggering MS/MS was set to 4  103 counts. The resulting MS/MS spectra were analyzed using
Proteome Discoverer™ software (version 2.0.0.802, Thermo Scientific), which was set up to
search the S. cerevisiae proteome database, as downloaded from www.uniprot.org/proteomes (ID
number UP000002311). Peptides were assigned using SEQUEST HT (Eng et al., 1994), with
search parameters set to assume the digestion enzyme trypsin with a maximum of 2 missed
cleavage, a minimum peptide length of 6, precursor mass tolerances of 10 ppm, and fragment mass
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tolerances of 0.02 Da. Carbamidomethylation of cysteine was specified as a static modification,
while glygly on lysine, oxidation of methionine and N-terminal acetylation were specified as
dynamic modifications. The target false discovery rate (FDR) of 0.01 (strict) was used as
validation for peptide-spectral matches (PSMs) and peptides. Proteins that contained similar
peptides and which could not be differentiated based on the MS/MS analysis alone were grouped,
to satisfy the principles of parsimony. Label-free quantification as previously described (Silva et
al., 2006) was performed in Proteome Discoverer™ with a minimum Quan value threshold of
0.0001 using unique peptides, and “3 Top N” peptides used for area calculation. All samples were
analyzed in triplicate, and the resulting values were averaged.
Polysomes analysis, hel2 3  FLAG crosslinking to ribosomes
Yeast cultures were grown to mid-log phase before addition of either cycloheximide (to a
final concentration of 100 μg/mL, 3 μg /mL, or 0.015 μg /mL), or 0.1% MMS, or 5 μg /mL 4-NQO
for 30 minutes. Cultures were chilled on ice and formaldehyde added to 1% of the culture volume.
After 1 hour, these were quenched by addition of 1/10 volume of 2.5 M glycine in 25 mM Trisbase. Cells were pelleted by centrifugation at 4°C, resuspended in polysome lysis buffer (20 mM
Tris pH 7.5, 140 mM KCl, 5 mM MgCl2, 0.5 mM DTT, 1% Triton-100, 100 μg/mL cycloheximide,
200 μg/mL heparin), washed once and lysed with glass beads using a FastPrep (MP Biomedical).
Supernatant from cleared lysate corresponding to 1 mg of total RNA was layered over a 10-50%
sucrose gradient and centrifuged at 37,000 rpm for 160 min in an SW41Ti (Beckman) swinging
bucket rotor. Gradients were fractionated using a Brandel tube-piercing system combined with
continuous absorbance reading at A254 nm. Protein was extracted by the NaOH/TCA method and
resuspended in HU buffer (8 M Urea, 5% SDS, 200 mM Tris pH 6.8, 100 mM DTT).
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Reporters for measuring mRNA decay in mammalian-cell culture
Control mRNAs were prepared using runoff transcription on PCR-amplified DNA
templates and T7 RNA polymerase (Zaher and Unrau, 2004), followed by PAGE purification.
8oxo-G-mRNAs were generated by ligating an RNA oligo containing the modified guanosine to a
similarly in-vitro-transcribed RNA. To eliminate heterogeneity at the ligation site, the 3’ end
contained a self-cleaving hammerhead ribozyme sequence, which results in a 2’-3’ cyclic
phosphate after cleavage. The ends were dephosphorylated using T4 polynucleotide kinase (NEB)
in 100 mM morpholinoethanesulfonate (MOPS)-NaOH [pH 5.5], 10 mM MgCl2, 10 mM βmercaptoethanol, 300 mM NaCl (Schurer, 2002) leaving a 3’-OH group; the reaction was
incubated at 37°C for 5 hours, extracted with phenol/chloroform and ethanol precipitated.
An RNA oligo with a modified guanosine was purchased from Chemgenes (5’GGACUACAAAGAC (8-oxo-rG) ACGACGACAAGUAAUCUCU). The 5’ end of the oligo was
phosphorylated using T4 PNK (NEB) in the presence of ATP followed by ligation to the 3’ end of
the mRNA using T4 RNA ligase 2 (NEB) and a DNA splint at a molar ratio of (1:1.5:1.2). The
RNA and DNA were combined, heated to 80°C, and slowly cooled to room temperature before
addition of buffer and ligase followed by incubation at 37°C overnight. The ligated products were
purified on denaturing PAGE, eluted in 300 mM NaCl overnight and ethanol precipitated.
In order to observe turnover of the mRNA reporters in vivo, both the ligated RNA and
transcribed RNA controls were capped using the Vaccinia capping system (NEB) in the presence
of [ -32P]-GTP and SAM. This was followed by addition of a 3’ polyA sequence using E coli
polyA polymerase (NEB). Reactions were assembled per the manufacturer’s instructions and
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incubated for 30 min at 37°C, phenol/chloroform extracted, and ethanol precipitated. Prior to
electroporation, the RNAs were CIP treated (NEB) to remove 5’ phosphates, followed by phenol
chloroform extraction and ethanol precipitation.
Measurements of mRNA decay
TREx HEK cells (ThermoFisher Scientific) were cultured in DMEM (Gibco/life
technologies) +FBS (Sigma) +Pen/Strep (Gibco/life technologies) using standard protocols. RNA
was electroporated into cells using a Neon Transfection System (Thermo Fisher Scientific). On
the day of experiment, cells were washed and resuspended in buffer R at ~1-2x107 cells/mL.
Approximately 5 g of reporter mRNA and 5 g of GFP mRNA were combined with 100 L of
cells/buffer for each reaction. After electroporation, cells were immediately added to 1 mL media
without antibiotics and recovered for 30 min. The cells and media were then divided equally into
six aliquots and incubated until reaching the indicated timepoints. RNA was isolated using Trizol
and precipitated in isopropanol before analysis by northern blotting.
Northern blotting
1 g of RNA from each timepoint was resolved on 1.5% formaldehyde agarose gel,
followed by transfer to positively-charged nylon membrane (GE Lifesciences) using a vacuum
blotter (Biorad). Nucleic acids were UV cross-linked to the membrane and baked at 80°C for 15
minutes. Membranes were then pre-hybridized in Rapid-Hyb buffer (GE Lifesciences) for 30
minutes in a hybridization oven. Radiolabeled DNA probe, which was labeled using
polynucleotide kinase and [ -32P]-ATP, was added to the buffer and incubated overnight.
Membranes were washed with nonstringent buffer (2 × SSC, 0.1% SDS) three times, in some cases
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followed by three washes in stringent buffer (0.2 × SSC, 0.1% SDS), all at hybridization
temperature. Membranes were exposed to a phosphorimager screen and analyzed using a Biorad
personal molecular imager.
Data was analyzed using Prism (Graphpad) and half-life calculated by fitting the data using
linear regression to a one phase decay equation.
Data availability
The mass spec data, including the .msf and .xml files for the proteomics data, are available
in the ProteomeXchange database under accession number PXD013834 within the PRIDE
repository (http://www.ebi.ac.uk/pride/archive/projects/PXD013834 ). The source data used to
generate plots in Figs. 1a-e, 2b-d, 3g-k and 6a; and Supplementary Figs. 1b-d, 1g-j and 5 are
provided as a Source Data file. Uncropped and unprocessed immunoblot scans for Fig. 4i-m and
5 are also provided as a Source Data File. All other data are available from the corresponding
authors on reasonable request.
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CHAPTER 5: Ribosome-quality control
antagonizes the activation of the integratedstress response on colliding ribosomes
Liewei L. Yan and Hani S. Zaher
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ABSTRACT
Stalling during translation triggers ribosome quality control (RQC) to maintain
proteostasis. Recently, stalling has also been linked to the activation of integrated-stress response
(ISR) by Gcn2. How the two processes are coordinated is unclear. Here we show that activation
of RQC by Hel2 suppresses that of Gcn2. We further show that Hel2 and Gcn2 are activated by a
similar set of agents that cause ribosome stalling, with maximal activation of Hel2 observed at a
lower frequency of stalling. Interestingly, inactivation of one pathway was found to result in the
overactivation of the other, suggesting that both are activated by the same signal of ribosome
collisions. Notably, the processes do not appear to be in direct competition with each other; ISR
prefers a vacant A site, whereas RQC displays no preference. Collectively, our findings provide
important details about how multiple pathways that recognize stalled ribosomes coordinate to
mount the appropriate response.
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INTRODUCTION
A defining feature of all organisms is their ability to sense and respond to a constantly changing
environment. For instance, they excel at recognizing fluctuations in nutrient availability and
respond by reprogramming gene expression to meet metabolic needs (Hinnebusch, 2005; Pakos‐
Zebrucka et al., 2016). They are also able to react to endogenous and exogenous stresses. Among
the different cellular responses, the Integrated Stress Response (ISR), by which eukaryotic cells
alter their translational and transcriptional output in response to a number of homeostatic
imbalances and disease conditions, is perhaps one of the most important adaptive pathways (Hetz
et al., 2013; Kroemer et al., 2010; Masson, 2019). To this end, dysregulation of ISR signaling has
been linked to various pathological disorders that include diabetes, cancer and neurodegeneration
(Augusto et al., 2019; Bi et al., 2005; Delépine et al., 2000; Eyries et al., 2014; Lin et al., 2013;
Ma et al., 2013; Mouton-Liger et al., 2012; Ye et al., 2010).
Unique to ISR is its activation in response to diverse stress conditions (Pakos‐Zebrucka et al.,
2016). These stimuli all lead to the phosphorylation of eukaryotic initiation factor 2 (eIF2).
Mammals have four distinct eIF2 kinases: GCN2, PERK, PKR and HRI; which are activated in
response to amino-acid deprivation, ER stress, double-stranded RNA (typically associated with
viral infections) and heme availability, respectively. Phosphorylation of eIF2 by these kinases
shifts the factor from a substrate to a competitive inhibitor for the guanine exchange factor eIF2B,
inhibiting recycling of the GDP-bound eIF2 to a GTP-bound one (Gomez et al., 2002;
Krishnamoorthy et al., 2001; Sudhakar et al., 2000). This results in depletion of initiatortRNA•eIF2•GTP ternary complex and leads to a global reduction of protein synthesis, but allows
translation of a set of mRNAs whose protein products are required for cell survival and recovery,
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including ATF4 in mammals and Gcn4 in yeast. Both undergo an atypical-initiation mechanism
(Dever et al., 1992; Harding et al., 2000; Hinnebusch, 1993, 2005; Vattem and Wek, 2004), and
are the main effectors of ISR as they upregulate biosynthetic pathways as well as autophagy
(B’Chir et al., 2013; Hinnebusch, 2005; Kroemer et al., 2010; Natarajan et al., 2001; Valasek et
al., 2002).
Saccharomyces cerevisiae has only one eIF2 kinase, Gcn2, and the organism has proven to
be an invaluable model for studying ISR (Masson, 2019), especially in response to amino-acid
starvation (Sonenberg and Hinnebusch, 2009). Initial studies focused on clues afforded by its
domain architecture and possible analogies to the stringent response in bacteria, which is activated
by Rel-A mediated recognition of deacylated tRNAs bound to the ribosome (Atkinson et al., 2011).
In addition to its kinase domain, Gcn2 harbors ribosome- and tRNA-binding domains (Ramirez et
al., 1991; Wek et al., 1995; Zhu and Wek, 1998; Zhu et al., 1996). The latter is homologous to
His-tRNA synthetase (HisRS-like), and allows the factor to preferentially bind deacylated tRNA
over aminoacylated ones (Dong et al., 2000; Lageix et al., 2015). These observations led to the
hypothesis that Gcn2 is activated in response to the accumulation of deacylated tRNA. Several
biochemical and genetics studies supported this model; for instance mutations that abrogate
binding to the ribosome or deacylated tRNAs inhibit activation of ISR (Dong et al., 2000; Lageix
et al., 2015; Qiu et al., 2001, 2002; Ramirez et al., 1992). Furthermore in yeast, for full activation
of ISR in response to amino-acid depletion, Gcn2 requires two additional factors: Gcn1 and Gcn20
(Garcia-Barrio, 2000; Marton et al., 1997; Sattlegger and Hinnebusch, 2005). Each of these factors
possesses a domain similar to elongation factor eEF3 (Marton et al., 1997; Visweswaraiah et al.,
2012), which removes deacylated tRNA from the E site of the ribosome. Although this model of
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Gcn2 activation is appealing, several new studies have called it into question and suggested a more
ribosome-centric mode of activation. For example, in mice lacking a tRNA isoacceptor and a
ribosome recycling factor, which leads to ribosome stalling, eIF2 is phosphorylated in a GCN2dependent manner without accumulation of uncharged tRNAs (Han et al., 2018; Ishimura et al.,
2016). In agreement with this model, two recent studies have shown the factor to be robustly
activated by the P stalk of the ribosome relative to deacylated tRNAs (Harding et al., 2019; Inglis
et al., 2019). These observations suggest a direct role for ribosome slowing or stalling in activating
Gcn2.
In eukaryotes, ribosome stalling also activates the mRNA-surveillance pathway of no-go
decay (NGD) and the associated ribosome-quality-control pathway (RQC). Briefly, upon stalling
on defective mRNA, the trailing ribosomes collide into the stalled ribosome (Yan and Zaher,
2019). The E3 ligase Hel2 (Znf598 in mammals) recognizes collided ribosomes and adds ubiquitin
to a number of ribosomal proteins (Ikeuchi et al., 2019; Juszkiewicz et al., 2018; Simms et al.,
2017). The ubiquitination appears to play an important role in recruiting downstream factors
involved in ribosome rescue, mRNA degradation and nascent-peptide ubiquitination (Garzia et al.,
2017; Juszkiewicz and Hegde, 2017; Matsuo et al., 2017; Sundaramoorthy et al., 2017). How ISR
activation is coordinated with that of RQC during stalling is unknown.
Here we show that, in yeast, Gcn2 is activated under conditions that promote ribosome
stalling, including alkylation and oxidation stresses known to modify mRNAs and activate RQC.
We further show that activation of RQC, through Hel2-mediated ubiquitination of ribosomal
proteins, antagonizes activation of ISR, and vice versa. Notably, Hel2 was found to suppress the
premature activation of Gcn2 under nonstress conditions. Finally, we provide evidence that
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suggests that, similar to RQC, Gcn2 is activated by ribosome collisions, but prefers the A site of
the stalling ribosome to be empty. Altogether, our findings suggest that cells carefully monitor
ribosome speed to sense changes in their environment and mount an appropriate response.
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RESULTS
Hel2 antagonizes the activation of Gcn2
We recently showed that alkylation and oxidation stresses modify mRNAs and trigger
ribosome stalling (Yan et al., 2019). The resulting ribosome collisions were in turn found to
activate K63-linked ubiquitination of ribosomal proteins by the E3 ligase Hel2. Interestingly, our
group and others have identified several conserved targets for Hel2 on colliding ribosomes
(Matsuo et al., 2017; Yan et al., 2019), suggesting that ribosome collisions are likely to serve
important roles for multiple signals. As a result, we were motivated to investigate whether
ribosomal-protein ubiquitination is utilized by organisms to alter gene expression in response to
stress. We carried out RNA-sequencing analysis of wild-type and hel2 yeast cells in the absence
and presence of MMS (Figure 1, Supplementary Figure 1 and Supplementary Table 1). We note
that deletion of HEL2 completely inhibits MMS-mediated ribosomal-protein ubiquitination (Yan
et al., 2019) and hence any changes to RNA-expression levels in this strain is likely to be the result
of the absence of ribosome modification.
We initially focused on differences between wild-type cells and those lacking HEL2 under
normal conditions. Our analysis showed the deletion of HEL2 to result in modest changes to
mRNA levels. A closer examination of the data, however, revealed that these cells display a
signature typically observed in response to environmental and physiological stresses. In particular,
we observed an overexpression of genes associated with DNA-damage response as well as heatshock ones (Supplementary Figure 1, Supplementary Table 1). We further noted an upregulation
of genes typically associated with amino-acid deprivation conditions, including those involved in
the arginine-biosynthetic pathway (Figure 1A). These observations were consistent with recent
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reports showing that deletion of HEL2 leads to the activation of ISR (Meydan and Guydosh, 2020).
It, thus, seems that the absence of Hel2 triggers an unwarranted stress response and that ribosomeprotein ubiquitination could suppress its activation.
We were next interested in exploring how this signature is altered in response to alkylation
stress. As expected (Jelinsky and Samson, 1999), the addition of MMS was found to have profound
effects on gene expression. We observed induction of genes involved in multiple processes;
including those involved in DNA-damage, heat-shock and integrated-stress responses (Figure 1B).
In the DNA-damage and heat shock responses, DDR2, HSP12 and RNR3 were induced by almost
a hundredfold. In the integrated-stress response, genes in the arginine-biosynthetic pathway
(ARG1, ARG4 and ARG7) stood out and were induced by more than tenfold. Consistent with
MMS-induced activation of ISR, expression of ribosomal-protein genes was significantly reduced.
Collectively, our analysis of MMS-stressed cells revealed that multiple stress responses are
robustly activated in response to alkylation stress, consistent with earlier observations in budding
(Natarajan et al., 2001) as well as fission yeast (Berlanga et al., 2010).
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Figure 1. Transcriptional profiling of wild-type and hel2 cells in the absence and presence of
MMS.
A) Volcano plots of -log10p values against log2 relative-fold-changes in the RNA levels of all genes
in the hel2 strain to the wild-type one. Genes that are significantly upregulated are shown in red
and those that are significantly downregulated are shown in blue. B) Similar to A, but for the
relative change between wild-type cells treated with MMS and mock-treated ones. C) Volcano
plot used to follow the relative change in mRNA levels for hel2 cells in the presence of MMS
versus wild-type cells in the presence of MMS, but only for genes that were upregulated in the
presence of MMS in the wild-type cells, i.e. genes shown in red in B. D) Similar to C, but for genes
that were downregulated in the presence of MMS in the wild-type cells, i.e. those shown in blue
dots in B. E) Bar graphs of -log10p values of the gene-ontology (GO) analysis conducted on the
100 most upregulated genes in the hel2 cells relative to the wild-type ones in the presence of
MMS. F) Heat-map of the relative mRNA levels of Gcn4-regulated genes in MMS-treated cells to
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mock-treated ones for each biological replicate. The genes are hierarchically organized based on
their fold difference.
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Since Hel2 appears to suppress the activation of a stress response in the absence of any
stressors, we wondered if the factor could also play a role in altering the response under alkylation
stress. RNA-sequencing analysis of genes induced in response to MMS revealed that most of these
genes are further induced, by as much as 30-fold, in the absence of Hel2 (Figure 1C). In contrast,
most of the genes that were repressed in the presence of MMS were further repressed in the absence
of the factor (Figure 1D). These observations suggest that Hel2 antagonizes the pathways that are
activated in response to alkylation stress. To gain an unbiased insight into the identity of these
pathways, we performed a gene-ontology (GO) analysis of the top 100 genes that were further
induced in Hel2 cells relative to the wild-type ones. As expected, GO analysis identified aminoacid synthetic pathways as the top ten processes that are modulated by Hel2 (Figure 1E). Since
many of the genes involved in these processes are targets of Gcn4 (the main ISR effector), this
suggests that Hel2 suppresses its activation. Indeed, analysis of the expression levels of the Gcn4
regulon (Rawal et al., 2018) showed that deletion of HEL2 results in significant over-induction of
these targets (Figure 1F). Collectively, our RNA-sequencing analysis suggests that Hel2
suppresses the premature activation of Gcn2 and attenuates it under alkylation stress.

Deletion of Hel2 increases eIF2a phosphorylation by Gcn2
During ISR, yeast eIF2 is phosphorylated by Gcn2, which suppresses global translation
initiation while simultaneously promoting the translation of Gcn4 (Hinnebusch, 2005), which our
RNA-sequencing analysis suggested to be induced. To add further support for these observations,
we investigated the phosphorylation status of eIF2 in response to MMS addition and
presence/absence of Hel2. As expected, the addition of the drug was found to result in the
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Figure 2. Ribosome stalling activates eIF2 phosphorylation in a process that is antagonized
by Hel2.
A) Western-blot analysis of total proteins isolated from wild-type and hel2 cells treated with
0.1% MMS for the indicated times. B) Bar graph of western-blot analysis used to follow phosphoeIF2 a levels in WT and hel2D cells upon MMS treatment for the indicated times. The signal for
phospho-eIF2a was normalized to that of PGK1. p-value for time point 0 is 0.0018 as determined
by a multiple-t test in GraphPad Prism. C) Bar graph of qPCR analysis used to measure the relative
levels of the ARG1 transcript in the indicated cells with no treatment. D) Similar to C, but for cells
treated with MMS for the depicted times. E) Western-blot analysis of proteins isolated from the
indicated cells that were grown in the absence of presence of 0.1% MMS for 30 minutes. In all
cases, plotted is the mean values determined from at least three biological repeats with the error
bars representing the standard deviation around it.
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accumulation of phospho-eIF2 in a time-dependent manner (Figure 2A, 2B), and in agreement
with our model, deletion of HEL2 accelerated its accumulation (Figure 2A, 2B). Notably, in the
absence of Hel2, the levels of phospho-eIF2 increased by more than fivefold in the absence of
MMS (Figure 2B). These observations were confirmed by directly immunoblotting for Gcn4,
which showed the transcription factor to accumulate to much higher levels in the absence of HEL2
(Figure 2A). qPCR analysis of the ARG1 transcript, a Gcn4 target, confirmed that ISR is
prematurely activated in the absence of Hel2. More specifically, we observe an almost twofold
increase in ARG1 transcript levels in the hel2 cells relative to wild-type ones (Figure 2C),
corroborating our RNA-sequencing data (Figure 1A). Additionally, while the addition of MMS
was found to increase the levels of ARG1 transcript by as much as 25-fold, deletion of HEL2
increased its levels more rapidly and almost to a hundredfold after only 15 minutes of incubation
with the drug (Figure 2D). To confirm that the increased phosphorylation of eIF2a observed in the
absence of Hel2 is mediated by Gcn2, we deleted the kinase from wild-type and hel2D cells. As
expected, and since Gcn2 is the only known kinase of eIF2a in yeast, we could not detect any
phospho-eIF2 in hel2D; gcn2D in the absence or presence of MMS (Figure 2E). Altogether, our
western-blot and qPCR analyses confirmed our transcriptomic analysis that Hel2 suppresses the
activation of ISR.

Gcn2 and its coactivators suppress RQC activation
Our analysis so far focused on the suppressive effect of Hel2 on Gcn2 activation and our
findings suggest that two pathways may compete with each other. Consistent with this proposal,
we document overactivation of Gcn2 in the absence of Hel2 (Figures 1 and 2). Logically, this
model would also predict an overactivation of RQC in the absence of Gcn2 and its coactivators.
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As expected, in the absence of Gcn1 and Gcn2 we observe no accumulation of phospho-eIF2
upon addition of MMS. In the absence of Gcn20, phosphorylation of eIF2 was reduced but not
completely inhibited (Figure 3A). This is in agreement with previous reports showing Gcn1 and
Gcn2 are essential for eIF2 phosphorylation, but Gcn20 is not (Hinnebusch, 2005). More
relevant, however and corroborating our prediction, was the observation that MMS-induced
ubiquitination was increased in the absence of Gcn1 and Gcn2, suggesting that the factors compete
with Hel2 for collided ribosomes (Figures 3A and 3B).

An inability to phosphorylate eIF2 results in increased Hel2-mediated
ubiquitination
The finding that deletion of Gcn1 and Gcn2 was accompanied by increased ribosomalprotein ubiquitination (Figure 2B) can be rationalized by at least two non-mutually exclusive
models. In the first one, Gcn1 and/or Gcn2 compete with Hel2 for the same interface on the
collided ribosomes. In the second model, deletion of GCN1 or GCN2 suppresses the effect of
MMS on translation initiation- allowing loading of ribosomes even when many of the mRNAs
are damaged- and hence increases the occurrence of collisions. In this latter model, bypassing the
requirement of Gcn1/Gcn2 deletion to inhibit MMS-induced eIF2 phosphorylation would result
in increased Hel2-mediated ubiquitination. To accomplish this, we generated SUI2- (the gene
encoding eIF2) mutant strains where serine 52 was altered to alanine in wild-type and hel2
backgrounds. As expected, addition of MMS to sui2-S52A cells resulted in no phosphorylation of
eIF2, irrespective of the background (Figure 3C). Most important, however, was the
observation that ubiquitination significantly increased in sui2 cells upon the addition of MMS by
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almost threefold relative to SUI2 cells (Figure 3D). This increase in ubiquitination is Hel2
mediated, as no MMS-induced ubiquitination was observed in hel2 strains (Figure 3C).

Figure 3. RQC and ISR do not appear to directly compete with each other.
A) Western-blot analysis used to follow eIF2 phosphorylation and ubiquitination as a function
of MMS in wild-type, gcn1, gcn2 and gcn20 cells. B) Bar-graph analysis of three independent
immuno blots similar to the one shown in (A), used to follow the relative levels of indicated
ubiquitin bands in the denoted samples. C) Western-blot analysis of total protein isolated from
wild-type, sui2-S52A (eIF2 cannot be phosphorylated), hel2 and sui2-S52A;hel2 cells that
had been grown in the absence or presence of 0.1% MMS for 30 minutes. D) Relative levels of
ubiquitin bands and phospho-eIF2a in the indicated cells, respectively. Analysis was carried out
on three independent immuno blots similar to the one shown in (C). For all bar graphs, plotted is
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the mean values determined from three biological repeats with the error bars representing the
standard deviation around it.
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Since Gcn1 and Gcn2 are present in sui2 cells, the increase in ubiquitination from MMS addition
is likely to be the result of increased initiation on damaged mRNA rather than direct competition
between Gcn1/Gcn2 with Hel2.

Ribosome collisions activate Gcn2
MMS is an alkylating agent known to modify nucleic acids, including RNA (Lawley,
1974). Consequently, this leads to ribosome stalling and eventual collisions, which we previously
showed to activate Hel2 (Yan et al., 2019). Ribosome stalling has been recently found to be
important for activating GCN2 in mammals (Ishimura et al., 2016). If the observed MMS-induced
activation of Gcn2 is the result of ribosome stalling, one would predict that addition of compounds
that promote readthrough to suppress the accumulation of P-eIF2. The aminoglycoside
paromomycin is such a compound and has been documented to lead to readthrough of rare codons
by allowing for the misincorporation of near-cognate aa-tRNAs (Kramer et al., 2010). Addition of
the drug to yeast cells on its own resulted in no observable change to the phosphorylation status of
eIF2. However, its addition to cells in the presence of MMS slightly delayed the accumulation
of P-eIF2 (Supplementary Figure 2). We note that this slight effect of paromomycin is expected,
given that the drug cannot suppress the impact of many of the MMS-induced modified nucleotides
on tRNA selection.
Although our data so far suggest that MMS activates Gcn2 through stalling, whether this
activation is mediated by collisions is currently unknown. To address this, we titrated MMS from
low to very-high concentrations (0-3%) and assessed P-eIF2 accumulation, reasoning that at high
concentrations mRNAs are damaged at multiple positions. As this would stall multiple ribosomes
on a given transcript, the probability of ribosomes colliding into each other is reduced (Figure 4A).
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Strikingly, we observe maximal phosphorylation of eIF2a to occur at intermediate concentration
of 0.33%-1% (Figures 4B and 4C), suggesting that Gcn2 is activated in response to ribosome
collision. As expected, and since Hel2 is known to be activated in response to ribosome collisions,
ubiquitination of uS3 (as assessed by immunoblotting for FLAG-tagged uS3) was also found to
saturate at intermediate concentrations of MMS (0.12%) (Figures 4B and 4C). Similarly, using an
anti-ubiquitin antibody we observe accumulation of smaller ubiquitinated-protein products at these
intermediate concentrations of MMS (Figure 4B). No ubiquitination of these proteins was
observed in hel2 cells (Figure 4D), suggesting that anti-ubiquitin blots can be used to follow Hel2
activity circumventing the need to tag individual ribosomal proteins in all of our cells.
Interestingly, for eIF2 phosphorylation, the levels of phospho-eIF2 saturate at higher
concentrations of MMS compared to that of Hel2-mediated ubiquitination; 0.3% and 0.04%,
respectively (Figures 4B, C, D and E), suggesting that higher frequency of ribosome collisions are
needed to activate Gcn2. In agreement with this idea, in hel2 cells, for which collided ribosomes
cannot be rescued through RQC, the levels of phosphorylated factor saturate at half the
concentration of MMS (0.12%) (Figure 4E). As a result, it is highly likely that Gcn2 is activated
by collided ribosomes and that under low frequency of collisions Hel2 resolves these ribosomes
before they can initiate ISR.

Drugs that stall translation but stabilize A-site tRNA binding do not activate
Gcn2
We previously showed that induction of ribosome collisions through the addition of
cycloheximide at an intermediate concentration, around its Kd for the ribosome, results in Hel2mediated ubiquitination of ribosomal proteins (Simms et al., 2017). Similarly, in mammals, the
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addition of emetine at intermediate concentrations activates ZNF598-mediated ubiquitination
(Juszkiewicz et al., 2018). As a result, we hypothesized that if collisions are also responsible for
Gcn2 activation that cycloheximide addition to intermediate concentrations should result in the
accumulation of phospho-eIF2. We were, therefore, surprised to observe no significant
phosphorylation of eIF2 at any concentrations tested (0.015-100 mg/mL) independent of the
presence of Hel2 (Supplementary Figure 3A). Notably, we observed robust Hel2-dependent
ribosome ubiquitination at intermediate concentrations of the inhibitor (Supplementary Figure
3B). This was in disagreement with our model and suggested that activation of Gcn2 by stalled
ribosomes is distinct from that of Hel2. In support of these ideas, we observe a similar pattern in
the presence of the unrelated translation inhibitor anisomycin. The drug has no observable effect
antibiotics inhibits binding of the A-site tRNA (Brodersen et al., 2000), but most of these do not
work in eukaryotes. Recently, tigecycline has been used effectively in lysates to carry out profiling
of ribosomes with an empty A site (Wu et al., 2019). The compound, however, does not work
efficiently in live yeast cells, presumably due to its permeability. Nevertheless, we can show that
addition of the compound to very high concentrations (2 mg/mL) inhibits cellular growth,
suggesting that we can overcome some of the permeability issues (Supplementary figure 3D). This
in turn allowed us to address whether the compound can activate Gcn2 at intermediate
concentrations. Addition of tigecycline was found to robustly activate phosphorylation of eIF2
at concentrations of 2.5-5 mg/mL, and to lower levels at 10 mg/mL (Figure 4F). Deletion of
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Figure 4. Intermediate concentrations of MMS and tigecycline are required for maximal
activation of Gcn2.
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A) Schematic showing how intermediate, but not high, concentrations of inhibitors lead to
ribosome collision. B) Western-blot analysis used to follow phosphorylation of eIF2 and uS3
ubiquitination as a function of MMS concentration. In all cases cells were treated with the indicated
concentration of MMS for 30 minutes. C) Relative levels of phospho-eIF2a, Ub-uS3 and indicated
Ubiquitin bands in (B) collected from cells treated with the depicted concentration of MMS for 30
minutes. Quantification was conducted by densitometry analysis of at least three independent
immuno-blots similar to the ones shown in (B); band intensities were normalized to Pgk1 signal.
D) Western-blot analysis of total proteins isolated from wild-type and hel2 cells treated with the
indicated MMS concentration for 30 minutes. E) Bar graph showing the relative levels of phosphoeIF2a and Ubiquitin bands in WT and hel2D cells treated with the indicated concentration of MMS
for 30 minutes. Analysis was conducted as per (C). F) and G), similar to D) and E), respectively,
but for cells treated with tigecycline for 30 minutes. H) Western-blot analysis of total proteins
isolated from wild-type and hel2 cells treated with the indicated compounds for the indicated
amount of time. I) Bar graph analysis of three biological repeats of the immuno-blots shown in
(H) used to assess the relative levels of phospo-eIF2a and Ubiquitin bands. J) Fluorescence image
of an ethidium-bromide-stained acid-PAGE gel used to resolve tRNAs isolated from wild-type
and hel2 cells treated with the indicated compounds for 30 minutes. Note a sample, which was
isolated from wild-type cells in the absence of any compounds, was deacylated with mild-base
treatment and resolved on the left most lane. In all cases, plotted is the mean values determined
from at least three biological repeats with the error bars representing the standard deviation around
it.

HEL2 was found to decrease the concentration of drug required for robust activation of Gcn2
(Figure 4F). In particular, we measured a maximal increase of ~sevenfold for Phospho-eIF2a levels
at tigecycline concentration of 5 mg/mL for wild-type cells compared to that of ~tenfold at
tigecycline concentration of 2.5 mg/mL for hel2D ones (Figure 4G). The observation that
tigecycline and MMS robustly induce both RQC and ISR activation, but cycloheximide and
anisomycin only activate RQC, suggests that ISR activation by Gcn2 prefers the stalled ribosomes
to have an empty A site. In agreement with this model, addition of 4-NQO, which oxidizes RNA
and inhibits tRNA selection (Simms et al., 2014; Thomas et al., 2019) activates both processes.
Similarly, the addition of 3-Amino-1,2,4-triazole (3-AT)- which inhibits histidine synthesis,
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resulting in depletion of His-tRNAHis- also activates both processes. We note that the addition of
hydroxyurea (HU), which has been shown to activate ISR through an unknown mechanism
(Hughes et al., 2000), activates Hel2-mediated ubiquitination (Figures 4H and 4I). Collectively,
these observations suggest that activation of ISR and RQC converges on collided ribosomes; with
ISR being sensitive to the status of the A site, whereas RQC is not.
In addition to ribosome-mediated activation of Gcn2, the factor is activated in response to
accumulation of deacylated tRNAs. As a result, it is likely that many of the conditions used in our
previous experiments can result in tRNA deacylation; although, apart from 3-AT, it is unclear how
they would mediate the deacylation process. Regardless, we isolated total RNA from wild-type
and hel2 cells in the absence of any compound and in the presence of MMS, 4-NQO and HU,
and resolved the tRNAs on acid-PAGE gels (Varshney et al., 1991). We deacylated tRNAs through
mild-base treatment to serve as a control. As predicted, none of the conditions resulted in general
changes to the global levels of deacylated tRNAs as assessed by their mobility-shift relative to the
deacylated control (Figure 4J). In contrast, nitrogen starvation, which activated ISR
(Supplementary Figure 3E) resulted in a slight increase of deacylated-tRNA levels (Supplementary
3F). While our data are consistent with a model whereby alkylation and oxidation stresses activate
Gcn2 through ribosome stalling, given that the concentration of total tRNAs is estimated to be >
1000 fold in excess of that of Gcn2, we cannot rule out a role for tRNA deacylation in the process.

Stalling by a catalytically inactive release factor activates RQC but not ISR
Our analysis with translation inhibitors, and alkylation and oxidation agents suggests that
Gcn2 activation is sensitive to the status of the A site of the ribosome. To add further support for
this model that the A site needs to be empty for Gcn2 activation, we sought to employ a distinct
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strategy that does not rely on addition of compounds. More specifically, we took advantage of a
dominant-negative variant of release factor eRF1, for which the universal GGQ motif in the active
site that is required to engage the peptidyl-transferase center of the ribosome (Brown et al., 2015;
Frolova et al., 1999) is mutated to GAQ. We and others have shown that this mutation has no effect
on binding, but almost completely inhibits peptide release (Petropoulos et al., 2014; Shaw and
Green, 2007). As a result, expression of this mutant factor will cause ribosome stalling and
collisions at stop codons with the lead ribosome having its A site occupied with the release factor
(Figure 5A). The wild-type eRF1 and GAQ mutant were introduced on a plasmid into wild-type
cells under galactose induction. As expected, only the GAQ mutant promoted ubiquitination
(Figure 5B), in agreement with the idea that it induces ribosome collisions. We note that,
ubiquitination was observed in the absence of galactose most likely due to leaky induction as these
cells were cultured in Raffinose (absence of glucose). Indeed, even in the absence of galactose, the
growth rate of these cells was slower than that of ones transformed with wild-type eRF1.
Furthermore, induction of the GAQ variant was much less than that of the GGQ wild-type factor
(Figure 5B) due to its toxic effect. More important than its effect on ubiquitination was the
observation that induction of the GAQ mutant resulted in little to no change in the levels of
phsopho-eIF2 (Figure 5B), especially when compared to that observed in the presence of MMS
(Supplementary Figure 4). These observations suggest that ribosome collisions induced by an
eRF1-bound-lead ribosome do not trigger ISR. To directly confirm that expression of GAQ leads
to ribosome collisions, we conducted sucrose-gradient fractionation of polysomes isolated from
cells expressing eRF1GGQ and eRF1GAQ. Polysome profiles of the GAQ cells indicated that they
accumulated significant amount of higher-order-polysome structures(Figure 5C, top). These
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structures were found to be resistant to RNase I treatment (Figure 5C, bottom). Under normal
conditions, during which ribosomes are sparsely distributed across mRNAs, addition of RNase I
collapses polysomes into monosomes. Under conditions where ribosomes collide, RNase I is
incapable of accessing mRNA between them and polysomes collapse to higher order structures
such as disomes instead (Guydosh and Green, 2014). These observations suggest that eRF1GAQ
induces significant ribosome collisions, but yet fails to activate Gcn2.
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Figure 5. Collided ribosomes with an eRF1-bound-lead ribosome do not activate ISR but
activate RQC.
A) Schematic showing how a catalytically dead mutant (GAQ) of eRF1 can be used to cause
ribosome collisions at stop codons with the factor bound to the A site of the lead ribosome. B)
Western-blot analysis of total proteins isolated from cells expressing wild type or catalytically
dead mutant of eRF1 in the absence and presence of induction by galactose. C) Polysome profiles
of lysates isolated from cells expressing the indicated-release-factor variants. Top shows profiles
of untreated lysates; bottom shows those of RNase I-treated lysates.

Inhibition of collided-ribosomes clearance activates Gcn2 and ribosomalprotein ubiquitination
During RQC, following Hel2-mediated ubiquitination of ribosomal proteins, stalled
ribosomes are rescued through the action of Slh1 (Ikeuchi et al., 2019). Hence, in the absence of
this factor, collided ribosomes are likely to linger a while longer. Consequently, in our model of
ribosome collisions being responsible for Gcn2 activation, one would predict that deletion of
SLH1 would result in greater phosphorylation of eIF2. Furthermore, one should also observe
greater MMS-induced ubiquitination. In complete agreement with this prediction, in the absence
of Slh1, we observe significant accumulation of phospho-eIF2 in the absence of any stressors
(Figure 6A). More specifically, we measured a ~fourfold increase in the levels of P-eIF2
phospho-eIF2 levels in slh1 cells relative to wild-type ones (Figure 6B). In agreement with
these observations, qPCR analysis revealed that MMS induction of the Gcn4 target ARG1 is
twofold higher in the slh1 strain relative to the wild-type one; upon the addition of MMS,
ARG1 expression is increased by less than tenfold in the wild-type strain, whereas in slh1 its
induction is increased by > twentyfold (Figure 6C). In addition to its impact on Gcn2 activation,
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Figure 6. Ribosome collisions activate Gcn2.
A) Western-blot analysis of total proteins isolated from the depicted cells treated with 0.1% MMS
for the indicated times (oe indicates overexpression). B) Bar-graph analysis of three independent
immuno blots similar to the one shown in (A), used to follow the relative levels of phospho-eIF2a
and ubiquitin bands in the indicated samples. C) qPCR analysis of the AGR1 transcript in wildtype and slh1 cells after a 10-minute incubation period with 0.1% MMS. D) Ribosome profiles
of lysates isolated from the indicated strains that were incubated in the absence or presence of
0.1% MMS for 30 minutes. The lysates were either mock treated or RNase I treated, as shown,
before resolving them over a 10-50% sucrose gradient. The disome peak that appears to be resistant
to RNase I is labeled as such. For all bar graphs, plotted is the mean values determined from three
biological repeats with the error bars representing the standard deviation around it.
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deletion of SLH1, resulted in a significant increase in MMS-induced protein ubiquitination
(Figures 6A and B). These findings greatly suggest that in the absence of Slh1, collided ribosomes
are not cleared efficiently and as a result activate both Gcn2 and Hel2.

Alkylation stress causes ribosome collisions.
The observation that MMS and 4-NQO activate RQC, suggests that these compounds lead
to ribosome collisions, but we could not demonstrate that this actually occurs in vivo (Yan et al.,
2019). Our observation that these compounds also induce ISR (Figure 4) gave us a rationale as to
why collisions were not detected under these conditions. In particular, since these compounds
cause eIF2 phosphorylation, their addition also results in global inhibition of translation and, as
a result, loading and eventual collision of ribosomes on mRNAs is severely limited. These ideas
were confirmed by utilizing a GCN2-deletion strain. We used an RNase-protection assay of
mRNAs in polysomes and in complete agreement with our model, upon addition of MMS, only in
the gcn2 strain were we able to observe significant accumulation of disomes (Figure 6D). These
findings suggest that indeed alkylation stress results in ribosome collisions.

Gcn1 associates with collided ribosomes
Previous studies have shown that Gcn1, Gcn2 and Gcn20 co-sediment with polysomes
during sucrose-gradient fractionation (Marton et al., 1997; Sattlegger, 2000; Sattlegger and
Hinnebusch, 2005). This together with the observation that Gcn1 and Gcn20 have a domain
homologous to elongation factor 3 (Visweswaraiah et al., 2012), suggest that the factors directly
bind to ribosomes. But whether the factors recognize specific conformations of the ribosomes that
accumulate under stress is currently unknown. The observation that conditions that increase levels
of collided ribosomes activate Gcn2 suggests that at least one of the factors interact with collided
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ribosomes. To test this prediction, we set out to conduct sucrose-gradient fractionation of RNAse
I-treated lysates and investigate the association of Gcn1 with different ribosome fractions as
function of MMS addition. We note that addition of cycloheximide, which is used routinely during
profiling, results in significant levels of collided ribosomes even in the absence of any stressors
(Supplementary Figure 5). As a result, we opted not to use any antibiotics in our profiling analysis.
The absence of inhibitor explains why we observe significantly lower levels of polysomes due to
increased ribosome runoff during our lysate preparation. This, however, should not affect our
analysis of stalled ribosomes especially in the absence of Hel2, during which collided ribosomes
cannot be rapidly resolved.
As expected, the addition of MMS to wild-type cells resulted in an almost complete loss
of polysomes resulting from phospho-eIF2-induced inhibition of translation (Supplementary
Figure 6). In contrast, the profile of the sui2-mutant cells exhibited polysomes in the presence of
MMS (Supplementary Figure 6), due to the inability of these cells to inhibit initiation in the
presence of alkylation stress. Interestingly, further deletion of HEL2 from these cells resulted in
increased levels of polysomes in the presence of MMS; this is in agreement with the fact that these
cells are incapable of resolving collided ribosomes. As a result, we used these cells to assess the
association between Gcn1 and ribosomes (Figure 7A). Similar to what others have reported
(Marton et al., 1997; Sattlegger, 2000; Sattlegger and Hinnebusch, 2005), Gcn1 was observed to
only marginally associate with polysomes. Remarkably, in the presence of MMS, Gcn1 was found
to associate with the heavy fraction of the polysomes, suggesting that it prefers
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Figure 7. Gcn1 associates with collided ribosomes.
A) Ribosome profiles of lysates isolated from sui2-S52A;hel2 cells incubated in the absence and
presence of 0.1% MMS for 30 minutes. Shown is the absorbance at 254 nm of lysates fractionated
over a 10-35% sucrose gradient. Below the profiles is western-blot analysis of fractions collected
from sucrose-gradient fractions for the indicated proteins. B) Similar to A), but lysates were treated
with RNase I prior to fractionation over a 10-35% sucrose gradient. C) and D) Densitometry
analysis of immuno blots similar to the ones shown in (A) and (B), respectively, which was used
to analyze the relative distribution of the indicated proteins across sucrose gradients. Analysis was
conducted on three biological repeats, with the mean values plotted and the error bars representing
the standard deviation around them.
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stalled ribosomes (Figure 7A). We then conducted polysome profiling on RNase I-treated lysates,
which collapsed most of the polysomes into a monosome. Even under these conditions, Gcn1 was
observed to remain associated with the heavy fractions, suggesting that factor associates with
collided ribosomes (Figure 7B). Quantification of the signal corresponding to Gcn1 to assess its
distribution across the sucrose gradient confirmed that the protein indeed migrates with the heavy
polysome fractions (Figure 7C). This is in contrast to proteins that are known not to stably associate
with ribosomes such as PGK1 and eRF1 (Figure 7C and Supplementary Figure 7). Notably, similar
analysis of RNaseI-treated lysates revealed that in the presence of MMS, the factor remains
associated with the resulting collided ribosomes (Figure 7D). In particular, in the absence of MMS,
~7% of the protein was found to remain associated with the collided ribosomes (fractions 5-7)
relative to 20% that was observed to associate with polysomes when lysates were not treated with
RNase I (Figures 7C and 7D). In contrast, for MMS-treated cells the relative association of the
factor with polysomes only slightly decreased from 30% to 27% as a result of RNase I treatment.
The observation that under conditions that activate Gcn2, more of its coactivator associates with
collided ribosomes is in agreement with our model that collisions are the primary signal for ISR.
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DISCUSSION
During protein synthesis, the ribosome receives multiple cues to ensure that the correct
protein is made at the right place, right time and at the right concentration. These cues are the result
of signals triggered by varying cellular needs and environmental conditions such as proliferation
and stress. The integrated-stress response (ISR), which responds to stresses through the activation
of initiation factor eIF2 kinases, is one such important pathway in eukaryotes. Phosphorylation
of eIF2 represses global translation, but also derepresses translation of key pro-survival mRNAs.
In yeast, ISR is activated by the eIF2 kinase Gcn2 in response to amino-acid deprivation. The
most widely accepted model evokes an active role for deacylated tRNA in the process (Dong et
al., 2000). In this model, under amino-acid-deprivation conditions, deacylated tRNAs accumulate
and are recognized by Gcn2 and its coactivators Gcn1 and Gcn20. Interestingly, Gcn1 and Gcn20
have been shown to bind the ribosome, and they are thought to deliver the deacylated tRNA from
the A site of the ribosome to Gcn2, activating its kinase activity (Sattlegger, 2000). In addition to
amino-acid deprivation, recent data has shown Gcn2 to respond to other stressors that do not
change the levels of deacylated tRNAs, suggesting an alternative mechanism for its activation
(Harding et al., 2019; Inglis et al., 2019; Ishimura et al., 2016). In this alternative model, the
ribosome itself, and in particular ribosome stalling, plays a more critical role in activating Gcn2.
In agreement with this model, here we showed that alkylation and oxidation agents that modify
mRNAs and stall the ribosome robustly activate Gcn2 as assessed by accumulation of phosphoeIF2 (Figures 1, 2, 3 and 4). Interestingly, ribosome stalling also activates the mRNAsurveillance pathway of no-go decay (NGD) and ribosome-quality control (RQC) of nascent
peptides. Both of these processes depend critically on an E3 ligase Hel2. Notably, the very same
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alkylating and oxidizing agents that activate Gcn2 also activate Hel2 (Yan et al., 2019), suggesting
that ISR and RQC must be coordinated somehow. Indeed, here we provide compelling evidence
that suggests that the two processes antagonize each other (Figures 1, 2, 3, 4 and 6).
In addition to this apparent competition between the two processes, ISR and RQC appear
to be exquisitely sensitive to the concentration of stressor. Optimum activation was observed to
take place at intermediate concentrations of damaging agents (Figure 4B), with RQC activation
occurring at lower concentrations. It thus appears that Hel2 is more sensitive to changes to the
translation apparatus and responds faster than Gcn2. The sensitivity of Hel2 to the concentration
of translation inhibitors has been noted by several groups (Ikeuchi et al., 2019; Juszkiewicz et al.,
2018; Simms et al., 2017), and has been used to formulate a model for its activation through
ribosome collisions (Simms et al., 2017). Structural studies provided a molecular rational for this
activation, for which collided ribosomes form an interface that can be recognized by the ligase
(Ikeuchi et al., 2019; Juszkiewicz et al., 2018). Interestingly, however, promoting ribosome
collisions through the addition of translation inhibitors at intermediate concentrations, known to
activate RQC, was found not to activate ISR (Supplementary Figure 3A-C). A simple model that
could explain these observations is that Gcn2 is not activated by ribosome collisions, and instead
the factor responds to ribosome stalling through a different mechanism, although this model cannot
explain why stalling by translation inhibitors is incapable of triggering ISR. In an alternative
model, Gcn2 is sensitive to the status of the stalled ribosome during collisions. Given that chemical
agents and translation inhibitors stall the ribosome through different mechanisms, this model could
explain the observed disparities between the effect of the two classes of molecules on ISR
activation. Specifically, the ISR activators MMS, 4-NQO and 3-AT leave the A site of the
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ribosome empty; whereas inhibitors such as cycloheximide and anisomycin keep the A site
occupied by a tRNA, albeit in different conformations (Wu et al., 2019). As a result, we
hypothesized that Gcn2 prefers the A site to be empty for its activation. To test this hypothesis, we
looked for inhibitors that prevent aminoacyl-tRNA from binding the A site. For instance, the
tetracycline class of antibiotics is known to accomplish this in bacteria (Brodersen et al., 2000),
but most have no effect on translation in eukaryotes. Fortuitously, the antibiotic tigecycline was
recently shown to be effective in preventing A-site occupancy in yeast lysate (Wu et al., 2019),
suggesting that the drug could be used to inhibit aa-tRNA from binding the A site in vivo. Indeed,
the addition of drugs to very high concentrations (> 2 mg/mL) was found to inhibit yeast growth
(Supplementary Figure 3D). Most important and in contrast to cycloheximide and anisomycin,
tigecycline was found to activate Gcn2 (Figure 4F). Furthermore, robust activation was observed
at intermediate concentrations of drug, around those that inhibit growth modestly. Therefore,
similar to Hel2, Gcn2 appears to be activated by ribosome collisions, but its activation is sensitive
to the status of the A site of the ribosome. In agreement with this model, overexpression of a
catalytically dead mutant of eRF1, which causes ribosome collisions on stop codon with the A site
of the lead ribosomes occupied by the factor, does not trigger ISR (Figure 5).
To add further support for this model of collision-mediated activation of Gcn2, we sought
to confirm that stressors that activate the factor also lead to the formation of collided ribosomes.
To this end, we used an RNase I-protection assay, for which collided ribosomes are not accessible
to the enzyme and remain intact in their higher-order form. As expected, addition of MMS to yeast
cells that cannot phosphorylate eIF2 (gcn2 and sui2-S52A) results in the formation of stable
higher order collided polysomes, as assessed by sucrose-gradient fractionation of RNase I-treated
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yeast lysate (Figures 6 and 7, and Supplementary Figure 6). More notable was the observation that
Gcn1 (a Gcn2 coactivator and is required for ISR) remains associated with the polysomes even
after the RNase I treatment (Figure 7). Moreover, addition of MMS was observed to result in
further association between the factor and polysomes, suggesting that Gcn1 is likely to prefer
collided ribosomes over spread-out polysomes.
Our data suggest that both Hel2 and Gcn2 are activated by the very same signal of ribosome
collisions. We find that inhibition of RQC, through deletion of HEL2, results in the overactivation
of ISR, and vice versa (Figures 1, 2, 3 and 6). There are at least three models that can explain this
connection between the two processes. In the first one, Gcn2 coactivators compete with Hel2 for
the same interface on the ribosome. In the second one, ubiquitination of ribosomal proteins by
Hel2 inhibits the activation of Gcn2. In the third and simplest model, inhibition of ISR or RQC
pathways results in increased ribosome collisions, through de-repression of translation initiation
or inhibition of collided-ribosome clearance, respectively. This increased frequency of collision
would then lead to over-activation of whichever of the two pathways that remains intact. We favor
this last model, since inhibition of eIF2 phosphorylation by using the S52A mutant of the factor
was found to result in a significant increase in Hel2-mediated ubiquitination in the presence of
MMS (Figure 3). The observation that Gcn2 prefers a different conformation of collided ribosomes
is in agreement with this model. Nevertheless, we cannot rule out that multiple models may
contribute to this apparent competition between the two pathways.
During revision of this study, Wu et al. (Wu et al., 2020) reported that collided ribosomes
activate the stress-activated protein kinase (SAPK) pathway through the MAPKKK ZAKa in
mammals. In particular, the authors found the factor to preferentially associate with collided
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ribosomes and that this association was responsible for its activation of the SAPK (p38/JNK) and
GCN2, but whether the factor displays a preference of the status of the A site of the stalled
ribosome was not immediately clear. Notably, Wu and colleagues used the translation inhibitors
anisomycin and emetine at intermediate concentrations to promote ribosome collisions and showed
that both of these inhibitors activate Gcn2. As emetine is known not to be able to inhibit protein
synthesis in yeast, at least in vivo (Battaner and Vazquez, 1971), we could only test anisomycin.
Interestingly and in contrast to what was observed in mammalian cells, we could not detect
significant accumulation of phospho-eIF2a in the presence of anisomycin (Supplementary Figure
3). This distinction between mammals and yeast might be explained by differences in the mode of
Gcn2 activation. For instance, it is unclear whether yeast has a ZAK homologue that acts upstream
of Gcn1, Gcn2 and Gcn20 during ISR activation. Alternatively, and given how conserved ISR
activation is, it is likely that this observed difference is the result of disparate mode of interactions
between the drug and the ribosome. Anisomycin inhibits peptidyl-transfer, and as a result the Asite tRNA adopts a so-called A/T state (Valle et al., 2002). This tRNA has been shown to be
unstable in this state and readily dissociates from the ribosome (Dorner et al., 2006), which may
give ZAKa or GCN1 enough time to bind collided ribosomes.
The model of ribosome-collision-mediated ISR activation is appealing because it easily
rationalizes how Gcn2 and its coactivators (Gcn1 and Gcn20) are activated by ribosomes only
under stress. Under normal conditions, ribosome collisions occur infrequently as a result of
aberrant mRNAs, and it makes sense that Hel2 is activated to trigger NGD and RQC. Under stress
conditions, ribosome collisions occur frequently, Hel2 is likely to get overwhelmed and Gcn2 gets
activated. The finding that Hel2-mediated ubiquitination is more sensitive to drug concentration is
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consistent with these ideas (Figure 2). Multiple factors could contribute to the ability of Hel2 to
recognize collided ribosomes and activate RQC before the activation of Gcn2. For instance, the
factor’s relatively higher affinity, concentration or faster kinetics to those of Gcn2 and its
coactivators could ensure RQC is activated prior to ISR activation. Future experiments aimed at
dissecting the thermodynamic and kinetics contributions for both processes are likely to shed
important insights into how RQC and ISR are coordinated.
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METHODS
Strain Construction

Yeast strains used in this study are listed below. Yeast cells were grown at 30°C in YPD
media. Deletion, mutant and chromosomally tagged yeast strains were constructed in the BY4741
background (MATa; his3Δ1; leu2Δ0; met15Δ0; ura3Δ0) using common PCR-knockout
techniques. Oligonucleotide sequences are listed in Supplementary Table 2.

Media Preparation

All solid and liquid media have been prepared according to standard lab protocols. Unless
otherwise stated, MMS, 4-NQO, cycloheximide, HU and 3-AT were added to final concentrations
of 0.1%, 5 μg/mL, 100 μg/mL, 100 mM and 100 mM respectively. Cells were incubated with drugs
for 30 min, unless stated otherwise.
RNA seq
The RNA-seq data sets were prepared from total RNA isolated using the hot-phenol
extraction method (Simms et al., 2017) from mid-log phase yeast cells in the absence and presence
of 0.1% MMS incubated for 90-min at 30°C. For each condition, 30

g of total RNA from three

biological replicates were processed and mRNA libraries were generated and processed by the
Genome Technology Access Center in the Department of Genetics at Washington University
School of Medicine. Briefly, polyA enriched libraries were prepared from total RNA using OligodT beads. Samples were prepared according to library kit manufacturer’s protocol, indexed,
pooled, and sequenced on an Illumina NovaSeq. Basecalls and demultiplexing were performed
222

with Illumina’s RTA version 1.9 and bcl2fastq2 software with a maximum of one mismatch in the
indexing read. It was then sequenced with 2 X 150-bp paired-end reads. RNA-seq reads were then
aligned to the Ensembl release 76 (GCA_000146045.2) primary assembly with STAR version
2.5.1a (Dobin et al., 2013). Gene counts were derived from the number of uniquely aligned
unambiguous reads by Subread:featureCount version 1.4.6-p5 (Liao et al., 2014). Isoform
expression of known Ensembl transcripts were estimated with Salmon version 0.8.23. Sequencing
performance was assessed for the total number of aligned reads, total number of uniquely aligned
reads, and features detected. The ribosomal fraction, known junction saturation, and read
distribution over known gene models were quantified with RSeQC version 2.6.2 (Wang et al.,
2012). Genes with more than 20 reads were normalized over all read counts across all samples.
Differentially expressed genes were identified by Perseus 1.6.12 (Tyanova et al., 2016) using
pairwise comparisons between genotypes/conditions. Significant changes in transcript abundance
were calculated by ANOVA contrasts (p ≤ 0.05), excluding transcripts with an FDR > 0.05 to
account for multiple comparisons.
Polysome profiling with RNase I

Yeast cultures from mid-log phase yeast cells were harvested by centrifuging at room
temperature. Cells were then resuspended in polysome-lysis buffer (20 mM Tris pH 7.5, 140 mM
KCl, 1.5 mM MgCl2, 0.5 mM DTT, 200 μg/mL heparin, 1% Triton), washed once and lysed with
glass beads using a FastPrep-24 (MP Biomedical). Supernatants from cleared lysates
corresponding to 500 ug of total RNA were treated with 100 U of RNase I (Thermo Fisher,
cat#AM2294) at 30 C for 30 minutes. The treated lysates were then layered over a 10–50%
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sucrose gradient and centrifuged at 35,000 rpm for 160 min in an SW41Ti (Beckman) swingingbucket rotor. Gradients were then fractionated using a Brandel tube-piercing system combined
with continuous absorbance reading at 254 nm. Proteins were isolated through a TCA precipitation
method and resuspended in HU buffer (8 M Urea, 5% SDS, 200 mM Tris pH 6.8, 100 mM DTT,
1 mM ethylenediaminetetraacetic acid (EDTA), bromophenol blue).

Overexpression of eRF1 and its GAQ mutant

Sequences encoding wild-type and GAQ eRF1 were PCR amplified and cloned into pYES2
plasmid (ThermoFisher) by Gibson assembly (NEB). Plasmids were transformed into yeast using
the lithium acetate method (Gietz and Woods, 2002). Individual colonies were inoculated into Ura complete synthetic media with raffinose as the sole carbon source. Overnight cultures were
diluted to an Abs600nm of 0.05 and grown to an Abs of 0.4 before cells were divided into two
cultures and galactose was added to a final concentration of 2% to only one of the cultures. Cells
were grown for an additional 3 hours before collecting them for western-blot and ribosome-profile
analyses.

Quantitative RT-PCR

Total RNA from yeast cells was isolated following the hot phenol method (Köhrer and
Domdey, 1991) . cDNA was generated with M-MuLV reverse transcriptase (NEB, cat#M0253L)
from 1-10 μg of total RNA that was treated with DNase I (Thermo Scientific, cat# EN0601) using
a random hexamer (Thermo Scientific, cat# SO142) for priming. Quantitative RT-PCR was
conducted using iTaq Universal SYBR Green Supermix (BIO-RAD, cat#1725121) with ~ 50 ng
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of cDNA. The relative fold change was obtained by following the Ct method. The relative
transcript abundance for each gene from three biological repeats was determined by normalizing
to the expression level of the TAF10 gene.

Western blotting

Total lysates from mid-log-phase cells were harvested and lysed in 1 mL of ice-cold lysis
buffer (300 mM NaOH, 1%

-mercaptoethanol). Proteins were precipitated through the addition

of TCA to 7.5% and resuspended in HU buffer (8 M Urea, 5% SDS, 200 mM Tris pH 6.8, 100
mM DTT, 1 mM ethylenediaminetetraacetic acid (EDTA), bromophenol blue) using a volume that
was normalized to the amount of cells harvested. Proteins were separated by SDS–PAGE and
analyzed by immunoblotting. The following antibodies were used: rabbit anti phospho- eIF2
(Ser51) (Cell Signaling Technology, cat# 9721S), rabbit anti-Gcn4 (from Thomas Dever lab,
1:2000 v/v dilution), rabbit anti Gcn1 (from Alan Hinnebusch lab, 1:2000 v/v dilution), mouse
anti-ubiquitin HRP (Santa Cruz, Cat#: sc8017; 1:2,000 v/v dilution), mouse anti-FLAG (Sigma;
Cat#: F1804; 1:5,000 v/v dilution), rabbit anti-uS4 (Rps9) (Abcam, Cat#:ab117861; 1:5,000 v/v
dilution), and rabbit anti-eRF1(Eyler et al., 2013) (1:2000 dilution). Secondary antibodies of goat
anti mouse IgG HRP (Thermo Scientific, Cat#: 31430) and goat anti rabbit IgG HRP (Thermo
Scientific, Cat#: 31460) were used at (1:10,000 v/v dilution). Densitometry analysis was conducted
using Image Lab (Bio-Rad Laboratories). Unless otherwise stated, relative signal of the protein of
interest was obtained by normalizing to that of PGK1.

QUANTIFICATION AND STATISTICAL ANALYSIS
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Statistical and graphs analysis for RT-PCR (from 3 biological repeats) and western blot
(from 3 biological repeats) results were processed by GraphPad Prism 8.4.3 (Graphpad Software,
La Jolla, CA). For RNA seq analysis, differentially expressed genes from 3 biological repeats were
identified by Perseus 1.6.12 (Tyanova et al., 2016) using pairwise comparisons between
genotypes/conditions. Significant changes in transcript abundance were calculated by ANOVA
contrasts (p ≤ 0.05), excluding transcripts with an FDR > 0.05 to account for multiple comparisons.
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CHAPTER 6: Conclusions and Future
Directions
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ABSTRACT
The overarching goal of my thesis research was to understand how elongating ribosomes
signal to and impact conserved stress-related pathways in eukaryotes. Through several in vitro
studies, we first identified a molecular rationale for how quality-control factors can identify stalled
ribosomes while demonstrating that ribosome collisions are required to trigger NGD and RQC.
Using genetic and biochemical methods, we revealed that ribosome collision is the signaling
platform for both ISR and ribosome-quality control (RQC), a pathway that mitigates translational
stresses caused by ribosome stalling. Interestingly, inactivation of one pathway was found to result
in the over-activation of the other, with RQC activation occurring at a lower frequency of
collisions. In contrast, the activation of ISR required a high frequency of collisions and was
sensitive to the status of the A site of the ribosome. As our work has shown, ribosome collisions
caused by chemically damaged mRNA occur frequently; pathways such as ISR, which are also
activated by ribosome collisions but drastically alter cellular function, need to be managed with
additional controls. Hence, this ability to adjust cellular response based on the severity of the stress
is crucial for the survival of the cell. Altogether, my research has revealed an additional layer of
regulation during the coordination of multiple signaling events that likely extends to other
biological systems.
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SUMMARY: Chemical damages to mRNA trigger ribosome-based quality
control in the cell.
Ribosomes often face defective adducts that disrupt their movement along the mRNA
template (Brandman and Hegde, 2016)(Simms et al., 2017). These adducts are primarily caused
by chemical damage to mRNA and are highly detrimental to the decoding process on the ribosome.
Hence, unless dealt with, chemical damage to RNA has been hypothesized to lead to the production
of toxic protein products. In the effort to establish the impact of RQC in eliminating damaged
mRNA molecules, we investigated the abundance of harmful modifications caused by endogenous
cellular processes. To achieve this, we conducted quantitative analysis of ribonucleoside
modifications in both total RNA as well as mRNA by liquid chromatography-mass spectrometry
(LC-MS) on wildtype (WT) and Xrn1 deletion mutant. Our data show that in mRNA, the ratio of
8-oxoG to G increased by more than twofold in the absence of XRN1, one of the core component
of NGD (Simms et al., 2017). Moreover, deletion of XRN1 was found to result in the significant
increase of alkylative adducts, known to disrupt Watson-Crick base pairing, within mRNA, and to
result in a more modest increase of ones that do not modify Watson-Crick base pairing. We then
utilized damaging agents such as 4-Nitroquinoline 1-oxide (4-NQO) and methyl methanesulfonate
(MMS) that were known to be able to modify nucleic acids (Simms and Zaher, 2016) to determine
the effect of these damaging agents on RNA molecules in vivo through LC-MS. Our findings
suggest that the addition of 4-NQQ and MMS leads to widespread accumulation of damaged
nucleotides in the mRNA, which in turn should lead to pervasive stalling of ribosomes. To
understand the impact of nucleic-acid-damaging agents on translation in vivo, we evaluated the
level of ubiquitination on nascent peptides with or without treatment. Our result indicates that the
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addition of both alkylative and oxidative damaging agents results in significantly more protein
aggregates (foci) in the absence of a functional RQC pathway (ltn1) and further support our
hypothesis and show that both alkylative and oxidative damaging agents induced translational
stresses that require RQC pathway to resolve them. Finally, To interrogate the dynamics of protein
ubiquitination on the ribosome in response to the presence of a damaging agent, we utilized a
quantitative proteomic approach coupled with diglycine (diGly)-modified peptides immunoaffinity enrichment to identify site-specific alterations to ubiquitin-modified peptides on purified
ribosomes (Kim et al., 2011). Mass spec (MS) analysis revealed that the abundance of diGlymodified peptides from ribosomal proteins on both large (60s) and small (40s) subunits were
altered upon 4-NQO treatment. The data also indicates that the K63 ubiquitin on ribosomal
proteins increased strongly (>10 fold) to 4-NQO treatment, whereas K48 ubiquitin had a moderate
increase (1-3 fold) to the treatment. We further comforted that the ubiquitination events that
occurre on ribosomal proteins during stalling are all induced upon 4NQO treatment. Altogether,
our data demonstrate the detrimental effect of chemically damaged mRNA on cellular homeostasis
and uncover mechanisms that organisms evolved to counter their accumulation.
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SUMMARY: Ribosome quality control antagonizes the activation of the
integrated stress response on colliding ribosomes.
Cells evolved multiple cellular pathways to regulate translation in response to fluctuations
in nutrient availability, endogenous and exogenous stresses (Pakos‐Zebrucka et al., 2016). At the
global level, pathways such as the integrated Stress Response (ISR) provide eukaryotic cells the
capacity to adjust translation and transcriptional output and maintain homeostasis in changing
environments (Hinnebusch, 2005; Pakos‐Zebrucka et al., 2016). Historically, it has been proposed
that GCN2 is activated in response to the accumulation of deacylated tRNA (Dong et al., 2000;
Lageix et al., 2015; Qiu, 2002; Qiu et al., 2001; Ramirez et al., 1992). Yet, recent studies on ISR
suggested an alternative model for activation that points to ribosome stalling, and the P stalk of
the ribosome instead of deacylated tRNAs as the signal that activates Gcn2 (Harding et al., 2019;
Inglis et al., 2019; Ishimura et al., 2016). Here we carried out RNA-sequencing analysis of wildtype and hel2 yeast cells in the absence and presence of MMS. Our analysis showed the deletion
of HEL2 to result in significant over-induction of Gcn4 targets, which suggests that Hel2 is used
to suppress premature activation of Gcn2 in the absence of stress conditions. To add further support
for our RNA-sequencing analysis, we investigated the phosphorylation status of eIF2a in response
to MMS addition and presence/absence of Hel2. In agreement with our model, deletion of HEL2
accelerated the accumulation of phospho-eIF2. We then titrated MMS from low and very-high
concentrations and assessed P-eIF2 accumulation, reasoning that at high concentrations mRNAs
are damaged at multiple positions. The data demonstrates that the activation of both Hel2 and Gcn2
is initiated by agents that cause ribosome stalling, while the maximal activation of Hel2 was
observed at a lower frequency of stalling. By testing multiple classes of chemical compounds that
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have been documented to induce collision, our data indicate that the processes do not appear to be
in direct competition with each other. Specifically, our data suggest that activation of ISR and
RQC converges on collided ribosomes; with ISR being sensitive to the status of the A site, whereas
RQC is not. To further understand the relationship between ISR and RQC, we generated phosphordead mutation of SUI2 (gene encoding eIF2) where serine 52 was altered to alanine. Significant
increase in Hel2-mediated ubiquitination in the presence of MMS was observed in the S52A
mutant while its eIF2 phosphorylation was found to be abolished. Since Gcn1 and Gcn2 are
present in sui2 cells, the increase in ubiquitination from MMS addition is likely to be the result of
increased initiation on damaged mRNA rather than direct competition between Gcn1/Gcn2 with
Hel2. Collectively, our findings provide important details about how multiple pathways that
recognize stalled ribosomes coordinate to mount the appropriate response.
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FUTURE DIRECTION: Ribosome collision as a platform for coordinating
stress responses
One interesting observation made during my thesis work is that ribosomal protein
ubiquitylation appears faster than H2A.X phosphorylation, a DNA damage response hallmark
(Löbrich et al., 2010). This data suggests the possibility that RNA damage occurs on a much faster
time scale than DNA damage. This difference might be due to the fact that the chemical structure
of RNA, and specifically mRNA, is relatively protein-free and single-stranded, thus exposing the
nitrogen and oxygen atoms of the Watson-Crick face of the nucleobase to potential chemical attack
(Simms and Zaher, 2016). It is also likely that stalling of translation appears sooner than changes
to DNA metabolism, such as changes to replication, which suggests a potential avenue for how
cells respond to chemical insults.
This hypothesis is reinforced by the observation that Hel2-dependent-K63-linked
ubiquitylation is highly enriched upon DNA damage agent treatment (Yan et al., 2019).
Furthermore, recent publications report that Hel2-mediated k63-linked polyubiquitination on
ribosomal proteins is required for multiple pathways that utilize ribosomes as a signaling platform,
including NGD and 18S non-functional rRNA decay (Matsuo et al., 2017b),(Ikeuchi et al., 2019a;
Sugiyama et al., 2019a). More importantly, K63-linked polyubiquitin chains play an essential role
in signal amplification processes for various cellular stress responses, including DNA repair and
nuclear factor κB (NF-κB) activation (Oh et al., 2018). Their role in signaling has recently
expanded to translation, as it was reported that K63-linked ubiquitylation of ribosomal proteins
activates multiple downstream quality control pathways, and the modification by Hel2 provides a
platform for the interaction of ribosomes with other E3s or regulatory components (Ikeuchi et al.,
2019b; Matsuo et al., 2017b; Sugiyama et al., 2019a).
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Finally, we recently reported that RQC and ISR are activated by similar signals and
antagonize each other’s activity (Yan and Zaher, 2021). Indeed, many of the stressors that activate
ISR also modify nucleic acids and often disrupt their functional properties. These changes to the
chemical structure of the nucleobase can alter the metabolic processes while compromising
replication, transcription and translation (Yan and Zaher, 2019a). To address this challenge,
multiple signaling processes that include DNA damage response (DDR) and ribosome-quality
control (RQC)(Yan and Zaher, 2019b) have evolved to maintain genome integrity and cellular
proteostasis, respectively. How these activities of ISR, DDR and RQC are coordinated under stress
conditions is currently unclear. Altogether, we hypothesize that ribosome ubiquitination, resulting
from damaged mRNAs, could be read for downstream expression of stress genes.
To address this hypothesis, and as a proof of concept, I first analyzed the RNAseq data
generated from WT and Hel2 deletion mutants that are treated with MMS. Our preliminary data
show that the expression level of DDR gene (RNR3) increases 100 fold in the presence of MMS,
which is validated by qRT-PCR analysis (Figure 1). To further reinforce our hypothesis that the
DDR response is directly dependent on translation, we pretreated cells with cycloheximide.
Inhibiting transition before the addition of a DNA damaging agent almost completely inhibited the
induction of DDR gene (RNR3). Similar suppression of RNR genes after MMS treatment was
observed in cells that lack Hel2, which is a mutation leading to the absence of ribosomal protein
ubiquitination.
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Figure 1. RNR3 activation in response to alkylation is reduced in the absence of Hel2 and
Not4.
A,B) Bar graph showing the relative transcript levels of RNR3 as assessed by qRT-PCR. Means
and SD of three biological repeats are plotted.

This is interesting because genes encoding the ribonucleotide reductase complex, responsible for
generating dNTPs, are an integral part of this pathway, as many DNA-repair pathways are
replication-based and require dNTPs (Chabes et al., 2003). For instance, a DNA damaging agent
such as MMS strongly induces the transcription of RNR3 (Zhou and Elledge, 1992), and as such
the abundance of RNR3 has served as an important diagnostic in dissecting how DDR is activated.
More importantly, there is a potential overlap between RQC and DDR, since a high-throughput
study indicated that Hel2 is a substrate of one of the main effectors of DDR, Rad53 (Swaney et
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al., 2013), while the induction of the RNR genes also requires the presence of Not4, an E3 ligase
that has roles in RQC, transcription, mRNA decay (Mulder et al., 2005). All these observations
point to a role for Hel2 in DDR, but whether its relationship with the ribosome is related to DDR
is unknown.
In the effort to explore the mechanism by which Hel2 is contributing to DDR activation
and RQC activation, studies such as epistatic analysis that explore how deletion of HEL2 affects
RNR3 induction in the presence of DDR-signaling mutants would provide clues as to whether Hel2
contributes to DDR. We can use the alpha factor of yeast in combination with MMS to uncover 1)
whether the connection between Hel2 and DDR is cell cycle related, and 2) the specific DDR
pathway that is activated by Hel2. The result would be further validated by evaluating the
accumulation of phosphorylated factors, such as Rad53, using western blotting in the presence and
absence of Hel2. Furthermore, the phosphorylation status of Hel2 can be quantified by using
western blotting technique such as Phos-tag acrylamide (Fujifilm) in the presence and absence of
DDR kinases such as Rad53 and Dun1. Finally, the phosphorylation sites of Hel2 can be mapped
by LC-MS/MS, and phospho-dead mutations of Hel2 will be studied for their function in DDR
and RQC signaling. Together, these experiments will provide information on whether Hel2 is an
integral part of DDR signaling or serves as an alternative signaling pathway.
We should next assess the localization of Hel2 during stress response. Hel2 is known to
recognize and ubiquitinate collided ribosomes in the cytosol,(Ikeuchi et al., 2019a; Juszkiewicz et
al., 2018) yet if Hel2 is a substrate of Rad53 during stress response, and since the Rad53 is a known
nuclear protein (Smolka et al., 2006), then the localization of Hel2 upon the addition of MMS
would provide information about the mechanism of Hel2 adopted to coordinate RQC and DDR.
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To achieve this goal, we will monitor the dynamic of the localization of Hel2 through 1)
immunoblotting with subcellular fractionation (Oh et al., 2020) of a strain of Hel2 tagged with
Flag epitope tag; 2) with fluorescence microscopy with GFP-tagged Hel2 in the presence or
absence of stressors such as MMS. If Hel2 localizes to nucleus upon stress, we will assess whether
this nuclear localization is important for its function in DDR and/or RQC. The result will be further
validated by tagging the endogenous HEL2 gene with a nuclear-export signal (NES) from protein
kinase A inhibitor (PKI) (Fornerod et al., 1997). We should evaluate the impact of localization of
Hel2 on both RNR3 induction and ubiquitination of ribosomal proteins upon the addition of MMS.
The results of these experiments will provide clues as to whether the nuclear localization of Hel2
contributes to its function in DDR and RQC.
If nuclear localization of Hel2 is important, we should determine how it might be regulating
the recruitment of RNA polymerase II (pol II) to DDR gene loci such as RNRs. Since Hel2 was
initially identified as a histone E3 ligase that removes excessive histone during stress condition
(Singh et al., 2012), it is possible that Hel2 is recruited to the promoter regions of DDR genes upon

stress and making the DNA accessible for transcription machinery. Interestingly, by reanalyzing
previously published immunoprecipitation mass spectrometry data of Hel2 without any treatment
(Sitron et al., 2017), I identified that all core components of polymerase-associated factor 1 (Paf1)
complex (Paf1C) potentially interact with Hel2, with Ctr9 being the one with the highest hits. It
has been suggested that Paf1C plays a vital role in transcriptional elongation and chromatin
modifications (Jaehning, 2010; Tomson and Arndt, 2013; Xie et al., 2018). In summary, PAF1C
is recruited to pol II through CTR9 (Kim et al., 2010). Aside from its interactions with the
polymerase, Paf1C works with elongation factors in yeast to regulate transcription elongation
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procession (Kim et al., 2010; Krogan et al., 2002; Squazzo et al., 2002; Xie et al., 2018). As a
result, the interaction between Hel2 and Paf1C might be one of the mechanisms through which
Hel2 is recruited to the promoter regions of DDR genes. To test this hypothesis, we should first
validate the interaction between Hel2 and Ctr9 through immunoblotting. We should then perform
chromatin immunoprecipitation analysis using a tagged Hel2 (C-terminal). After validating the
function of the tagged Hel2 for RQC activation and MMS-induced RNR3 induction, we will
examine the recruitment of Hel2 to the RNR loci upon the MMS treatment with or without Ctr9
using a ChIP-grade myc antibody. ChIP analysis on RNAP II will be conducted to monitor its
recruitment to the same loci in the presence and absence of Hel2 and/or Ctr9. The role of Paf1C in
regulating the function of Hel2 will be further investigated by monitoring 1) the localization of
Hel2 in the absence and presence of Ctr9, 2) the amount of excessive H3 in the presence and
absence of Ctr9 and/or Hel2, and 3) the MMS-induced expression of RNR3 in the presence and
absence of Ctr9 and/or Hel2. Since phosphorylation status regulates protein interactions, it would
be informative to investigate the interaction between Ctr9 and phosphor-dead mutant of Hel2
through immunoblotting. And finally, in the effort to map the interactome of Hel2 and its partners
during DNA damage response, we should preform immunoprecipitation mass spectrometry of
tagged Hel2 (flag) with or without NES in the presence or absence of MMS. These results would
provide evidence to support the function of Hel2 in facilitating Pol II and the transcription
machinery during stress condition.
The next question to address is which domains of Hel2 are important for its role in DDR
signaling. Hel2 has an N-terminal RING domain (important for target ubiquitination), three C2H2-
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Figure 2. RNR3 activation in response to alkylation in K to R mutation in eS7, uS3 and
uS10.
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RNR3 is significantly reduced in ubiquitin K to R mutation in eS7 (A) but not in uS3 and uS10
ubiquitin K to R mutation (B,C). Bar graph showing the relative transcript levels of RNR3 as
assessed by qRT-PCR. Means and SD of three biological repeats are plotted.

type zinc-finger domains and a proline-rich domain at its C-terminus (Winz et al., 2019). In terms
of the function of domains related to ribosome quality control, deletion of the RING domain or
mutations of conserved cysteines in its ZnF completely abrogates NGD and RQC, whereas a
protein lacking the C-terminal domain only fails to activate RQC, and instead activates a different
branch of NGD (Ikeuchi et al., 2019c). The function of the domains can be investigated by
complementing the deletion strain with truncation/single-point mutants of the protein. Moreover,
studying the impact of these mutations on 1) the localization of Hel2, 2) the interaction with Paf1C
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components, and 3) the autophosphorylation with Rad53 will give us important clues about how
signaling to DDR might be propagated from a stalled ribosome.
Having characterized the involvement of Hel2 during DDR, we should investigate the role
of ribosomal-protein ubiquitination in activating the factor responsible for relaying signals to the
nucleus. Since Hel2 modifies many ribosomal proteins upon stalling, instead of mutating Hel2, we
should focus on identifying the ribosomal protein/s responsible for initiating the signal. Moreover,
many Hel2 targets appear to serve independent roles in downstream signaling pathways. For
instance, uS10 ubiquitination is required for RQC (Ikeuchi et al., 2019c), whereas that of uS3 is
important for nonfunctional ribosome decay (NRD) (Sugiyama et al., 2019b). Hence, the
regulation of DDR might be achieved through the ubiquitination of one of the ribosomal proteins.
What makes this appealing is the fact that many of the agents that cause DNA damage also modify
RNA and lead to ribosome stalling. As a result, it makes sense for crosstalk to occur between the
two processes.
Based on our previous work using mass-spec analysis that identified lysine residues on
ribosomal proteins that are targeted by Hel2 (Yan et al., 2019), we generated lysine to arginine
mutations that compromise the major ubiquitination events involving ribosomal proteins such as
eS7, uS3 and uS10. We then measured their effect on MMS activation of RNR3. Our preliminary
data shows that the mutations on eS7 reduces the induction of RNR3 significantly upon MMS
treatment (Figure 2). This result indicates that the ubiquitination events on different ribosomal
proteins upon ribosome stalling impact DDR differently. Since eS7 is first modified by another E3
ligase (Not4) before Hel2 adds K63-linked chains, it is possible that Not4 also plays a role in
converting the signal on ribosomes to transcription machinery. This hypothesis is further supported
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by the observation that NOT4 deletion reduces MMS induced RNR3 expression to about 10 times
lower than that of HEL2 mutants. The role of Not4 in connecting RQC to DDR remains unclear,
but genetic and biochemistry data indicates that its role extends from RQC to mRNA decay and
transcription regulation (Mulder et al., 2005).
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CONCLUSIONS OF THE THESIS
The overarching goal of my thesis research was to understand how elongating ribosomes
signal to and impact conserved stress-related pathways in eukaryotes. For my research, we first
identified a molecular rationale for how quality-control factors can identify stalled ribosomes
while demonstrating that ribosome collisions are required to trigger NGD and RQC. To investigate
the role of the ribosome as a platform for downstream signaling events, we revealed that both ISR
and ribosome-quality control (RQC) mitigate translational stresses caused by ribosome stalling.
Moreover, we provided evidence that the inactivation of one pathway was found to result in the
over-activation of the other, with RQC activation occurring at a lower frequency of collisions. In
contrast, the activation of ISR required a high frequency of collisions and was sensitive to the
status of the A site of the ribosome.
As our work has shown that ribosome collisions caused by chemically damaged mRNA
occur frequently, it is possible that pathways such as ISR, which are also activated by ribosome
collisions but drastically alter cellular function, need to be managed with additional controls. As
the field progresses, this data will be integral to our understanding of how cells adjust cellular
response based on the severity of the stress for survival. This data also revealed an additional layer
of regulation during the coordination of multiple signaling events that likely extends to other
biological systems.
One exciting discovery during my thesis work is that modifications on the ribosome as a
result of stresses such as the addition of damaging agents happens much faster than DNA damage
responses. Our preliminary data indicates that there is likely to be cross-talk between RQC and
DDR, likely through ribosome ubiquitination by Hel2 and Not4. Furthermore, the E3 ligase Hel2
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might have a role in removing histone for transcription machinery to access DDR genes. Future
discoveries are needed to fully appreciate and understand the complexity and beauty of
collaborations between ribosome and chromosome regulation.
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